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Abstract 
 
The ability of the catalytic, asymmetric acyl halide-aldehyde cyclocondensation (AAC) reaction 
to produce stereoenriched β-lactone products has found extensive utility in natural product 
synthesis.  The asymmetric Al(III)-catalyzed AAC-SN2’ ring opening sequence was exploited in 
synthetic efforts towards the enantioselective total synthesis of the aspidospermane alkaloid (−)-
rhazinilam (1).  The synthetic sequence features an enantioselective cyclization of a tethered 
pyrrole moiety onto an optically-active allene to set the quaternary carbon stereocenter while 
concomitantly forming rhazinilam’s tetrahydroindolizine core.  In addition, attempts at forming 
the requisite biaryl bond via a Pd-catalyzed cross-coupling reaction are also discussed. 
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Recently, it was found that the Cinchona alkaloids quinine and quinidine can catalyze the AAC 
reaction to produce disubstituted β-lactones in high yield and in essentially enantiomerically and 
diastereomerically pure form.  Reaction conditions were developed which allowed for the 
 iv 
effective formation of masked polypropionate units by employing the Cinchona alkaloid-
catalyzed AAC reaction.  Based on the pseudoenantiomer of the Cinchona alkaloid used, 
different stereoarrays of polypropionate units are obtained.  A variety of optically active 
aldehydes are viable in this transformation as reaction conditions can be optimized for a specific 
substrate.  A matched/mismatched phenomenon was observed where the matched case produced 
the desired polypropionate unit in good yield and high diastereoselectivity and the mismatched 
case afforded an unexpected β-lactone product in diminished yield and diastereoselectivity. 
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(+)-Discodermolide (81) is a marine, microtubule-stabilizing polyketide that can only be isolated 
in scarce amounts from nature.  Due to our inability to harvest it in supple amounts, the total 
synthesis of (+)-discodermolide has been the focus of many research groups.  Application of the 
cinchona alkaloid-catalyzed AAC reaction towards the catalytic, asymmetric total synthesis of an 
analogue of (+)-discodermolide (100) is discussed.   
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1.0  EFFORTS TOWARDS THE TOTAL SYNTHESIS OF (-)-RHAZINILAM 
1.1 ISOLATION AND BIOACTIVITY 
(−)-Rhazinilam (1) is a naturally occurring antimitotic agent isolated from the plants Melodinus 
australis (1965)1, Rhazya stricta (1970)2 and most recently Kopsia singapurensis (1987)3 
(Figure 1).  Single crystal X-ray diffraction studies (1972) unambiguously elucidated the 
tetracyclic skeleton of rhazinilam, which is a relative of the Aspidosperma class of alkaloids.4  
Rhazinilam was found to possess a 5,6,7,8-tetrahydroindolizine subunit, a phenyl-pyrrole biaryl 
bond with a dihedral angle of 95° and a nine-membered lactam.  It is believed that rhazinilam is 
an artifact of the isolation process, potentially arising from oxidation of (+)-1,2-
dehydroaspidospermidine (2).5,6  Strong evidence for this comes from the observation that 
precursor 2, upon prolonged exposure to air does, in fact, form rhazinilam.7
 
 
                                                 
1 Banerji, A.; Majumder, P. L.; Chatterjee, A. G. Phytochemistry 1970, 9, 1491-1493. 
2 Linde, H. H. A.  Helv. Chim. Acta. 1965, 48, 1822-1842. 
3 Thoison, O.; Guénard, D.; Sévenet, T.; Kan-Fan, C.; Quirion, J.-C.; Husson, H.-P.; Deverre, J.-R.; Chan, K. C.; 
Potier, P. C. R. Acad. Sci. Paris II 1987, 304, 157-160. 
4 Abraham, D. J.; Rosenstein, R. D. Tetrahedron Lett. 1972, 13, 909-912. 
5 De Silva, K. T.; Ratcliffe, A. H.; Smith, G. F.; Smith, G. N. Tetrahedron Lett. 1972, 13, 913-916. 
6 Lévy, J.; Soufyane, M.; Mirand, C.; de Maindreville, M. D.; Royer, D. Tetrahedron: Asymm. 1997, 8, 4127-4133. 
7 Goh, S. H.; Ali, A. R. M.; Wong, W. H. Tetrahedron 1989, 45, 7899-7920. 
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Figure 1: (-)-Rhazinilam (1) and (+)-1,2-dehydroaspidospermidine (2) 
 
Rhazinilam has attracted attention as a potential cancer chemotherapeutic agent due to its 
ability to disrupt mitosis.  Biological studies have shown that rhazinilam mimics the effects of 
both vinblastine and Taxol™ on microtubule dynamics.8  In vitro, rhazinilam expresses the 
vinblastine-type effect of inducing non-reversible assembly of tubulin into spiral polymer and the 
Taxol™-type effect of inhibiting cold-induced disassembly of microtubules.  In addition, 
rhazinilam possesses the ability to induce the formation of asters in mitotic cells and microtubule 
bundles in interphase cells.  Rhazinilam displays cytotoxic activity against the KB cell line, as 
well as inhibition of microtubule disassembly in low micromolar concentrations (IC50 = 2 μM 
and IC50 = 3 μM, respectively).9   
Due to its interesting pharmacological profile, structurally less complex congeners of 
rhazinilam have been synthesized and subjected to structure-activity relationship studies in order 
to determine the relevant biologically active areas.9, a-e10   The studies suggest that the presence of 
the phenyl-pyrrole subunit and the lactam functionality are imperative for antitubulin activity.  In 
                                                 
8 (a) David, B.; Sévenet, T.; Morgat, M.; Guénard, D.; Moisand, A.; Tollon, Y.; Thoison, O.; Wright, M. Cell Motil. 
Cytoskeleton 1994, 28, 317-326. (b) Banwell, M.; Edwards, A.; Smith, J.; Hamel, E.; Verdier-Pinard, P. J. Chem. 
Soc., Perkin Trans. 1, 2000, 1497-1499. 
9 Dupont, C.; Guénard, D.; Tchertanov, L.; Thoret, S.; Guéritte, F. Biorg. Med. Chem. 1999, 7, 2961-2969. 
10 (a) David, B.; Sévenet, T.; Thoison, O.; Awang, K.; Païs, M.; Wright, M.; Guénard, D. Biorg. Med. Chem. Lett. 
1997, 7, 2155-2158. (b) Pascal, C.; Dubois, J.; Guénard, D.; Tchertanov, L.; Thoret, S.; Guéritte, F. Tetrahedron 
1998, 54, 14737-14756. (c) Dupont, C.; Guénard, D.; Thal, C.; Thoret, S.; Guéritte, F. Tetrahedron Lett. 2000, 41, 
5853-5856. (d) Alazard, J.-P.; Millet-Paillusson, C.; Boyé, O.; Guénard, D.; Chiaroni, A.; Riche, C.; Thal, C. Biorg. 
Med. Chem. Lett. 1991, 1, 725-728. (e) Pascal, C.; Dubois, J.; Guénard, D.; Guéritte, F. J. Org. Chem. 1998, 63, 
6414-6420.   
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addition, studies point to restricted rotation around the biaryl bond and/or the ethyl group as 
having a pivotal role in bioactivity as well.  Overall, none of the synthetic analogues performed 
as well as (−)-rhazinilam (1).   
1.2 PAST SYNTHESES 
To date, four racemic syntheses and one asymmetric synthesis of rhazinilam have been reported.  
The first of these was a racemic synthesis by Smith in 1973 (Figure 2).11  The key transformation 
in Smith’s synthesis involved formation of the tetrahydroindolizine skeleton, which commenced 
with N-alkylation of pyrrole 3 with tosylate 4 to yield pyrrole 5.  Treatment of pyrrole 5 with 
AlCl3 facilitated an intramolecular cyclization of the heterocycle onto the γ-lactone to afford 
tetrahydroindolizine 6.  Subsequent formation of tetracycle 7 was achieved by reduction of the 
aryl nitro group followed by macrolactamization.     
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11 Ratcliffe, A. H.; Smith, G. F.; Smith, G. N. Tetrahedron Lett. 1973, 14, 5179-5184.   
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Figure 2: Key steps in Smith’s synthesis of rhazinilam 
 
It was not until almost 30 years after Smith’s total synthesis of rhazinilam when Sames reported 
a second racemic synthesis.12  The key steps involved formation of tetrahydroindolizine 9 via 
Grigg cyclization of prepared iminium salt 8 and utilization of a stoichiometric amount of  
platinum complex to dehydrogenate one of the gem-diethyl groups on tricycle 10, via C-H 
activation, to afford alkene 11 (Figure 3).  This methodology was later employed again by Sames 
in the only asymmetric synthesis of rhazinilam to date.13  With the aid of a chiral auxiliary, the 
platinum complex was able to selectively distinguish between the two gem-diethyl groups to set 
the proper ethyl-bearing stereocenter needed for the asymmetric synthesis of (−)-rhazinilam.  
While highly innovative, the stereodefining transformation not only was plagued with an inverse 
relationship between the diastereoselectivity and isolated yield obtained, but also required the 
use of a stoichiometric amount of the platinum complex. 
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12 Johnson, J. A.; Sames, D. J. Am. Chem. Soc. 2000, 122, 6321-6322. 
13 Johnson, J. A.; Li, N.; Sames, D. J. Am. Chem. Soc. 2002, 124, 6900-6903. 
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Figure 3: Key steps in Sames’ syntheses of rhazinilam 
 
In the time between the racemic and asymmetric syntheses reported by Sames, Magnus 
completed a total synthesis of racemic rhazinilam which yielded the natural product in nine steps 
in 8% overall yield (Figure 4).14  In a similar fashion to Sames’ sequence, the key transformation 
was formation of tetrahydroindolizine 13 via alkylation then Grigg cyclization of thiophenyl 
imine 12.  The natural product was completed by first reducing the aryl nitro group present in 
carboxylic acid 14 followed by macrolactamization.       
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14 Magnus, P.; Rainey, T. Tetrahedron 2001, 57, 8647-8651. 
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Figure 4: Key steps in Magnus’ synthesis of rhazinilam 
 
In 2005, after the Nelson group’s initial attempt at an asymmetric total synthesis of (−)-
rhazinilam, a concise racemic synthesis of rhazinilam was published by Trauner and 
coworkers.15  The key transformation in Trauner’s synthesis forms the nine-membered lactam 15 
via an intramolecular Pd(0)-catalyzed cross-coupling reaction using an unfunctionalized pyrrole 
as a coupling partner (Figure 5).  This transformation unquestionably demonstrates the electron-
rich nature and nucleophilicity of the pyrrole moiety existent in the tetrahydroindolizine core.   
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Figure 5: Key step in Trauner’s synthesis of rhazinilam 
                                                 
15 Bowie, A. L.; Hughes, C. C.; Trauner, D. Org. Lett. 2005, 7(23), 5207-5209. 
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1.3 RETROSYNTHETIC ANALYSIS AND AAC TECHNOLOGY 
 
The key step in our synthetic approach to an enantioselective synthesis of (−)-rhazinilam is based 
upon concomitant formation of the quaternary carbon stereocenter and tetrahydroindolizine core 
via cyclization of a pyrrole moiety onto an optically active allene.  The strategy envisioned 
entails formation of the stereogenic center and tetrahydroindolizine core first with latter 
installation of the biaryl bond and lactam (Figure 6).  The retrosynthetic analysis of the natural 
product opens the nine-membered lactam by cleaving across two bonds to yield two separate 
fragments.  The first disconnection comes from cleavage of the amide bond, which can be made 
by an intramolecular macrolactamization reaction.  The second disconnection occurs across the 
biaryl bond, which can be derived from a Suzuki-type cross-coupling between boronic acid 16 
and triflate 17.  The tetrahydroindolizine intermediate 17 will come from a Lewis acid-catalyzed 
cyclization of the pyrrole moiety onto an optically-active allene.  Utilizing both the catalytic 
asymmetric acyl halide-aldehyde cyclocondensation (AAC) reaction and the SN2' ring opening 
developed in the Nelson group, the chiral allenic precursor can be made from nucleophilic attack 
of a pyrrole-containing organocuprate onto propargylic β-lactone 18.  
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Figure 6: The Nelson Group’s retrosynthetic analysis of (-)-rhazinilam 
 
In 1999, the original asymmetric aluminum(III)-catalyzed AAC reaction was developed by the 
Nelson group as an alternative method for the production of aldol adducts (Eq. 1).16a-c In this 
transformation, ketene is generated in situ by reaction of an acyl bromide with Hünig’s base.  
Then, under catalysis of the symmetric Al(III) triamine catalyst A, the generated ketene 
undergoes a [2+2] cycloaddition with an aldehyde to yield enantiomerically enriched β-lactones.  
In 2004 a second evolution of the catalyst was developed, the unsymmetric Al(III) triamine B, 
which allows for the incorporation of substituted ketenes in the [2+2] cycloaddition reaction.  
Some attractive attributes of these AAC reactions are the ability to employ a wide variety of 
aldehydes in this transformation and the fact that the Al(III)-catalyzed AAC reaction can be 
scaled up without any deleterious effects. 
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16  (a) Nelson, S. G.; Peelen, T. J.; Wan, Z. J. Am. Chem. Soc. 1999, 121, 9742-9743. (b) Nelson S. G.; Kim, B.-K.; 
Peelen, T. J. J. Am. Chem. Soc. 2000, 122, 9318-9319. (c) Nelson S. G.; Zhu, C.; Shen, X. J. Am. Chem. Soc. 2004, 
126, 14-15. (d) Nelson, S. G.; Cheung, W. S.; Kassick, A. J.; Hilfiker, M. A. J. Am. Chem. Soc. 2002, 124, 13654-
13655. 
 
 8 
Al
Me
N
NTfTfN
Ph
iPr iPr
(S,S)-Al-catalyst A
Al
Me
N
NN
CF3
iPr
(S,S)-Al-catalyst B
iPr
ArO2S SO2CF3
 
 
The unique electrophilicity possessed by these enantiomerically enriched β-lactones allows for 
reactivity diversification based on the type of nucleophile employed (Eq. 2).  Hard nucleophiles 
add directly to the lactone carbonyl, furnishing addition-elimination products while soft 
nucleophiles attack in a SN2 fashion, yielding β-substituted carboxylic acids.  These different 
optically active ring-opened products are suited for further facile structural manipulation in many 
different directions.  For this reason, β-lactones are useful intermediates and building blocks in 
organic synthesis.16d   
 
O
O
R1
Hard Nucleophile
Soft Nucleophile Nuc R1
O OH
HO R1
O Nuc
Add. - Elim.
SN2 (2)
 
 
In addition to the normal modes of reactivity expressed by optically active β-lactones, 
propargylic β-lactones are also subject to SN2' ring opening by organocuprate reagents.  The 
products from these reactions are axially chiral allenes, which are useful intermediates in organic 
synthesis (Figure 7).  By employing this AAC-SN2' ring opening sequence, a concise asymmetric 
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total synthesis of the naturally occurring antibiotic (−)-malyngolide (19) was achieved.17  It was 
believed that (−)-rhazinilam could also be synthesized utilizing the AAC-SN2' ring opening 
sequence, where the chirality of the molecule is set during subsequent cyclization upon the 
optically active β-allenic acid.  
 
O
O
R1
·
CO2H
R1
R2R2-MgBr
10 mol% CuCN
23 mol% LiBr OO
Me
nC9H19
OH
19  
Figure 7: The AAC-SN2' ring opening sequence and (-)-malyngolide (19) 
1.4 RESULTS AND DISCUSSION 
1.4.1 Background 
In order to proceed with the synthesis of (−)-rhazinilam (1) as envisioned, the first major 
synthetic target would be an appropriate Grignard precursor to open the ring of the 
enantioenriched β-lactone 18.  First, the synthon had to be a pyrrole substituted at nitrogen with a 
3-halo propyl chain.  This would allow for the formation of the tetrahydroindolizine skeleton 
upon intramolecular cyclization of the pyrrole moiety onto the tethered allene (Figure 8).  
Secondly, the pyrrole would have to be functionalized in the 3-position so to allow for future 
installation of the biaryl bond via a Pd0-catalyzed cross-coupling reaction.  Lastly, it was 
imperative that the functionality at the 3-position of the pyrrole be compatible with the ensuing 
                                                 
17 Wan, Z.; Nelson, S. G. J. Am. Chem. Soc. 2000, 122, 10470-10471. 
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Lewis-acid catalyzed cyclization.  Possibilities of poisoning the Lewis acid catalyst, as well as 
deactivation of the pyrrole moiety either electronically or sterically, were issues to be addressed.  
 
O
O
Et
N
Z
+
X
·
CO2H
Et
N
Z
N
Et
CO2H
Z
Lewis acid catalyst
Z = weak EWG; EDG
X = I, Br,Cl
Lewis acid catalyst
Z = strong EWG (C=O, -OTf),
      strong Lewis base or
      sterically encumbered
      group
1
3 4
5
1
1
2
23 3
4
4
5 5
X
no desired product
18
CuCN,
  LiBr,−78 °C2'
3'
4'
2'
3'
4'
2'
3'
4'
2
 
Figure 8: Restrictions for Grignard precursor 
 
Based on these considerations, it was decided that a pyrrole with either an alkyl or silyl ether 
substituent at the 3-position would be a good candidate for the Grignard precursor (Figure 9).  In 
addition to being amenable to subsequent elaboration into a viable Pd0 cross-coupling partner 
(triflate) for the biaryl bond formation, it was speculated that having a 3-alkoxy substituted 
pyrrole would also aid the desired regioselectivity in the ensuing cyclization.  Though they are 
inductively electron-withdrawing groups (EWG), alkyl ethers are resonance electron donating 
groups (EDG).  As a result of this resonance donation, the C-2 carbon of the pyrrole moiety will 
be more electron rich, and hence favored to cyclize rather than the less activated C-5 position. 
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Figure 9: 3-Alkoxy/silyloxy substituted pyrroles as Grignard precursors 
 
1.4.2 Synthesis of 1-silyloxy-5,6,7,8-tetrahydroindolizine 28 
The initial approach to (−)-rhazinilam was made using 3-silyloxy pyrrole 20 as the requisite 
precursor for eventual formation of the tetrahydroindolizine skeleton (Figure 10).  
Retrosynthetically, pyrrole 20 could be derived from 3-hydroxy-2-carboxylate pyrrole 21 via a 
deprotection/protection process.  Utilizing extensive research done by Wasserman and 
coworkers, pyrrole 21 could be derived from vicinal tricarbonyl species 22.18  Trione 22 can be 
synthesized from the commercially available phosphorous ylide 23.      
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NOH
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OTIPS
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Figure 10: Synthetic analysis of 3-silyloxy pyrrole 20 
 
Starting from phosphorus ylide 23, addition of a solution of 3-chloropropionyl chloride in 
benzene produced the addition-elimination adduct 24 in 94% yield (crude) (Scheme 1).19  
Oxidative cleavage of phosphoranylidine 24 was achieved by stirring with Oxone™,18i affording 
chloro-tricarbonyl 22 in 82% yield (crude).18d  Reaction of primary chloride 22 with saturated 
aqueous NaHCO3 afforded a 98% yield (crude) of the elimination product, ene-trione 25.        
 
Scheme 1 
Ph3P CO2tBu
-+
Cl Cl
O
Oxone,
THF:H2O (2:1)
Cl OtBu
O
O·H2O
O
C6H6, 4 oC
Cl OtBu
O
PPh3
O
23
24
94% yield (crude)
22
82% yield (crude)  
 
                                                                                                                                                             
18 (a) Wasserman, H. H.; Han, W. T.  Tetrahedron Lett. 1984, 25, 3743-3746. (b) Wasserman, H. H.; Cook, J. D.; 
Fukuyama, J. M.; Rotello, V. M. Tetrahedron Lett. 1989, 30, 1721-1724. (c) Wasserman, H.H.; Lombardo, L. J. 
Tetrahedron Lett. 1989, 30, 1725-1728. (d) Wasserman, H. H.; Fukuyama, J.; Murugesan, N.; van Duzer, J.; 
Lombardo, L.; Rotello, V.; McCarthy, K. J. Am. Chem. Soc. 1989, 111, 371-372. (e) Wasserman, H. H.; Rotello, V. 
M. J. Org. Chem. 1989, 54, 2785-2786. (f) Wasserman, H. H.; Cook, J. D.; Vu, C. B. Tetrahedron Lett. 1990, 31, 
4945-4948. (g) Wasserman, H. H.; Kuo, G.-H. Tetrahedron 1992, 48, 7071-7082. (h) Wasserman, H. H.; Vu, C. B.; 
Cook, J. D. Tetrahedron 1992, 48, 2101-2112. (i) Wasserman, H. H.; Ennis, D. S.; Blum, C. A.; Rotello, V. M. 
Tetrahedron Lett. 1992, 33, 6003-6006. (j) Wasserman, H. H.; Blum, C. A. Tetrahedron Lett. 1994, 35, 9787-9790. 
(k) Wasserman, H. H.; Baldino, C. M.; Coats, S. J. J. Org. Chem. 1995, 60, 8231-8235. 
19 This ylide is commercially available but can also be made easily on large scale (25g-30g, 97% yield); Cooke, Jr., 
M. P.; Burman, D. L. J. Org. Chem. 1982, 47, 4955-4963. 
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THF,
Sat. aq. NaHCO3
OtBu
O
O·H2O
O
25
98% yield (crude)  
 
Due to a unique reactivity pattern, vicinal tricarbonyls are synthetic platforms for the production 
of a variety of heterocycles.18b,f-h,j  Reacting the very electrophilic tricarbonyl 25 with 3-
bromopropylamine in the presence of  iPr2NEt, followed by silica gel-induced dehydration and 
aromatization gave 3-hydroxy-2-carboxylate pyrrole 21 in 55% yield (Scheme 2).18b  Treatment 
of pyrrole 21 with trifluoroacetic acid (TFA) initiated a tandem tbutyl-ester 
deprotection/decarboxylation sequence, producing the very light- and air-sensitive pyrrolone 
26.20  Immediate silylation of the pyrrolone with TIPSOTf provided 3-silyloxy pyrrole 20 in 
67% yield over the two steps. 
 
Scheme 2 
N
OH
CO2tBu
TFA, CH2Cl2
iPr2NEt, CH2Cl2, 
TIPSOTf, 0 °C to rt
N
OTIPS
Br
Br
H2N Br·HBr
OtBu
O
O·H2O
O
1) iPr2NEt, CH2Cl2
2) SiO2 N
Br
O
25
21
55% yield
26
20
67% yield
(from 21)  
 
                                                 
20 1H NMR data for crude pyrrolone 26 can be found in the experimental section. 
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Preparation of β-lactone 18,21 required for coupling with the Grignard reagent derived from 3-
silyloxy pyrrole 20, was undertaken using the AAC methodology developed in the Nelson 
group.16  Reacting acetyl bromide and pent-2-ynal in the presence of a catalytic amount of (S,S)-
aluminum triamine catalyst A produced β-lactone 18 in 85% yield and 87% ee (Scheme 3).  The 
Grignard reagent from pyrrole 20, needed to open β-lactone 18, was formed by adding a solution 
of bromide 20 in THF to Mg0 activated by 1,2-dibromoethane.  Slow addition of the generated 
Grignard reagent to a solution of CuCN, LiBr and β-lactone 18 in THF at −78 °C provided the 
desired SN2' adduct, β-allenic acid 27, in 50% yield.17  Unfortunately, despite multiple attempts, 
the yield of this transformation could not be improved.22   
 
Scheme 3 
O
H TfN
N
NTf
Ph
iPriPr
+
iPr2NEt, -78 °CEt
O
O
Et A
5 mol % A, CH2Cl2,
N
OTIPS
Br
1) Mg0, THF
2) CuCN, LiBr, 
17, THF, -78 °C
·
CO2H
Et
N
TIPSO
Br Me
O
Al
Me
20 27
50% yield
18
85% yield,
87% ee
 
 
                                                 
21 Wan, Z. Ph. D. Thesis, University of Pittsburgh  2001, 121. 
22 The Grignard reagent produced for bromide 20 seemed to be short-lived.  Even immediate use of the prepared 
Grignard reagent after all starting bromide was consumed (as monitored by TLC) gave only 50% of allenic acid 27.  
Considerable amounts of protonated Grignard reagent, as well as some Wurtz-coupled product, were always 
observed.   
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Despite the low yield, this sequence provided the compound required to test the intramolecular 
cyclization of the pyrrole moiety onto the optically active allene.  Subjecting allene 27 to a 
substoichiometric amount of Cl2Pd(MeCN)2 (20 mol%) afforded the desired cyclized product, 
tetrahydroindolizine 28, in 50% yield (Figure 11).23  Equally important, almost complete transfer 
of chirality from the enantioenriched β-lactone to the bicycle was observed. Stereoselectivity for 
this transformation arises from facial selectivity of the ensuing cyclization due to complexation 
of the Pd2+ metal center to the carboxylate and proximal olefin.  This coordination directs the 
pyrrole to approach from the β-face (as drawn in Figure 11) in order to satisfy the 
stereoelectronic requirement of antiperiplanar addition to the activated alkene.  
 
·
CO2H
Et
N
TIPSO
N
TIPSO Et
CO2H
20 mol% Cl2Pd(MeCN)2
CH2Cl2
·
Et
N
R
M
HO O
·
CO2H
Et
N
R M
N
Et
M
HO O
R
N
R Et
CO2H
27 28
50% yield
Protonolysis
 
Figure 11: Proposed mechanism for Pd(II)-catalyzed cyclization (M = Pd) 
                                                 
23 Zipp, G. G. Unpublished results. 
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As anticipated, 3-silyloxy pyrrole 20 could be elaborated to the tetrahydroindolizine fragment of 
the (−)-rhazinilam skeleton, even allowing further elaboration to a triflate cross-coupling partner, 
albeit in low yield.23  However, in the latter half of the sequence, the compounds became 
increasingly more unstable.  In each reaction, as well as in storage, decomposition occurred 
which attenuated yields.  For this reason a more optimal route was sought.   
1.4.3 Synthesis of 1-benzyloxy-5,6,7,8-tetrahydroindolizine 35 
After failure of converting silyloxy tetrahydroindolizine 28 to an acceptable amount of the 
desired triflate precursor needed for the studies of using a Pd0-catalyzed cross-coupling reaction 
to form the biaryl bond, different protecting groups for the requisite hydroxy group were 
considered.  The main concerns for proper choice of a protecting group were not only that the 
integrity of the protecting group be uncompromised during the Grignard reagent formation, but 
that it also be labile enough to be removed easily after formation of the tetrahydroindolizine core.  
After deliberation, it was felt that a pyrrole with a benzyloxy group in the 3-position would be a 
suitable candidate. 
To pursue this strategy, 3-benzyloxy pyrrole 29 became the new synthetic target.  Pyrrole 
29 is derived from ethoxy pyrrolone 30 by transetherification followed by hydride reduction 
(Figure 12).  Ethoxy pyrrolone 30 could be synthesized from commercially available ethyl 
acetoacetate in three steps.  Reacting ethyl acetoacetate with triethyl orthoformate in the presence 
of a catalytic amount of H2SO4 provided ester 31 in 86% yield.24  Allylic bromination of ester 31 
with NBS provided a 90% yield of bromide 3224b which, upon subjection to a mixture of 3-
                                                 
24 (a) Smissman, E. E; Voldeng, A. N.  J. Org. Chem. 1964, 29, 3161-3165. (b) Kochhar, K. S.; Pinnick, H. W. J. 
Org. Chem. 1984, 49, 3222-3224. 
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chloropropylamine hydrochloride and 1.0 M aqueous NaOH in CH2Cl2, afforded ethoxy 
pyrrolone 30 in 62% yield.25         
 
EtO
O O
N O
EtO
Cl
(EtO)3CH,
H2SO4 EtO OEt
O NBS, (BzO)2,
EtO OEt
O
Br
Cl NH2·HCl
1M aq. NaOH,
CH2Cl2
CCl4
EtO
O O
N O
EtO
Cl
N
BnO
Cl
29 30
31
86% yield 3290% yield
30
62% yield  
Figure 12: Synthetic analysis of pyrrole 29 and synthesis of pyrrolone 30 
 
In order to obtain the benzyloxy analogue of optically active allene 27, 3-benzyloxy pyrrole 29 
had to be synthesized.  Transetherification of ethoxy pyrrolone 30 with benzyl alcohol proceeded 
under acid catalysis at 90 °C and reduced pressure (13-22 mmHg) to yield 3-benzyloxy 
pyrrolone 33 in 60% yield (Scheme 4).26  Reduction of 33 with excess iBu2AlH afforded a 50% 
yield of 3-benzyloxy pyrrole 29.24b  Optically active β-allenic acid 34 was synthesized in 65% 
                                                 
25 Kochhar, K. S.; Carson, H. J.; Clouser, K. A.; Elling, J. W.; Gramens, L. A.; Parry, J. L.; Sherman, H. L.; Braat, 
K.; Pinnick, H. W. Tetrahedron Lett. 1984, 25, 1871-1874. 
26 Laffan, D. D. P.; Bänziger, M.; Duc, L.; Evans, A.; McGarrity, J. F.; Meul, T. Helv. Chem. Acta 1992, 75, 892-
900. 
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yield by adding the pre-formed Grignard reagent of chloride 29 to a −78 °C solution of β-lactone 
18, CuCN and LiBr in THF. 
 
Scheme 4 
N O
BnO
Cl
N
BnO
Cl
·
CO2H
Et
N
BnO
N O
EtO
Cl
BnOH, MsOH,
90 °C, 13-22 mmHg
iBu2AlH, THF,
0 °C to rt
1) Mg0, THF
2) CuCN, LiBr, 18,
THF, -78 °C
30 33
60% yield
29
50% yield
34
65% yield  
 
With the synthesis of the benzyloxy allenic acid 34 now completed, the next goal was to cyclize 
the pyrrole and form the tetrahydroindolizine core.  Subjecting optically active allene 34 to a 
substoichiometric amount of Cl2Pd(MeCN)2 in CH2Cl2 provided the desired 1-benzyloxy- 
tetrahydroindolizine 35 in 58% yield and 72% ee (Scheme 5).  However unlike the silyloxy 
derivative, 30 mol% of the Cl2Pd(MeCN)2 was needed for complete consumption of the starting 
material.  The necessity of the higher catalyst loading may be due to a few reasons.  First, the 
benzyloxy substituent is more inductively electron-withdrawing than the silyloxy group, which 
would decrease the electron density in the pyrrole ring.  This would render the pyrrole less 
nucleophilic, thus deactivating the heterocycle towards cyclization.  Second, a benzyloxy group 
is a more efficient coordinating group than a silyloxy group and therefore the benzyl ether may 
be unproductively sequestering some of the Pd catalyst needed for activation of the allene.  
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Scheme 5 
·
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N
BnO Et
CO2Me
34 35
58% yield
36
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An attempt to improve the yield of the cyclized product was made by esterifying acid 34 with 
TMSCHN2 to produce methyl ester allene 36 in 88% yield.  By transforming the acid 
functionality into an ester, the stability of the starting allene as well as isolation of the desired 
bicyclic product would both be aided.27  Disappointingly, methyl ester allene 36 performed no 
better in the cyclization than allenic acid 34, yielding 59% of the methyl ester 
tetrahydroindolizine 37 in 72% ee.   
                                                 
27 Based on observations made from storage, the methyl ester allene seemed to have a slower rate of decomposition 
than the corresponding β-allenic acid.  
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1.4.4 Formation of triflate precursor 45 
With the benzyloxy bicycle now formed, efforts were focused on transforming the 
tetrahydroindolizine core into a viable cross-coupling partner.  In order to form the biaryl bond 
present in the skeleton of (−)-rhazinilam, the benzyl ether on the tetrahydroindolizine core 
needed to be deprotected and a triflate group installed.  Removal of the benzyl group was 
initially undertaken using transfer hydrogenation conditions.  Due to the slower rates associated 
with transfer hydrogenation compared to the use of hydrogen gas, we felt we would be able to 
monitor the reaction by TLC and quench the reaction mixture after the more active benzyl group 
was removed, but before the pendant neo-pentyl double bond was reduced. 
The initial conditions attempted for this transformation consisted of 1,4-cyclohexadiene as 
the source of molecular hydrogen and 10% activated Pd/C (100% (w/w)) in EtOH (Scheme 6).28  
Tetrahydroindolizines 35, 37 and 38 (obtained by reducing 37 with LAH (90% yield) followed 
by silylation of 39 with TIPSOTf (82% yield)) were subjected to these conditions.  
Unfortunately, none of the transfer hydrogenation experiments produced any desired product.  
While in all cases the starting material was consumed, the crude 1H NMR spectra from the 
reactions did not show definitive peaks that would correlate to the expected pyrrolone products.    
 
Scheme 6 
N
BnO Et
CO2H
1,4-cyclohexadiene, EtOH
10% act. Pd/C (100 % (w/w))
no
desired 
product
35  
                                                 
28 Felix, A. M.; Heimer, E. P.; Lambros, T. J.; Tzougraki, C.; Meienhofer, J. J. Org Chem 1978, 43, 4194-4196. 
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A second attempt at the deprotection of the benzyl ether on the tetrahydroindolizine core was 
made, this time subjecting both 35 and 37 to hydrogen gas with 10% activated Pd/C (100% w/w) 
in EtOH.  Similar to the transfer hydrogenation experiments, 35 and 37 were consumed 
completely, though again producing crude 1H NMR spectra that were indistinctive.   However, 
subjecting the crude products from the deprotection reactions to triflic anhydride in the presence 
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of triethylamine actually yielded 19% of triflate tetrahydroindolizine 40 (from 37).29 An 
interesting observation from this result is that the neo-pentyl double bond, thought to be less 
activated towards reduction in these conditions due to sterics, was reduced in the same amount of 
time it took for the aryl benzyl group to be removed.     
In order to maintain the integrity of the pendant olefin and to optimize the deprotection, 
alternative conditions were sought to debenzylate the pyrrole.  Experiments were conducted 
using model 3-benzyloxy pyrrole 41, which was synthesized in a similar manner as 3-benzyloxy 
pyrrole 29.   Reacting phenethylamine with allylic bromide 32 afforded the ethoxy pyrrolone 42 
in 64% yield (Scheme 7).  Transetherifying 42 with benzyl alcohol produced an 80% yield of 
benzyl ether 43 which was subsequently reduced with iBu2AlH to yield 36% of model benzyloxy 
pyrrole 41.  The studies conducted on model pyrrole 41 included an investigation of the 
acceleration effect of acetic acid as a media for transfer hydrogenation, as well as some Brønsted 
acid and Brønsted acid-Lewis base conditions to remove a benzyl group (Table 1).30
 
Scheme 7 
N O
BnO
N O
EtO
BnOH, MsOH,
Ph Ph
EtO OEt
O
Br
1.2M aq. NaOH,
CH2Cl2
phenethylamine,
90 °C, 13-22 mmHg
32
42
64% yield
43
80% yield  
                                                 
29 Characterized by 1H NMR, LRMS and HRMS data. 
30 (a) Kalinin, A. V.; Reed, M. A.; Norman, B. H.; Snieckus, V. J. Org. Chem. 2003, 68, 5992-5999. (b) Kiso, Y.; 
Ukawa, K.; Nakamura, S.; Ito, K.; Akita, T. Chem. Pharm. Bull. 1980, 28, 673-676. (c) Matteson, D. S.; Man, H.-
W.; Ho, O. C. J. Am. Chem. Soc. 1996, 118, 4560-4566. (d) Node, M.; Kodama, S.; Hamashima, Y.; Baba, T.; 
Hamamichi, N.; Nishide, K. Angew. Chem. Int. Ed. 2001, 40, 3060-3062. 
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NBnO
iBu2AlH, THF,
0 °C to rt
Ph
41
36% yield  
 
Table 1: Deprotection of model 3-benzyloxy pyrrole 41 
entry
a
b
c
d
e
f
N
BnO
Ph
N
O
Ph
Conditions a-f
41
Conditionsa Resultsb
1,4-cyclohexadiene, 10% act.
Pd/C, EtOH:HOAc/(3:2)c
Time
1,4-cyclohexadiene, 10% act.
Pd/C, HOAcc
MsOH in CHCl3
MsOH in Me2S
TFA
TFA:Me2S/(2:1)
10 hours
8 hours
5.5 hours
20 hours
16 hours
20 hours
>95% conv. (78%)d
>95% conv. (61%)d
~50% conv.
~67% conv.
no conv.e
~95% conv.
 
a Trials a, b, d and f were run using 0.070 g (0.253 mmol) of 41.  Trials c and e were run using 0.050 g (0.180 mmol) 
of 41.  Reactions were run at 0.10M in the respective solvents.  b Based on crude 1H NMR.  In all cases, the 1H 
NMRs showed a mix of desired product and starting material.  c Used 100% (w/w) of 10% activated Pd/C.  d Crude 
yields.  e Based on TLC, no crude 1H NMR taken. 
 
As was expected, the use of HOAc as the solvent increased the rate at which the transfer 
hydrogenation occurred, albeit at a lower isolated yield.  In addition, the Brønsted acid-Lewis 
base condition of TFA:Me2S, which should have no affect on the pendant neo-pentyl olefin, 
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yielded a promising result.  Unfortunately, when these conditions were employed for the removal 
of the benzyl ether on tetrahydroindolizine 37, no desired product was obtained (Scheme 8).  It 
was hypothesized that deprotection of the benzyl ether was being inductively stymied by the 
electron-rich nature of the pyrrole moiety.  Installation of an electron withdrawing group, in this 
case a carbomethoxy group, onto the pyrrole should rectify this problem.  An electron-
withdrawing group would decrease the electron density within the pyrrole moiety thereby 
inductively labilizing the benzyl ether. 
 
Scheme 8 
N
BnO Et
CO2Me
no
desired
product
1,4-cyclohexadiene, 10% act. Pd/C,
EtOH:HOAc/(3:2)
or
TFA:Me2S/(2:1)
37  
 
The carbomethoxy group was easily installed onto the heterocyclic core in two steps.  Acylation 
of tetrahydroindolizine 37 with trichloroacetyl chloride followed by methanolysis with freshly 
prepared sodium methoxide produced benzyl ether 44 in 84% overall yield (Scheme 9).  As 
hypothesized, the carbomethoxy group did facilitate the deprotection of the hydroxy group.  
Subjection of benzyl ether 44 to TFA:Me2S/(2:1) successfully cleaved the benzyl group.31  The 
intermediate pyrrolone was too unstable to purify so the crude residue was treated directly with 
Tf2O and Hünig’s base to yield 43% of the desired cross-coupling partner, triflate 45.  
Installation of the carbomethoxy group proved even more efficacious as incorporation of the 
                                                 
31 Verified by crude 1H NMR analysis 
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electron-withdrawing substituent onto tetrahydroindolizine 46,32 to form ethyl ether 47, enabled 
removal of the ethyl substituent from the pyrrolo-ether by using BBr3.  Subsequent treatment of 
the crude pyrrolone with Tf2O and Hünig’s base produced triflate 45 in 57% yield.31  With the 
desired triflate at hand, it was time to attempt formation of the biaryl bond. 
 
Scheme 9 
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46 R = Et 44 R = Bn, 84% yield (over 2 steps)
47 R = Et, 84% yield (over 2 steps)
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R = Et, 57% yield (over 2 steps);
R = Bn, 43% yield (over 2 steps)  
 
 
                                                 
32  Received from G. Greg Zipp 
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1.4.5 Attempts at forming the biaryl bond 
1.4.5.1 Exploring siloxanes as cross-coupling partners 
 
Due to the existence of a variety of literature procedures to form biaryl bonds via Pd0-mediated 
cross-coupling reactions, formation of the requisite bond between pyrrole triflate 45 and an 
aniline derivative was studied on multiple fronts at once.  Turning to coupling chemistry 
developed by Hiyama and DeShong, siloxanes were explored as potential cross coupling 
partners.33  Model triflate 48 was synthesized in a similar fashion as 3-siloxy pyrrole 20 (Scheme 
10).  Starting with ene-trinone 25, addition of phenethylamine followed by stirring with silica gel 
provided 3-hydroxy-2-carboxylate pyrrole 49 in 38% yield.  Treatment of 49 with TFA induced 
a tandem tbutyl-ester deprotection/decarboxylation sequence to afford the very light and air 
sensitive pyrrolone 50 that underwent immediate triflation with Tf2O to yield model triflate 48 in 
70% overall yield from 49.34  
 
Scheme 10   
N
OH
CO2tBu TFA, CH2Cl2
OtBu
O
O·H2O
O
2) SiO2
N
O
H2N
Ph
1)
CH2Cl2
Ph Ph
,
25 4938% yield 50  
                                                 
33 (a) Hatanaka, Y.; Hiyama, T. Synlett 1991, 845-853. (b) Mowery, M. E.; DeShong, P. J. Org. Chem. 1999, 64, 
3266-3270. (c) Mowery, M. E.; DeShong, P. Org. Lett. 1999, 1, 2137-2140. (d) DeShong, P.; Handy, C. J.; Mowery, 
M. E. Pure Appl. Chem. 2000, 72, 1655-1658. (e) Manoso, A. S.; DeShong, P. J. Org. Chem. 2001, 66, 7449-7455. 
(f) Denmark, S. E.; Sweis, R. F. Acc. Chem. Res. 2002, 35, 835-846. 
34 1H NMR data for crude pyrrolone 50 can be found in the experimental section. 
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iPr2NEt, Tf2O,
CH2Cl2 N
OTf
Ph
48
70% yield  
 
In order to gauge the reactivity of pyrrole triflates in these siloxane cross-coupling reactions, a 
coupling reaction between model triflate 48 and commercially available phenyltrimethoxysilane 
was conducted.  Subjection of the model triflate to conditions developed by DeShong produced 
biaryl 51 in 17% yield (Scheme 11).33c Though the yield of the coupled product was poor, it 
demonstrated that the pyrrole triflates possessed some potential coupling ability with siloxanes.  
Consequently, syntheses of different phenylsiloxane cross-coupling partners that contained a 
nitrogen functionality in the 2-position was attempted.  Disappointingly, only two ortho-silyl 
compounds, N,N-dimethyl aniline siloxane 52 (47% yield) and N-Boc aniline trimethylsilane 53 
(32% yield), could be synthesized.35  However, subjecting both 52 and 53 to the same conditions 
that afforded biaryl 51 failed to yield any coupled product. 
 
Scheme 11 
N
PhSi(OMe)3,
Pd(OAc)2, PPh3,
TBAF, DMF, 90 °C
N
OTf
Ph Ph
Ph
48 51
17% yield  
                                                 
35 (a) Tacke, R.; Wiesenberger, F.; Lopez-Mras, A.; Sperlich, J.; Mattern, G. Z. Naturforsch 1992, 47b, 1370-1376. 
(b) The N-Boc aniline starting material used in the production of 53 is commercially available. 
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Due to the inability to synthesize the desired siloxane cross-coupling partners, as well as the 
failure to couple the available aniline-derived coupling precursors to model triflate 48, no further 
studies in the area of using siloxanes as potential cross-coupling partners were conducted. 
1.4.5.2 Attempts at using a Suzuki cross-coupling reaction 
 
At the same time at which siloxanes were being tested as potential cross-coupling partners, the 
use of boronic acids as viable cross-coupling partners showed some promise in model studies.23  
However, attempts to utilize aryl boronic acids with triflate 45 in a Suzuki cross-coupling 
reaction to form the requisite biaryl bond proved fruitless.36  Efforts to couple triflate 45 with 
commercially available o-nitro phenyl boronic acid (16) and phenyl boronic acid did not produce 
                                                 
36  A combination of trials were run by Zuosheng Liu, G. Greg Zipp and the author of this document.  The trials 
depicted in Scheme 12 were run by the author of this document. 
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any desired biaryl product (Scheme 12).  Surprisingly, unreacted starting material was fully 
recovered as reduction product 54 was not detected.   
 
Scheme 12 
N
TfO Et
CO2Me
MeO2C
NO2
B(OH)2
B(OH)2
KF, Pd(OAc)2,
PCy3, THF, rtRecovered
starting
material
Pd(OAc)2, P, DMF
Na2CO3, 100 °C Recoveredstarting
material
P = PPh3, dppf
N
Et
CO2Me
MeO2C
not detected!
16 45
54  
 
It is speculated that the failure of the Suzuki cross-coupling reactions to produce any desired 
product and any reduced starting material may be caused by two reasons.  First, despite the 
inductive electron-withdrawing nature of the carbomethoxy group the pyrrole-triflate bond may 
still not be labile enough for the Pd0 to insert into.  Second, the very sterically cumbersome 
quaternary carbon stereocenter which is in close proximity to the pyrrole-triflate bond may be 
sterically blocking the Pd0 from getting close enough to the desired bond.   
Due to the failure to form the biaryl bond via cross-coupling reaction using a pyrrole 
triflate, in addition to the moderate yields obtained during key reactions in the synthetic 
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sequence, synthetic efforts towards the total synthesis of (−)-rhazinilam were temporarily ceased 
in order to revise the synthetic sequence.      
1.5 EXPERIMENTAL 
General Information: 1H NMR spectra were recorded on Bruker DPX 301 and DPX 302 (300 
MHz) spectrometers.  Chemical shifts are reported in ppm from tetramethylsilane with either the 
solvent resonance as the internal standard (CHCl3: δ 7.27 ppm) or tetramethylsilane as an 
external standard (TMS: δ 0.00 ppm).  Data is reported as follows: chemical shift (ppm), 
multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, p = pentet app = apparent, br = 
broad, m = multiplet), coupling constants (Hz), integration.  13C NMR spectra were recorded on 
Bruker DPX 301 and DPX 302 spectrometers (75 MHz) with complete proton decoupling.  
Chemical shifts are reported in ppm from tetramethylsilane with either the solvent resonance as 
the internal standard (CDCl3: δ 77.0 ppm; C6D6: δ 128 ppm) or tetramethylsilane as an external 
standard (TMS: δ 0.00 ppm).  Optical rotations were measured on a Perkin-Elmer 241 digital 
polarimeter with a sodium lamp at ambient temperature and are reported as follows: [α]D (c 
g/100 mL) with units of degree•g•cm-3.  Infrared spectra were recorded on a Nicolet Avatar 360 
FT-IR spectrometer.  Mass spectra were obtained on a VG-7070 or Fisons Autospec high 
resolution magnetic sector mass spectrometer.  
Analytical thin layer chromatography (TLC) was performed on EM Reagent 0.25 mm 
silica gel 60-F plates.  Flash chromatography was performed as previously described on EM 
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silica gel 60 (230-240 mesh).37  Analytical gas liquid chromatography (GLC) was performed on 
a Varian 3900 gas chromatograph with a flame ionization detector and split mode capillary 
injection system using a VarianCP Wax 52CB column (30 m x 0.25 mm).  Hydrogen was used 
as the carrier gas at the indicated pressures.  Analytical high performance liquid chromatography 
(HPLC) was performed on a Hewlett Packard 1100 liquid chromatograph equipped with a 
variable wavelength UV detector (deuterium lamp, 190-600 nm), using a Daicel Chiralcel™ OD-
H column (250 x 4.6 mm) (Daicel Inc.).  HPLC grade isopropanol and hexanes were used as the 
eluting solvents.  Melting points were taken using a Mel-Temp apparatus and are uncorrected. 
Unless otherwise stated, all experiments were carried out under a nitrogen atmosphere in 
oven or flame-dried glassware using standard inert atmosphere techniques for introducing 
reagents and solvents.  Anhydrous solvents were obtained by passage through successive 
alumina- and Q5 reactant-packed columns on a solvent purification system.  All water used in 
reactions and in aqueous solutions was deionized.  Acetyl bromide and Tf2O were distilled from 
P2O5.  Phenethylamine, TMEDA, N,N-dimethylaniline, TMSCl and iPr2NEt were distilled from 
CaH2.  TIPSOTf and 3-chloropropionyl chloride were distilled prior to use.  All other reagents 
were used as purchased.  The yields reported are unoptimized.  
 
 (R)-4-(But-1-ynyl)oxetan-2-one (18):  To a solution of (S,S)-ligand A (0.461g, 
0.853 mmol) in CH2Cl2 (4.5 mL) at ambient temperature was added AlMe3 
(0.470 mL, 0.938 mmol, 2.0 M in hexanes) in a slow, dropwise manner.  Gas 
evolution was observed almost immediately upon addition.  The clear solution was stirred for 4 
hours at ambient temperature, after which the reaction mixture was diluted with CH2Cl2 (35 mL) 
O
O
Et
                                                 
37 Still, W.C.; Kahn, M.; Mitra, A. J. Org. Chem. 1978, 43, 2923-2925. 
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and subsequently cooled to −78 °C.  To the solution was added iPr2NEt (5.00 mL, 29.0 mmol) 
followed by slow, dropwise addition of acetyl bromide (2.40 mL, 32.4 mmol).  The reaction 
mixture was stirred for 15 minutes at −78 °C.  Subsequently, neat aldehyde (1.40 g, 17.1 mmol) 
was added in a dropwise fashion.  The resulting solution was stirred at −78 °C until complete 
consumption of the starting material, as monitored by TLC.  The reaction mixture was poured 
into cold ether (150 mL) and filtered through a plug of silica, eluting with more cold ether.  
Concentrated the ethereal filtrate in vacuo and purified the crude oil via bulb-to-bulb distillation 
(pot temperature 40 oC @ 0.1 mb).  In some cases, additional purification was performed using 
silica gel chromatography (10:1/pentanes:ether) to yield the title compound as a pale yellow oil 
(1.80 g, 85%):  1H NMR (300MHz, CDCl3) δ 5.03 (ddt, J = 6.3, 4.4, 1.9 Hz, 1H), 3.75 (dd, J = 
16, 6.2 Hz, 1H), 3.48 (dd, J = 16, 4.5 Hz, 1H), 2.28 (qd, J = 7.5, 1.9 Hz, 2H), 1.17 (t, J = 7.5 Hz, 
3H); 13C NMR (75 MHz, CDCl3) δ 167.2, 92.8, 74.5, 59.1, 46.2, 13.3, 12.5.  Separation of the 
enantiomers by chiral HPLC [Daicel Chiracel™ OD-H column, flow rate 0.950 mL/min., 15% 
iPrOH, 85% hexane, Tr: 8.25 min (S), 10.1 min (R)] provided the enantiomeric excess to be 
87%.38  
 
 5-Chloro-2,3-dioxopentanoic acid tert-butyl ester (22): To a 
solution of ylide 23 (2.58 g, 6.85 mmol) in benzene (17.6 mL) at  Cl O
tBu
O
O⋅H2O
O
~4 °C was added a solution of 3-chloropropionyl chloride (0.327 mL, 3.43 mmol) in benzene 
(1.7 mL) in a slow, dropwise fashion.  Upon complete addition of the acyl chloride, the reaction 
mixture was warmed to ambient temperature and stirred for 30 minutes.  The reaction mixture 
                                                 
38 The β-lactone was opened via addition-elimination to the lactone carbonyl by benzylamine.  The enantiomeric 
excess of the resulting amide was measured.   
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was then diluted with cold ether (25 mL) and stirred vigorously for an additional 5 minutes.  
Filtered off the precipitate via vacuum filtration and washed the solid with cold ether (2 x 100 
mL).  The filtrate was then concentrated in vacuo to yield dione ylide 24 as a yellow-white solid 
(1.44 g, 94%) that was used without further purification:  1H NMR (300 MHz, CDCl3) δ 7.74-
7.43 (m, 15H), 3.83 (t, J = 6.8 Hz, 2H), 3.38 (t, J = 6.8 Hz, 2H), 1.06 (s, 9H); EI-MS m/z 466 
(M+), 431, 374, 347, 277, 201; HRMS calcd for C27H28ClO3P: 466.1465; found 466.1473.   
To a mixture of the dione ylide 24 in THF (34 mL) and water (17 mL) was added oxone® 
(3.19 g, 5.19 mmol).  Stirred the resulting biphasic mixture vigorously for 4 hours, after which 
the reaction mixture was diluted with water (30 mL).  Separated the layers and extracted the 
aqueous layer with EtOAc (3 x 40 mL).  The combined organic extracts were washed with brine 
(1x), dried over Na2SO4, filtered and concentrated in vacuo to yield a yellow oil.  The yellow oil 
was dissolved in 1:1/hexanes:ethyl acetate (10 mL) and stirred at ambient temperature for 1 hour.  
The resulting white precipitate was removed via quick filtration over a plug of silica that was 
washed with 1:1/hexanes:ethyl acetate (2-3 column volumes).  Concentrated the filtrate in vacuo 
to yield the title compound as a ‘wet’ solid (0.603 g, 82%) that was used without any further 
purification:  1H NMR (300 MHz, CDCl3) δ 4.88 (s, 2H), 3.81 (t, J = 6.3 Hz, 2H), 3.07 (t, J = 6.3 
Hz, 2H), 1.52 (s, 9H). 
  
2,3-Dioxopent-4-enoic acid tert-butyl ester (25):  To a solution of trione 22 
(0.603 g, 2.53 mmol) in THF (16 mL) was added saturated aqueous NaHCO3 
(12 mL).  The biphasic mixture was stirred vigorously for 4 hours, after which the reaction 
mixture was diluted with water (15 mL).  The layers were separated and the aqueous layer was 
extracted with EtOAc (3 x 25 mL).  The combined organic extracts were then washed with brine 
OtBu
O
O⋅H2O
O
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(1 x 15 mL), dried over Na2SO4, filtered and concentrated in vacuo to yield the title compound as 
a yellow solid (0.500 g, 98%) that was used without further purification:  m.p. 59-62 oC; IR (thin 
film) 3382, 2984, 2930, 1746, 1712, 1612, 1106, 1058 cm-1; 1H NMR (300 MHz, CDCl3) δ 6.58 
(d, J = 7.7 Hz, 1H), 6.57 (d, J = 3.8 Hz, 1H), 6.02 (dd, J = 7.7, 4.2 Hz, 1H), 5.00 (s, 2H), 1.48 (s, 
9H). 
 
1-(3-Bromopropyl)-3-hydroxy-1H-pyrrole-2-carboxylic acid tert-butyl es-
ter (21): To a mixture of ene-trinone 25 (5.33 g, 26.4 mmol) and 3-
bromopropylamine hydrobromide (5.77 g, 26.4 mmol) in CH2Cl2 (470 mL) at 
ambient temperature was slowly added iPr2NEt (4.60 mL, 26.4 mmol).  The dark yellow solution 
became homogenous and was stirred for an additional 30 minutes at ambient temperature.  Silica 
gel (118 g) was then added and the resulting mixture was allowed to stir vigorously overnight.  
The silica gel was filtered off and washed with a copious amount of CH2Cl2.  The filtrate was 
concentrated in vacuo and purified by silica gel chromatography (50:1/hexanes:ethyl acetate) to 
yield the title compound as a yellow oil (8.07 g, 55%):  IR (thin film)  2973, 1642, 1555, 1393, 
1367, 1107 cm-1; 1H NMR (300 MHz, CDCl3) δ 8.44 (br s, 1H), 6.61 (d,  J = 2.7 Hz, 1H), 5.67 
(d, J = 2.8 Hz, 1H), 4.17 (t, J = 6.1 Hz, 2H), 3.22 (t, J = 6.2 Hz, 2H), 2.18 (app p, J = 6.1 
Ηz, 2Η), 1.57 (s, 9Η); 13C NMR (75 MHz, CDCl3) δ 162.6, 156.2, 127.7, 106.2, 96.2, 82.0, 47.8, 
34.2, 30.4, 28.7; EI-MS m/z 303 (M+), 247, 229, 123; HRMS calcd for C12H18BrNO3: 
303.0470, found 303.0471. 
N
Br
OH
CO2tBu
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1-(3-Bromopropyl)-3-triisopropylsilanyloxy-1H-pyrrole (20):  To a solution of 
3-hydroxy-2-carboxylate pyrrole 21 (1.10 g, 3.60 mmol) in CH2Cl2 (80 mL) was 
added trifluoroacetic acid (11 mL).  Stirred the solution vigorously for 6 hours at 
ambient temperature, after which the reaction mixture was cooled to 0 °C and quenched with 
saturated aqueous NaHCO3.  Diluted the reaction mixture with CH2Cl2, separated the layers and 
washed the organic layer with saturated aqueous NaHCO3 (1x).  The aqueous layer was extracted 
with CH2Cl2 (1x) and the combined organic extracts were dried over Na2SO4, filtered and 
concentrated in vacuo to yield 1,2-dihydro-pyrrolone 26 as an oil that was used without further 
purification:  Crude 1H NMR (300 MHz, CDCl3) δ 7.84 (d, J = 3.0 Hz, 1H), 5.15 (d, J = 3.2 Hz, 
1H), 3.71 (s, 2H), 3.57 (t, J = 6.5 Hz, 2H), 3.42 (t, J = 6.0 Hz, 2H), 2.14 (app p, J = 6.3 Hz, 2H). 
N
Br
OTIPS
The crude 1,2-dihydropyrrolone 26 was dissolved in CH2Cl2 (80 mL) and the solution 
cooled to 0 °C.  To the reaction mixture was added iPr2NEt (20 mL), followed by slow, dropwise 
addition of TIPSOTf (1.17 mL, 4.34 mmol).  The resulting solution was stirred at 0 °C for 20 
minutes and then allowed to warm to ambient temperature overnight.  Subsequently, the reaction 
mixture was cooled to 0 °C and quenched with water and then diluted with ether.  The layers 
were separated and organic layer washed with saturated aqueous NH4Cl.  The combined organic 
extracts were dried over Na2SO4, filtered and concentrated in vacuo to afford a crude oil that was 
purified by silica gel chromatography (50:1/hexanes:ethyl acetate) to yield the title compound as 
an orange oil (0.860 g, 67% overall yield from 21):  IR (thin film) 2943, 2866, 1556, 1346, 1006, 
676 cm-1; 1H NMR  (300 MHz, CDCl3) δ 6.35 (app t, J = 2.7 Hz, 1H), 6.22 (app t, J = 2.0 Hz, 
1H), 5.74 (dd, J = 2.8, 1.9 Hz, 1H), 3.91 (t, J = 6.2 Hz, 2H), 3.26 (t, J = 6.2 Hz, 2H), 2.17 (app p, 
J = 6.2 Hz, 2H), 1.20 (m, 3H), 1.09 (d, J = 6.3 Hz, 18 H); 13C NMR (75 MHz, CDCl3) δ 142.8, 
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117.9, 107.3, 101.3, 47.4, 34.1, 30.3, 17.9, 12.4; EI-MS m/z 359 (M+), 316, 280, 252, 208, 180, 
152; HRMS calcd for C16H30BrNOSi: 359.1280, found 359.1286. 
 
5-Ethyl-8-(3-triisopropylsilanyloxypyrrol-1-yl)octa-3,4-dienoic 
acid (27):  To a mixture of Mg0 (0.107 g, 4.40 mmol) in THF (5.5 mL) was 
added dibromoethane (14 μL).  After gas evolution occurred, to the 
activated Mg0 was added a solution of bromide 20 (0.792 g, 2.20 mmol) in 
THF (5.5 mL) over 10 mins.  The mixture was stirred until all the starting material was 
consumed, as monitored by TLC.  The prepared Grignard reagent was then added to a flask 
containing a −78 °C solution of β-lactone 18 (0.273 g, 2.20 mmol), CuCN (0.020 g, 0.220 mmol) 
and LiBr (0.044 g, 0.510 mmol) in THF (24 mL).  Stirred the reaction mixture for 1 hour, after 
which the reaction was quenched with saturated aqueous NH4Cl.  The reaction mixture was 
allowed to warm to ambient temperature, after which the layers were separated and the aqueous 
layer extracted with ether (3 x 100mL).  The combined organic extracts were then washed with 
saturated aqueous NH4Cl (5 X 50 mL), dried over Na2SO4, filtered and concentrated in vacuo.  
Purified the resultant oil by silica gel chromatography (6:1/hexanes:ethyl acetate) to yield the 
title compound as a yellow-orange oil (0.425 g, 50%): Unable to characterize due to product 
instability. 
•
CO2H
Et
N
TIPSO
 
(E)-4-((R)-1-(Triisopropylsilyloxy)-8-ethyl-5,6,7,8-tetrahydroindolizin-8-
yl)but-3-enoic acid (28):  To a solution of allenic acid 27 (0.177 g, 0.440 mmol) 
in CH2Cl2 (8.1 mL) was added Cl2Pd(MeCN)2 (0.023 g, 8.73 x 10-5 mol).  The 
resulting solution was stirred vigorously at ambient temperature for 8 hours.  The 
N
TIPSO Et
CO2H
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reaction mixture was diluted with 1:1/hexanes:ethyl acetate (12 mL) then quickly filtered over a 
plug of silica gel that was washed exhaustively with 1:1/hexanes:ethyl acetate.  Concentrated the 
filtrate in vacuo and purified the oil by silica gel chromatography (4:1/hexanes:ethyl acetate) to 
yield the title compound as an oil (0.090 g, 50%): Unable to characterize due to product 
instability. 
 
3-Ethoxy-but-2-enoic acid ethyl ester (31):  A solution of ethyl acetoacetate 
(25.5 mL, 200 mmol) and triethyl orthoformate (33.3 mL, 200 mmol) was 
treated with concentrated H2SO4 (6 drops from a pipet) and the resulting dark solution stirred at 
ambient temperature for 12 hours.  The reaction mixture was then treated with quinoline (10 
drops from a pipet) and via fractional vacuum distillation (50 °C, 0.075 mb) the title compound 
collected as a clear oil (27.2g, 86%) that was used without further purification:  IR (thin film) 
2982, 1712, 1624, 1275, 1143, 1054 cm-1; 1H NMR (300 MHz, CDCl3) δ 5.00 (s, 1H), 4.06 (q, J 
= 7.1 Hz, 2H), 3.80 (q, J = 7.0 Hz, 2H). 2.24 (s, 3H), 1.30 (t, J = 7.0 Hz, 3H), 1.21 (t, J = 7.1 Hz, 
3H); 13C NMR (75 MHz, CDCl3) δ 172.1, 167.5, 90.8, 63.9, 59.1, 18.9, 14.6, 14.4; EI-MS m/z 
158 (M+), 143, 129, 113, 85; HRMS calcd for C8H14O3: 158.0943, found 158.0935. 
EtO
O
OEt
 
4-Bromo-3-ethoxybut-2-enoic acid ethyl ester (32):  To a mixture of ester 
31 (64.60 g, 0.410 mol), N-bromosuccinimde (76.20 g, 0.430 mol) and CCl4   
(408 mL) was added benzoyl peroxide (1.02 g).  The resulting mixture was heated to reflux for 3 
hours, after which the solids were filtered off and the filtrate dried over MgSO4.  Filtered off the 
solids, concentrated the filtrate in vacuo and collected the title compound, via vacuum distillation 
(77 °C, 0.21 mb), as a yellow-tinged oil (87.4 g, 90%) that was used without further purification:  
EtO
O
OEt
Br
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IR (thin film) 2982, 1708, 1624, 1154, 1128; 1H NMR (300 MHz, CDCl3) δ 5.10 (s, 1H), 4.52 (s, 
2H), 4.15 (q, J = 7.1 Hz, 2H), 3.90 (q, J = 7.0 Hz, 2H), 1.37 (t, J = 7.0 Hz, 3H), 1.27 (t, J = 7.2 
Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 168.4, 166.3, 93.4, 64.6, 59.8, 26.0, 14.4, 14.0; EI-MS 
m/z 236 (M+), 208, 190, 162, 84; HRMS calcd for C8H13BrO3: 236.0048, found 236.0045.       
   
1-(3-Chloropropyl)-4-ethoxy-1,5-dihydropyrrol-2-one (30):  To a solution 
of NaOH (3.42 g, 85.5 mmol) in water (35 mL) at ambient temperature was 
added 3-chloropropylamine hydrochloride (11.1 g, 85.5 mmol).  Once the 
solution was homogenous, CH2Cl2 (60 mL) was added followed by dropwise addition of allyl 
bromide 32 (4.05 g, 17.1 mmol) in CH2Cl2 (10 mL).  The biphasic mixture was stirred 
vigorously overnight, after which the layers were separated and the aqueous extracted with ether 
(3x).  The combined organic extracts were dried over Na2SO4, filtered and concentrated in 
vacuo.  The resulting oil was allowed to sit at ambient temperature overnight and upon 
completion of cyclization, as monitored by TLC, purified by silica gel chromatography 
(1:1/hexanes:ethyl acetate) to yield the title compound as an orange-red solid (4.29 g, 62%):  IR 
(thin film) 2924, 1675, 1619, 1219 cm-1; 1H NMR (300 MHz, CDCl3) δ 5.01 (s, 1H), 4.00 (q, J = 
7.1 Hz, 2H), 3.89 (s, 2H), 3.56 (t, J = 6.6 Hz, 2H), 3.52 (t, J = 6.8 Hz, 2H), 2.04 (app p, J = 6.6 
Hz, 2H), 1.39 (t, J = 7.0 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 172.5, 172.1, 94.4, 66.9, 51.2, 
42.2, 39.2, 31.5, 14.0; EI-MS m/z 203 (M+), 168, 154, 140, 111; HRMS calcd for C9H14ClNO2: 
203.0713, found 203.0713.     
N O
EtO
Cl
 
         
 39 
4-Benzyloxy-1-(3-chloropropyl)-1,5-dihydropyrrol-2-one (33):  To a 
solution of 1,5-dihydropyrrolone 30 (0.584 g, 2.87 mmol) in benzyl alcohol 
(1.80 mL, 17.2 mmol) was added methanesulfonic acid (20.0 μL, 0.320 
mmol).  The solution was stirred vigorously for 3 hours at 90 °C under reduced pressure (~12 
mmHg).  Diluted the reaction mixture with 1:1/hexanes:ethyl acetate (20 mL) and purified by 
silica gel chromatography (1:1/hexanes:ethyl acetate) to yield the title compound as a solid 
(0.454 g, 60%):  m.p. 62-64oC;  IR (thin film) 2924, 2866, 1676, 1623, 1450, 1340, 1220, 970 
cm -1; 1H NMR (300 MHz, CDCl3) δ 7.40-7.29 (m, 5H), 5.12 (s, 1H), 4.94 (s, 2H), 3.91 (s, 2H), 
3.54 (t, J = 6.5 Hz, 2H), 3.50 (t, J = 6.9 Hz, 2H), 2.02 (app p, J = 6.6 Hz, 2H); 13C NMR (75 
MHz, CDCl3) δ 172.2, 171.8, 134.7, 128.8, 128.0, 95.6, 73.1, 51.3, 42.2, 39.3, 31.6; EI-MS m/z 
265 (M+), 230, 202, 91; HRMS calcd for C14H16ClNO2: 265.0870, found 265.0875. 
N O
BnO
Cl
 
3-Benzyloxy-1-(3-chloropropyl)-1H-pyrrole (29):  To a solution of 
benzyloxy-1,5-dihydropyrrolone 33 (1.04 g, 5.10 mmol) in THF (90 mL) at   
0 °C was added iBu2AlH (25.5 ml, 25.5 mmol, 1 M in hexanes) over 5 
minutes.  The yellow-tinged solution was stirred vigorously for 18 hours at ambient temperature 
before the solution was poured into cold, aqueous 1M NaOH (250 mL).  The layers were 
separated and the aqueous layer extracted with ether (3 x 200 mL).  The combined organic 
extracts were dried over MgSO4 and the mixture stirred vigorously for 1 hour.  Filtered the 
resulting mixture over a plug of celite, concentrated the filtrate in vacuo and purified the 
resulting oil by silica gel chromatography (50:1/hexanes:ethyl acetate) to yield the title 
compound as a light orange-brown oil (0.475 g, 50%):  IR (thin film) 2931, 2868, 1717, 1557, 
1499, 1330, 1025 cm -1; 1H NMR (300 MHz, CDCl3) δ 7.42-7.28 (m, 5H), 6.42 (app t, J = 2.7 
N
BnO
Cl
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Hz, 1H), 6.25 (app t, J = 2.2 Hz, 1H), 5.86 (dd, J = 2.9, 1.9 Hz, 1H), 4.89 (s, 2H), 3.94 (t, J = 6.4 
Hz, 2H), 3.42 (t, J = 6.0 Hz, 2H), 2.11 (app p, J = 6.3 Hz, 2H); 13C NMR (75 MHz, CDCl3) δ 
147.9, 137.7, 128.4, 127.8, 127.6, 118.8, 103.7, 97.8, 72.8, 46.5, 41.6, 33.9; EI-MS m/z 249 
(M+), 186, 158, 91; HRMS calcd for C14H16ClNO: 249.0920, found 249.0918.  
 
8-(3-Benzyloxypyrrol-1-yl)-5-ethylocta-3,4-dienoic acid (34):  To a 
mixture of flame-dried Mg0 (0.456 g, 18.8 mmol) in THF (3.4 mL) was 
added dibromoethane (0.162 mL, 1.88 mmol).  While the Mg0 was being 
n of chloride 29 (0.938 g, 3.76 mmol) in THF (8.2 mL) was slowly added to 
the reaction flask and the resulting mixture was allowed to stir at 30 °C overnight.  The prepared 
Grignard reagent was then slowly added to a solution of LiBr (0.075 g, 0.864 mmol), CuCN 
(0.034g, 0.376 mmol) and β-lactone 18 (0.396 g, 3.19 mmol) in THF (26 mL) at −78 °C.  The 
reaction mixture was stirred for 1 hour at −78 °C, and then quenched with saturated aqueous 
NH
•
CO2H
Et
N
BnO
activated, a solutio
4Cl.  The resulting mixture was warmed to ambient temperature, after which the layers were 
separated and the aqueous layer extracted with ether (3x).  The combined organic extracts were 
washed with saturated aqueous NH4Cl (4x), dried over Na2SO4, filtered and concentrated in 
vacuo.  Purified by silica gel chromatography (6:1/hexanes:ethyl acetate) to yield the title 
compound as an orange oil (0.680, 65%):  [α]D = + 4.0 (c 1.3, CHCl3);  IR (thin film) 3088 (br), 
2960, 2929, 1705, 1552, 1335 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.43-7.25 (m, 5H), 6.38 (app 
t, J = 2.7 Hz, 1H), 6.24 (app t, J = 2.3 Hz, 1H), 5.84 (dd, J = 2.8, 2.0 Hz, 1H), 5.29 (m, 1H), 4.88 
(s, 2H), 3.74 (t, J = 6.6 Hz, 2H), 3.03 (d, J = 7.2 Hz, 2H), 1.96-1.78 (m, 6H), 0.97 (t, J = 7.3 Hz, 
3H); 13C NMR (75 MHz, CDCl3) δ 201.7, 177.9, 147.5, 137.8, 128.3, 127.6, 118.4, 107.0, 103.5, 
 41 
97.1, 85.9, 72.6, 49.3, 35.2, 29.0, 25.7, 12.1; EI-MS m/z 339 (M+), 310, 280, 248, 202, 188; 
HRMS calcd for C21H25NO3: 339.1834, found 339.1827.   
 
 (E)-4-((R)-1-(Benzyloxy)-8-ethyl-5,6,7,8-tetrahydroindolizin-8-yl)but-3-eno-
ic acid (35):  To a solution of allenic acid 34 (0.086 g, 0.250 mmol) in CH2Cl2 
(2.5 mL) was added Cl2Pd(MeCN)2 (0.020 g, 76.2 μmol).  The resulting solution 
was vigorously stirred for 6 hours at ambient temperature.  Diluted the reaction 
mixture with 1:1/hexanes:ethyl acetate (2.5 mL) then quickly filtered the mixture over a plug of 
silica gel that was washed exhaustively with EtOAc.  The filtrate was concentrated in vacuo and 
purified by silica gel chromatography (4:1/hexanes:ethyl acetate) to yield the title compound as a 
deep red oil (0.050 g, 58%):  [α]D = +12.6 (c 1.6, CHCl3);  IR (thin film) 3023 (br), 2931, 2868, 
1702, 1562, 1451, 1339 cm -1; 1H NMR (300 MHz, CDCl3) δ 7.39-7.27 (m, 5H), 6.32 (d, J = 3.0 
Hz, 1H), 5.90 (d, J = 3.0 Hz, 1H), 5.73 (d, J = 15.5 Hz, 1H), 5.26 (dt, J = 15.4, 7.0 Hz, 1H), 4.94 
(s, 2H), 3.87 (ddd, J = 11.4, 5.0, 3.9 Hz, 1H), 3.74 (td, J = 10.5, 4.4 Hz, 1H), 3.06 (dd, J = 7.1, 
1.3 Hz, 2H), 2.09-1.72 (m, 6H), 0.82 (t, J = 7.4 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 178.1, 
142.4, 141.1, 138.6, 128.2, 127.3, 127.2, 118.7, 117.0, 115.1, 96.5, 72.9, 46.0, 41.9, 37.7, 31.2, 
30.4, 20.3, 8.5; EI-MS m/z 339 (M+), 310, 248, 204, 148; HRMS calcd for C21H25NO3: 339.1834, 
found 339.1833.  Separation of the enantiomers by chiral HPLC [Daicel Chiracel™ OD-H 
column, flow rate 1.00 mL/min., 10% iPrOH, 90% hexane, Tr: 16.88 min (R), 19.30 min (S)] 
provided the enantiomeric excess to be 72%.  
N
BnO Et
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8-(3-Benzyloxypyrrol-1-yl)-5-ethylocta-3,4-dienoic acid methyl ester (36):  
To a solution of allenic acid 34 (0.597 g, 1.76 mmol) in benzene (12.6 mL) 
and MeOH (3.40 mL) at ambient temperature was added TMSCHN2 (1.50 
mL, 3.00 mmol, 2.0 M in hexanes) in a dropwise fashion.  The resulting 
mixture was stirred for 30 minutes, after which the mixture was concentrated in vacuo and 
purified by silica gel chromatography (15:1/hexanes:ethyl acetate) to yield the title compound as 
a orange oil (0.545 g, 88%): [α]D = +8.1 (c 1.3, CHCl3); IR (thin film) 2962, 2931, 1738, 1558, 
1505, 1454, 1435, 1333, 1163 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.45-7.28 (m, 5H), 6.41 (app 
t, J = 2.6 Hz, 1H), 6.27 (app t, J = 2.4 Hz, 1H), 5.86 (dd, J = 2.8, 1.9 Hz, 1H), 5.32 (m, 1H), 4.90 
(s, 2H), 3.78 (t, J = 6.7 Hz, 2H), 3.69 (s, 3H), 3.02 (d, J = 7.1 Hz, 2H), 1.98-1.80 (m, 6H), 0.99 
(t, J = 7.3 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 201.8, 172.2, 147.7, 138.0, 128.4, 127.7, 
127.6, 118.5, 106.9, 103.8, 97.2, 86.4, 72.8, 51.7, 49.5, 35.3, 29.1, 25.8, 12.2; EI-MS m/z 353 
(M+), 322, 294, 263, 230, 202, 188; HRMS calcd for C22H27NO3: 353.1991, found 353.2003  
 
•
CO2Me
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N
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(E)-Methyl-4-((R)-1-(benzyloxy)-8-ethyl-5,6,7,8-tetrahydroindolizin-8-yl)but 
re
N
-3-enoate (37):  To a solution of allenic methyl ester 36 (0.408 g, 1.16 mmol) in 
CH2Cl2 (11.5 mL) was added Cl2Pd(MeCN)2 (0.089 g, 0.350 mmol).  The 
resulting solution was stirred vigorously at ambient temperature for 6 hours.  The 
 was diluted with 1:1/hexanes:ethyl acetate (12 mL) then quickly filtered over a 
plug of silica gel that was washed exhaustively with EtOAc.  Concentrated the filtrate in vacuo 
and purified the oil by silica gel chromatography (12:1/hexanes:ethyl acetate) to yield the title 
compound as an orange oil (0.240 g, 59%): [α]
reaction mixtu
D = +15.4 (c 1.9, CHCl3); IR (thin film) 2948, 
2874, 1738, 1563, 1453, 1435, 1342, 1205, 1158 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.41-7.25 
BnO Et
CO2Me
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(m, 5H), 6.30 (d, J = 2.5 Hz, 1H), 5.89 (d, J = 2.1 Hz, 1H), 5.69 (dt, J = 15.5, 1.2 Hz, 1H), 5.26 
(dt, J = 15.5, 7.0 Hz, 1H), 4.93 (s, 2H), 3.86 (ddd, J = 11.5, 4.8, 3.8 Hz, 1H), 3.73 (td, J = 11.6, 
4.4 Hz, 1H), 3.59 (s, 3H), 3.01 (dd, J = 7.0, 1.2 Hz, 2H), 2.11-1.71 (m, 6H), 0.82 (t, J = 7.4 Hz, 
3H); 13C NMR (75 MHz, CDCl3) δ 172.4, 142.5, 140.6, 138.8, 128.2, 127.3, 127.2, 119.4, 117.1, 
115.1, 96.6, 72.9, 51.5, 46.0, 41.9, 37.8, 31.3, 30.5, 20.4, 8.6; EI-MS m/z 353 (M+), 324, 294, 
262, 234; HRMS calcd for C22H27NO3: 353.1991, found 353.1974.  Separation of the 
enantiomers by chiral HPLC [Daicel Chiracel™ OD-H column, flow rate 1.00 mL/min., 5% 
iPrOH, 95% hexane, Tr: 6.29 min (R), 8.18 min (S)] provided the enantiomeric excess to be 72%.  
 
(E)-4-((R)-1-(Benzyloxy)-8-ethyl-5,6,7,8-tetrahydroindolizin-8-yl)but-3-en-1-
eq
N
ol (39):  To a solution of methyl ester 37 (0.047 g, 0.133 mmol) in THF (1.7 mL) 
cooled to 0 °C was added LAH (0.027 g, 0.710 mmol).  The reaction mixture 
was stirred for 30 minutes at 0 °C before being diluted with ether (2.0 mL) then 
uentially adding Hquenched by s 2O (40 μL), 5.0 N aqueous NaOH (40 μL) and H2O (110 μL).  
The resulting mixture was dried over MgSO4, filtered over celite and concentrated in vacuo to 
afford a crude oil that was purified by silica gel chromatography (9:1/hexanes:ethyl acetate) to 
yield the title compound as a clear oil (0.039 g, 90%): [α]D = +9.7 (c 1.0, CHCl3); IR (thin film) 
3394 (br), 2933, 2873, 1562, 1453, 1376, 1341, 1205, 1055 cm-1; 1H NMR (300 MHz, CDCl3) δ 
7.41-7.23 (m, 5H), 6.30 (d, J = 3.0 Hz, 1H), 5.88 (d, J = 3.0 Hz, 1H), 5.63 (d, J = 15.4 Hz, 1H), 
5.08 (dt, J = 15.4, 7.1 Hz, 1H), 4.93 (s, 2H), 3.85 (dt, J = 11.7, 4.0 Hz, 1H), 3.73 (td, J = 11.7, 
4.6 Hz, 1H), 3.50 (t, J = 6.1 Hz, 2H), 2.22 (app q, J = 6.1 Hz, 2H), 2.10-1.98 (m, 2H), 1.90-1.65 
(m, 4H), 0.82 (t, J = 7.4 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 142.3, 140.2, 138.5, 128.3, 
BnO Et
HO
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127.5, 127.3, 123.6, 117.4, 115.0, 96.4, 72.9, 61.7, 46.1, 41.8, 35.9, 31.4, 31.0, 29.7, 20.4, 8.7; 
EI-MS m/z 325 (M+), 296, 234, 160; HRMS calcd for C21H27NO2: 325.2042, found 325.2044.   
 
 (R)-1-(Benzyloxy)-8-((E)-4-triisopropylsilanyloxybut-1-enyl)-8-ethyl-5,6, 
7
lt
    
N
,8-tetrahydroindolizine (38):  To a solution of homoallylic alcohol 39 
(0.230 g, 0.707 mmol) in CH2Cl2 (6.8 mL) cooled to 0 °C was slowly added 
iPr2NEt (0.160 mL, 0.919 mmol) followed by TIPSOTf (0.230 mL, 0.848 
ing solution was stirred for 30 minutes, after which the reaction mixture was 
quenched with saturated aqueous NH
mmol).  The resu
4Cl.  The mixture was partitioned with ether and the organic 
layer washed with saturated aqueous NH4Cl (1x).  Subsequently, the aqueous layer was extracted 
with ether (1x) and the combined organic extracts were dried over Na2SO4, filtered and 
concentrated in vacuo.  Purified by silica gel chromatography (50:1/hexanes:ethyl acetate) to 
yield the title compound as a clear, colorless oil (0.279g, 82%): [α]D = +14.2 (c 2.1, CHCl3); IR 
(thin film) 2941, 2864, 1564, 1461, 1341, 1097, 1071 cm-1, 1H NMR (300 MHz, CDCl3) δ 7.41-
7.21 (m, 5H), 6.28 (d, J  = 3.0 Hz, 1H), 5.88 (d, J = 3.0 Hz, 1H), 5.60 (br d, J = 15 Hz, 1H), 5.15 
(dt, J = 15, 6.9 Hz, 1H), 3.83 (ddd, J = 11.0, 4.8, 3.6 Hz, 1H), 3.71 (td, J = 11.0, 4.3 Hz, 1H), 
3.62 (t, J = 7.0 Hz, 2H), 2.24 (app q, J = 6.9 Hz, 2H), 2.04 (dq, J = 11.0 Hz, 7.4 Hz, 1H), 1.95-
1.85 (m, 1H), 1.81-1.67 (m, 4H), 1.02 (br d, J = 2.5 Hz, 21H), 0.81 (t, J = 7.4 Hz, 3H); 13C NMR 
(75 MHz, CDCl3) δ 142.3, 138.8, 138.3, 128.2, 127.2, 127.1, 124.1, 117.8, 114.8, 96.5, 72.9, 
63.6, 46.1, 41.9, 36.5, 31.5, 30.7, 20.4, 18.0, 12.0, 8.7; EI-MS m/z 481 (M+), 452, 438, 390, 362, 
360, 318, 254, 188; HRMS calcd for C30H47NO2Si: 481.3376, found 481.3376.  
BnO Et
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4-Ethoxy-1-phenethyl-1,5-dihydropyrrol-2-one (42):  To a solution of NaOH 
(1.05 g, 26.2 mmol) in water (21 mL) at ambient temperature was added CH Cl  
(63 mL) followed by phenethylamine (13.3 mL, 106 mmol).  To the resulting 
mixture was added a solution of allyl bromide 32 (5.00 g, 21.1 mmol) in CH Cl  
) in a dropwise manner.  The reaction mixture was stirred vigorously at ambient 
temperature overnight.  Subsequently, the layers of the mixture were separated and the aqueous 
layer extracted with ether (2 x 50 mL).  The combined organic extracts were dried over MgSO , 
filtered and concentrated in vacuo and the resulting oil was allowed to stand at ambient 
temperature 8-10 hours.  Upon completion of cyclization, as monitored by TLC, the volatiles 
were removed in vacuo and the oil purified by silica gel chromatography (3:1/ethyl 
acetate:hexanes) to yield the title compound as an off-white solid (3.12 g, 64%): m.p. 56-58 °C; 
IR (KBr plate) 3106, 2938, 1665, 1620, 1378, 1226, 1031 cm-1; 1H NMR (300 MHz, CDCl ) δ 
7.29-7.16 (m, 5H), 4.97 (s, 1H), 3.91 (q, J = 7.1 Hz, 2H), 3.62 (s, 2H), 3.61 (t, J = 7.5 Hz, 2H), 
2.84 (t, J = 7.4 Hz, 2H), 1.33 (t, J = 7.1 Hz, 3H); 13C NMR (75 MHz, CDCl ) δ 172.34, 172.30, 
139.1, 128.9, 128.8, 126.4, 94.5, 66.8, 51.2, 43.0, 35.1, 14.1; EI-MS m/z 231 (M+), 140, 112; 
HRMS calcd for C H NO : 231.1259, found 231.1268. 
4-Benzyloxy-1-phenethyl-1,5-dihydropyrrol-2-one (43):  To a solution of N-
phenethyl-1,5-dihydropyrrolone 42 (6.24 g, 27.0 mmol) in benzyl alcohol (20.0 
mL, 192 mmol) was added methanesulfonic acid (0.230 mL, 3.56 mmol).  The 
resulting mixture was heated to 90 °C and stirred vigorously for 3 hours, under 
reduced pressure (13-22 mmHg).  Diluted the reaction mixture with 1:1/hexanes:ethyl acetate 
N
EtO
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3
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(20 mL) and purified by silica gel chromatography (1:1/hexanes:ethyl acetate) to yield the title 
compound as an off-white solid (6.37 g, 80%): m.p. 88-89 °C  IR (thin film) 2931, 2869, 1671, 
1623, 1454, 1348, 1219 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.37-7.14 (m, 10H), 5.08 (s, 1H), 
4.85 (s, 2H), 3.62 (s, 2H), 3.59 (t,  J = 7.2 Hz, 2H), 2.82 (t, J = 7.3 Hz, 2H); 13C NMR (75 MHz, 
CDCl3) δ 171.1, 171.6, 138.9, 134.7, 128.6, 128.5, 127.8, 126.3, 95.4, 72.8, 51.1, 42.9, 35.0; EI-
MS m/z 293 (M+), 202, 91; HRMS calcd for C19H19NO2: 293.1416, found 293.1406. 
 
3-Benzyloxy-1-phenethyl-1H-pyrrole (41):  To a solution of 1,5-
 s
was poured in
N
BnO
dihydropyrrolone 43 (3.19 g, 12.4 mmol) in THF (248 mL) at 0 oC was added 
iBu2AlH (49.6 ml, 49.6 mmol, 1 M in hexanes) over 5 minutes.  The yellow 
tirred vigorously at ambient temperature for 18 hours.  Subsequently, the solution 
to cold, aqueous 1M NaOH (478 mL) and extracted with ether (3 x 225 mL).  The 
combined organic extracts were dried over MgSO
solution was
Ph
4 and the resulting mixture stirred vigorously 
for 1 hour.  The mixture was filtered over a plug of celite and the filtrate concentrated in vacuo.  
Purified the residual oil by silica gel chromatography (50:1/hexanes:ethyl acetate) to yield the 
title compound as an off-white solid (1.24g, 36%):  m.p. 64-66 °C; IR (thin film) 2928, 1548, 
1508, 1451, 1019 cm -1, 1H NMR (300 MHz, CDCl3) δ 7.36-7.33 (m, 2H), 7.29-7.10 (m, 6H), 
6.96-6.94 (m, 2H), 6.20 (app t, J = 2.5 Hz, 1H), 6.13 (app t, J = 2.0 Hz, 1H), 5.80 (dd, J = 2.3, 
2.1 Hz, 1H), 4.80 (s, 2H), 3.78 (t, J = 7.3 Hz, 2H), 2.84 (t, J = 7.4 Hz, 2H); 13C NMR  (75 MHz, 
CDCl3) δ 147.4, 138.3, 137.6, 128.4, 128.2, 128.1, 127.3, 127.2, 126.2, 118.1, 103.3, 97.1, 72.4, 
51.2, 37.7;  EI-MS m/z 277 (M+), 186; HRMS calcd for C19H19NO: 277.1467, found 277.1464.       
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General procedure for removal of the benzyl group on 41 via transfer hydrogenation:  To a 
solution of model benzyloxy pyrrole 41 (0.070 g, 0.253 mmol) in HOAc (2.5 mL) was added 
Pd/C (0.070 g, 10% act. on carbon) followed by 1,4-cyclohexadiene (0.240 mL, 2.53 mmol).  
The reaction mixture was stirred vigorously at ambient temperature until complete, as monitored 
by TLC.  The mixture was then diluted with CH Cl  and filtered over a plug of celite, washing 
with more CH Cl .  Cooled the collected organic layer to 0 °C and slowly quenched with 
saturated aqueous NaHCO .  The layers were separated and the organic layer washed once more 
with saturated aqueous NaHCO .  The organic layer was then dried over Na SO , filtered, and 
concentrated in vacuo.    
General procedure for removal of the benzyl group on 41 via Brønsted acid and Brønsted 
cid-Lewis base conditions:  To a solution of model benzyloxy pyrrole 41 (0.070 g, 0.253 
mmol) in DMS (0.77 mL) at ambient temperature was added TFA (1.53 mL).  The reaction 
mixture was stirred vigorously at ambient temperature until complete, as monitored by TLC.  
The resulting solution was diluted with CH Cl  and cooled to 0 °C before it was slowly 
quenched with saturated aqueous NaHCO .  The layers were separated and the organic layer 
washed once more with saturated aqueous NaHCO .  The organic layer was then dried over 
Na SO , filtered and concentrated in vacuo.    
tert-butyl ester (49):  
To a solution of ene-trinone 25 (4.97 g, 24.6 mmol) in CH2Cl2 (391 mL) at 
ambient temperature was slowly added phenethylamine (3.08 mL, 24.6 mmol).  
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The dark yellow 
the resulting mix
with a copious a
purified by silica
ydroxy-2-carboxylate pyrrole 49 (1.10 g, 3.83 mmol) in 
CH2Cl2 80 mL) at ambient temperature was added trifluoroacetic acid (10 mL).  
q
CH2Cl2, the l
The combine
cooled to 0 °C.  To the reaction mixture was slowly added iPr2NEt (12 mL), followed by slow 
solution was stirred for 30 minutes, after which silica gel (111 g) was added and 
ture stirred vigorously overnight.  The silica gel was filtered off and washed 
mount of CH2Cl2.  The filtrate was concentrated in vacuo and the resulting oil 
 gel chromatography (50:1/hexanes:ethyl acetate) to yield the title compound as 
a yellow oil (2.7 g, 38%):  IR (thin film) 2975, 1639, 1553, 1393, 1154, 1108 cm-1; 1H NMR 
(300 MHz, CDCl3) δ 8.53 (br s, 1H), 7.21-7.10 (m, 3H), 6.98-6.95 (m, 2H), 6.18 (d, J = 2.8 Hz, 
1H), 5.57 (d, J = 2.9 Hz, 1H), 4.18 (t, J = 6.9 Hz, 2H), 2.89 (t, J = 6.9 Hz, 2H), 1.55 (s, 9H); 13C 
NMR (75 MHz, CDCl3) δ 162.5, 156.0, 138.3, 128.7, 128.4, 127.2, 126.5, 105.9, 95.7, 81.6, 
51.1, 38.2, 28.6; EI-MS m/z 287 (M+), 231, 213, 186, 122, 109; HRMS calcd for C17H21NO3: 
287.1521, found 287.1511.  
 
Trifluoromethanesulfonic acid 1-phenethyl-1H-pyrrol-3-yl ester (48):  To a 
solution of N-phenethyl-3-hN
TfO
 (
Ph
The reaction mixture was stirred vigorously for 6 hours, after which it was cooled 
uenched with saturated aqueous NaHCOto 0 °C and 3.  The resulting mixture was diluted with 
ayers separated and the organic layer washed with saturated aqueous NaHCO3 (1x).  
d organic extracts were dried over MgSO4, filtered and concentrated in vacuo to 
yield 1,2-dihydropyrrolone 50 as an oil that was used without further purification:  Crude 1H 
NMR (300 MHz, CDCl3) δ 7.56 (d, J = 2.9 Hz, 1H), 7.35-7.25 (m, 3H), 7.15- 7.13 (m, 2H), 5.04 
(d, J = 3.2 Hz, 1H), 3.69 (s, 2H), 3.61 (t, J = 6.9 Hz, 2H), 2.9 (t, J = 6.9 Hz, 2H).  
The crude 1,2-dihydropyrrolone 50 was dissolved in CH2Cl2 (80 mL) and the solution 
 49 
addition of Tf2O (0.770 mL, 4.60 mmol).  The reaction mixture was stirred at 0 °C for 20 
minutes then allowed to warm to ambient temperature overnight.  The resulting brown solution 
was t
mol) 
followed by TBAF (1.45 mL, 1.44 mmol, 1.0 M in THF).  The mixture was stirred 
 
reaction wa
mixture was
and diluted 
hen cooled to 0 °C and quenched with water.  The layers were separated and the aqueous 
layer was extracted with CH2Cl2 (2x).  The combined organic extracts were then washed with 
brine, dried over Na2SO4, filtered and concentrated in vacuo to produce an oil that was purified 
by silica gel chromatography (50:1/hexanes:ethyl acetate) to yield the title compound as an 
orange-red oil (1.70 g, 70% overall yield from 49):  IR (thin film) 3141, 3030, 2938, 1420, 1332, 
1242, 1210, 1138, 979 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.27-7.16 (m, 3H), 7.00-6.97 (m, 
2H), 6.50 (app t,  J = 2.2 Hz, 1H), 6.31 (app t, J = 2.7 Hz, 1H), 5.98 (dd, J = 2.9, 1.8 Hz, 1H), 
3.96 (t, J = 7.0 Hz, 2H), 2.94 (t, J = 7.0 Hz, 2H); 13C NMR (75 MHz, CDCl3) δ 138.0, 135.2, 
129.0, 128.9, 127.2, 119.4, 119.2 (q, J = 319 Hz, -CF3), 111.5, 101.4, 52.5, 38.1; EI-MS m/z 319 
(M+), 186, 158, 115, 130, 105; HRMS calcd for C13H12F3NO3S: 319.0490, found 319.0475. 
 
1-Phenethyl-3-phenyl-1H-pyrrole (51):  To a solution of triflate 48 (0.230 g, 0.720 
mmol), Pd(OAc)2 (0.016 g, 0.070 mmol) and triphenylphosphine (0.038 g, 0.144 
mmol) in DMF (7.2 mL) was added phenyltrimethoxysilane (0.269 mL, 1.44 m
N
Ph
Ph
at ambient temperature for 5 minutes, then degassed via one freeze-pump-thaw cycle.  The 
s then heated to 90 °C and stirred vigorously for 24 hours.  The resulting black 
 allowed to cool to ambient temperature before being quenched with water (7.2 mL) 
with ether (10 mL).  The layers were separated and the ethereal layer was washed 
with water (7 x 15 mL).  The aqueous layer was then extracted with ether (1 x 20 mL) and the 
combined organic extracts dried over Na2SO4, filtered and concentrated in vacuo.  Purified by 
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silica gel chromatography (40:1/hexanes:ethyl acetate) to yield the title compound as a off-white 
solid (0.030 g, 17%):  m.p. 67-70 °C; IR (thin film) 3027, 2927, 1554, 1497, 1453; 1H NMR 
(300 MHz, CDCl3) δ 7.48-7.45 (m, 2H), 7.32-7.20 (m, 5H), 7.15-7.08 (m, 3H), 6.87 (app t, J = 
2.0 Hz, 1H), 6.57 (app t, J = 2.5 Hz, 1H), 6.41 (dd, J = 2.7, 1.9 Hz, 1H), 4.08 (t, J = 7.2 Hz, 2H), 
3.05 (t, J = 7.2 Hz, 2H); 13C NMR (75 MHz, CDCl3) δ 138.3, 136.0, 128.7, 128.6, 128.5, 126.7, 
125.2, 125.0, 124.8, 121.5, 117.3, 106.2, 51.4, 38.3; EI-MS m/z 247 (M+), 156, 143; HRMS 
calcd for C18H17N: 247.1361, found 247.1361. 
 
[(2-Dimethylamino)phenyl]trimethoxysilane (52):  To a solution of N,N-
dimethylaniline (5.23 mL, 41.3 mmol), and TMEDA (6.22 mL, 41.3 mmol) in 
hexanes (26 mL) at 40 °C was added nBuLi (26
NMe2
Si(OMe)3
.0 mL, 41.3 mmol, 1.6 M in hexanes).  Stirred the 
reaction mixture for 6 hours, after which the yellow heterogeneous mixture was added to a 
resulting mixture 
of N-Boc aniline (1.00 g, 5.17 mmol) in THF (21 mL) at −78 °C was slowly 
solution of tetramethyl orthosilicate (5.33 mL, 36.1 mmol) in hexanes (26 mL) at 0 °C.  The 
was stirred at ambient temperature for 14 hours and subsequently filtered, 
washing the removed solids with pentanes.  The filtrate was concentrated in vacuo to yield a 
crude yellow oil that was purified via bulb-to-bulb distillation (pot temp. 40oC @ 0.075 mb first 
to remove left over tetramethyl orthosilicate, then 60oC @ 0.075 mb to collect desire product) to 
yield the title compound as a pale yellow oil (4.70 g, 47%):  13C NMR (75 MHz, C6D6) δ 161.6, 
138.0, 132.0, 128.8, 124.3, 120.4, 50.6, 46.4; EI-MS m/z 241 (M+), 226, 210, 195, 120;  HRMS 
calcd for C11H19NO3Si: 241.1134, found 241.1136. 
 
(2-Trimethylsilanylphenyl)carbamic acid tert-butyl ester (53):  To a solution NHBoc
TMS
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added tBuLi (7.50 mL, 12.5 mmol, 1.7 M in pentanes).  The solution was stirred at −78 °C for 15 
minutes and then warmed to −20 oC for 2 hours.  To the reaction mixture was added TMSCl 
(1.64 mL, 12.9 mmol) in a slow, dropwise manner and then warmed the reaction mixture to 
ra
diluted the react
ambient tempe ture.  Stirred the mixture at ambient temperature for 24 hours, after which 
ion with water, separated the layers and extracted the aqueous layer with EtOAc 
(3x).  The combined organic extracts were dried over Na2SO4, filtered and concentrated in 
vacuo.  Purified the resulting oil by silica gel chromatography (30:1/hexanes:ethyl acetate) to 
yield the title compound as a off-white solid (0.444 g, 32%):  m.p. 58-59 °C; IR (thin film) 3252, 
2976, 1695, 1513, 1365, 1248, 1175 cm -1; 1H NMR (300 MHz, CDCl3) δ 7.67 (br d, J = 7.8 Hz, 
1H), 7.42-7.32 (m, 2H), 7.11 (app t, J = 7.3 Hz, 1H), 6.39 (br s, 1H), 1.51 (s, 9H), 0.35 (s, 9H); 
13C NMR (75 MHz, CDCl3) δ 153.5, 142.5, 134.5, 131.0, 130.2, 124.1, 123.0, 80.2, 28.4, -0.47; 
EI-MS m/z 265 (M+), 209, 194, 149, 134, 119; HRMS calcd for C14H23NO2Si: 265.1498, found 
265.1490. 
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2.0  EFFICIENT FORMATION OF POLYPROPIONATE UNITS VIA THE 
CINCHONA ALKALOID-CATALYZED AAC REACTION 
2.1 BACKGROUND 
Propionate and polypropionate subunits are common structural motifs found in many 
biologically active natural products such as antibiotics and antitumor agents (Figure 13).39  
While the synthesis of polypropionate units has drawn much research interest, the formation of 
different arrays of these subunits still poses a significant challenge for the synthetic chemist.  
Biochemically, the production of polypropionate units is accomplished under the influence of 
two types of enzymatic catalysts, aldolases and antibodies (Figure 14).40
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Figure 13: Erythromycin (55) and (−)-dictyostatin (56) 
                                                 
39 (a) Defosseux, M.; Blanchard, N.; Meyer, C.; Cossy, J. Tetrahedron 2005, 61, 7632-7653. (b) Mochirian, P.; 
Cardinal-David, B.; Guérin, B.; Prévost, M.; Guidon, Y. Tetrahedron Lett. 2002, 43, 7067-7071. 
40 (a) Gijsen, H. J. M.; Wong, C.-H.  J. Am. Chem. Soc. 1995, 117, 7585-7591. (b) Machajewski, T. D.; Wong, C.-H. 
Angew. Chem. Int. Ed. 2000, 39, 1352-1375. 
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Figure 14: Formation of propionate units via enzymatic catalysis 
 
The most heavily studied and classical synthetic method for the formation of these subunits is 
undoubtedly the aldol reaction.41  The aldol addition reaction is recognized as a fundamental tool 
for the formation of C-C bonds in synthetic organic chemistry.  Due to the widespread use of this 
transformation in organic synthesis, there has been extensive exploration into performing it 
asymmetrically.  These asymmetric variants can be categorized into two major subclasses: those 
that use a stoichiometric amount of chiral modifier and those that are catalytic. 
Stoichiometric variants of the asymmetric aldol reaction consist of examples where 
asymmetric induction occurs via a chiral auxiliary that is incorporated onto an achiral substrate 
donor (Scheme 13).  While additional steps in a synthetic sequence are needed for the installation 
and removal of the chiral auxiliary, this drawback is outweighed by the benefits gained from 
their use.  First, the chiral auxiliaries utilized in the aldol addition reaction are normally prepared 
in a straightforward fashion from commercially available material.  Second, these moieties often 
facilitate the isolation-separation-purification processes of the incipient aldol adducts.  Lastly, 
the high diastereoselective reliability of these auxiliary-based aldol reactions makes this 
transformation very practical for both academic and industrial laboratories.    
                                                 
41 (a) Palomo, C.; Oiarbide, M.; García, J. M. Chem. Eur. J. 2002, 8, 36-44. (b) Palomo, C.; Oiarbide, M.; García, J. 
M. Chem. Soc. Rev. 2004, 33, 65-75.  
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Despite the benefits gained by using chiral auxiliaries, they ultimately suffer from the fact that 
they are used in a stoichiometric amount.  A more economical and elegant way to carry out these 
transformations is to introduce diastereoselectivity by employing a catalytic amount of chiral 
inductor.40b,42  This goal has been achieved by introducing asymmetric induction using a few 
different approaches.  In 1996, Mukaiyama and coworkers succeeded in performing the first 
catalytic, asymmetric aldol reaction by utilizing substoichiometric amounts of a chiral tin(II) 
complex as a Lewis acid to activate the aldehyde acceptor (Scheme 14).  Since this pioneering 
discovery, a steady improvement of chiral Lewis acids to perform this asymmetric 
transformation has been observed. 
      
Scheme 14 
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42 Alcaide, B.; Almendros, P. Eur. J. Org. Chem. 2002, 1595-1601. 
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Another successful attempt at performing a catalytic, asymmetric aldol addition reaction 
occurred by mediation with a chiral Lewis base where the aldol donor is activated.  This 
conceptually different approach was accomplished in 2000 by Denmark and coworkers (Scheme 
15).  In this reaction, trichlorosilyl enolates are used as the aldol donors and are activated by a 
catalytic amount of chiral phosphoramide Lewis base promoter.  The afforded aldol adducts were 
obtained in good yield with a high degree of enantioselectivity (up to 97% ee). 
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An innovative variant to the “standard” aldol methodologies which has gained an increasing 
amount of attention in recent years is the use of organocatalysts to perform asymmetric aldol 
reactions.  An enticing attribute of these organocatalytic reactions is the alleviation of having to 
pregenerate enolates or enolate equivalents.  Seminal research in this area, performed by List, 
Barbas III and coworkers, has shown that the simple amino acid L-proline promotes a 
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diastereoselective aldol addition reaction between hydroxyacetone and an aldehyde.43  
Subsequent studies conducted by Macmillan and coworkers further demonstrated the utility of L-
proline by successfully cross-coupling two different aldehydes with one another in an enantio- 
and diastereoselective fashion (Scheme 16).44  To date, a large variety of proline variants have 
been synthesized and screened for catalytic activity.   
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In 2004, the Nelson group developed an alternative method for the production of propionate 
units by employing a substoichiometric amount of chiral cinchona alkaloid in the AAC reaction 
(Scheme 17).45  In this 2nd generation AAC reaction, propionyl chloride undergoes a 
dehydrohalogenation reaction in the presence of Hünig’s base to generate methyl ketene in situ.  
Methyl ketene is then intercepted by a catalytic amount of either TMS-quinine or the 
pseudoenantiomeric TMS-quinidine to produce exclusively a chiral (Z)-enolate.  Subsequently, 
this chiral nucleophile reacts with an aldehyde via Zimmerman-Traxler chair transition state C to 
yield a syn-disubstituted β-lactone product in good yield and in essentially enantio- and 
diastereomerically pure form.   
                                                 
43 Notz, W.; Tanaka, F.; Barbas III, C. F. Acc. Chem. Res. 2004, 37, 580-591. 
44 Northrup, A. B.; Macmillan, D. W. C. J. Am. Chem. Soc. 2002, 124, 6798-6799. 
45 Zhu, C.; Shen, X.; Nelson, S. G. J. Am. Chem. Soc. 2004, 126, 5352-5353. 
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O
Me
Cl
O
RH
O
O
RMe
O OM
NR3*
R1
H
RTMS-quinine
LiClO4, iPr2NEt
+
70 - 85% yield
96 - >99% ee
9 - 19:1 d.r.
N
MeO
TMSO
H
N
H
TMS-quinine (TMS-QN)
N
MeO
TMSO
H
N
H
TMS-quinidine (TMS-QD)
C
 
 
Due to the highly efficient nature of this transformation, the Nelson group became intrigued by 
the further potential that this Cinchona alkaloid-catalyzed AAC possessed.  More specifically, 
interest in the effect double diastereoselection would have on the AAC reaction of chirally-
substituted aldehydes was piqued (Figure 15).  If the cinchona alkaloid-catalyzed AAC reaction 
is amenable to these more elaborate aldehydes, it would afford a new and efficient method for 
the formation of polypropionate units in an iterative fashion.       
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Figure 15: Formation of polypropionate units via the alkaloid-catalyzed AAC 
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2.2 RESULTS AND DISCUSSION 
In order to determine the potential of the Cinchona alkaloid-catalyzed AAC reaction to form 
polypropionate units, a variety of model aldehydes were synthesized and tested.  These 
aldehydes varied in stereo- and regiochemical content to observe not only the reactivity of these 
aldehydes in the AAC reaction but also the effect different substitution patterns would have on 
the diastereoselectivity of the ensuing cyclocondensation.  All the model aldehydes were 
synthesized using similar, straightforward reaction sequences which could be scaled up with no 
diminishing effects. 
2.2.1 Synthesis and reactivity of model aldehyde 57 
The initial studies to determine the potential of the cinchona alkaloid-catalyzed AAC reaction to 
form polypropionate subunits were made using model α,β-disubstituted syn-aldehyde 57 
(Scheme 18).46  The synthesis of aldehyde 57 began with commercially available hydrocin-
namaldehyde which was subjected to the original Cinchona alkaloid-catalyzed AAC reaction to 
produce disubstituted β-lactone 58 in 84% yield and in essentially enantio- and 
diastereomerically pure form.  Opening of β-lactone 58 with (MeO)NHMe·HCl in the presence 
of Me2AlCl afforded a 95% yield of β-hydroxy amide 59.  Protection of the now unmasked 
hydroxy group on amide 59 with TMSCl produced silyl ether 60 in 97% yield.  Subsequent 
reduction of the Weinreb amide moiety on silyl ether 60 with iBu2AlH afforded a 90% yield of 
the desired model aldehyde 57. 
                                                 
46 The studies concerning model syn-aldehyde 57 were performed by Dr. Jeff Wallace and Dr. Cheng Zhu.  The 
matched AAC reaction with aldehyde 57 where DMF was used as the cosolvent was performed by the author of this 
document (see Experimental).    
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With the desired model substrate at hand, syn-aldehyde 57 was subjected to the original 
Cinchona alkaloid-catalyzed AAC reaction conditions previously reported by the Nelson 
group.45  As expected, the added steric components on model aldehyde 57 greatly attenuated the 
reactivity of the aldehyde in the AAC reaction, with β-lactone 61 being produced in low yield.46  
However while the yield of β-lactone 61 was low, the reaction did prove that the alkaloid-
catalyzed AAC reaction had potential to produce iterative polypropionate units.  After 
optimization of the original AAC reaction conditions, which included changing the solvent ratio 
(10:1), using an excess of Lewis acid (3.0 equivs.) and elongating the addition time of the 
solution of PrCl in CH2Cl2, reaction conditions were found that produced the desired syn, anti, 
syn masked polypropionate unit 61 in 83% yield and as a single diastereomer (Scheme 19). 
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After successfully synthesizing the desired syn, anti, syn masked polypropionate 61, model syn-
aldehyde 57 was then subjected to a catalytic amount of the pseudoenantiomeric TMS-QN using 
the same optimized reaction conditions (Scheme 20).  The expected product from this reaction 
was β-lactone 62 which possesses an all syn stereoarray.  Surprisingly, only a very small amount 
of desired β-lactone 62 was obtained.  Instead, the major product obtained was the unexpected 
anti, anti, syn masked polypropionate unit 63, produced in 68% yield with a d.r. = 
19:1/trans:cis.47  Despite many efforts, the syn, syn, syn masked polypropionate unit 62 has yet 
to be synthesized using the Cinchona alkaloid-catalyzed AAC reaction.    
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47 The absolute stereochemistry of masked polypropionate unit 63 was unambiguously proven via x-ray 
crystallography following derivatization. 
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In order to explain the production of both the expected and unexpected β-lactone products, the 
transition states which they come from need to be examined.  As before with the original 
cinchona alkaloid-catalyzed AAC reaction, it is felt that this cyclocondensation occurs via a 
closed Zimmerman-Traxler transition state (Figure 16).  However, while invoking this closed 
transition state two important requirements must be accounted for.  First, since an α-chiral 
aldehyde is being used, the chiral (Z)-enolates that are generated in situ will prefer to approach 
the recipient aldehydes from an anti-Felkin trajectory to avoid a highly unfavored syn-pentane 
interaction from occurring.  Second, the preferred reactive enantioface of the chiral enolate is 
going to be solely dependent on the Cinchona alkaloid that is being employed.      
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Figure 16: Explanation of beta-lactone products from aldehyde 57 
 
As depicted in transition state D in Figure 16, the expected syn, anti, syn masked polypropionate 
unit 61 is prepared from reaction of the chiral (Z)-enolate derived from TMS-quinidine with 
aldehyde 57 via a closed Zimmerman-Traxler chair transition state.  However, for the case of 
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unexpected anti, anti, syn β-lactone product 63, this transition state is not operative.  Due to the 
fact that quinine and quinidine are pseudoenantiomers, their respective chiral enolates will prefer 
opposite enantiofaces when reacting with aldehyde 57.  In light of this, the (Z)-enolate derived 
from TMS-quinine reacts with syn-aldehyde 57 via boat transition state E to expose the oppose 
enantioface of the enolate to the aldehyde while maintaining an anti-Felkin approach.  Reaction 
through this transition state leads to production of the unexpected anti, anti, syn masked 
polypropionate unit 63.    
 
2.2.2 Synthesis and reactivity of model aldehyde 64 
At the same time at which model syn-aldehyde 57 was being tested in the cinchona alkaloid-
catalyzed AAC reaction, model anti-aldehydes were also being tested.  The synthesis of model 
aldehydes 64a,b began with monosubstituted β-lactone 65, which was produced in 94% ee from 
the Al(III)-catalyzed AAC (Scheme 21).  Using chemistry developed in the Nelson group, β-
lactone 65 was α-methylated with MeI and NaHMDS to produce disubstituted trans-β-lactone 
66 in 58% yield.48  Subsequent opening of β-lactone 66 proceeded in 92% yield to afford β-
hydroxy Weinreb amide 67.  At this point two different silyl ether derivatives, trimethylsilyloxy 
and triethylsilyloxy amides 68a and 68b, respectively, were made in order to test the effect the 
protecting group would have on the AAC reaction.  Silylation of the β-hydroxy group on amide 
67 using standard silylation conditions followed by iBu2AlH reduction of the Weinreb amide 
moiety afforded model aldehydes 64a,b in good overall yield.     
 
                                                 
48  Kassick, A. J. unpublished results. 
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For the initial studies to determine the viability of aldehydes 64a,b in the AAC reaction, 
conditions using a catalytic amount of TMS-quinine were selected (Table 2).  The major product 
obtained for all the aldehydes tested was the expected syn, anti, anti polypropionate unit 69.  
More interesting though was the inverse trend between yield and d.r. observed when taking into 
account the nature of the β-hydroxy protecting group.  For protecting groups that allowed the β-
hydroxy group to participate in chelation (TMS, PMB)49 the reactivity of the aldehyde in the 
AAC was high (~90% conversion) with the β-lactone product being produced with good 
diastereoselectivity (7-9:1/cis:trans).  However in the case where a bulkier silyl group was 
employed (TES), though the reactivity of the aldehyde was decreased (75% conversion) the β-
lactone product was produced in high diastereoselectivity (15:1/cis:trans).   
                                                 
49 The anti-aldehyde possessing a β-PMB ether was only synthesized for testing the protecting group effect and was 
not characterized.   
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Table 2: Protecting group effect on aldehyde 64 in the AAC 
 
O
O
OP
Me
Me Ph
PhH
O
Me
OP TMS-quinine (10 mol %),
 LiI, iPr2NEt, -78 °C
propionyl chloride,
10:1/CH2Cl2:Et2O
69
syn, anti, anti  
entry
a
b
c
d.r.Conversion
-OTESb
~92%
90%
75%
~7.5:1
9:1
15:1
-OP
-OPMBa
-OTMSb
 
a Based on crude 1H NMR.  b Conversions and d.r. measured using HPLC analysis (see Experimental for condition 
details).  Major diastereomer is the depicted cis β-lactone product 
 
Further optimization of the Cinchona alkaloid-catalyzed AAC reaction for anti-aldehydes 64a,b 
continued by testing the effect the co-solvent had on the outcome of the reaction (Table 3).  For 
both substrates tested, all the co-solvents employed had a minor effect on the conversion of the 
starting aldehydes to the β-lactone products, with DMF slightly hindering the reaction.  The most 
drastic effect though was observed in the diastereoselectivity of the β-lactone products obtained.  
Based on the diastereoselectivities, the use of DMF as a co-solvent was far superior to both THF 
and Et2O for aldehydes 64a,b.  When DMF was used, the desired syn, anti, anti polypropionate 
units 69a,b were both produced exclusively as a single diastereomer.  
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Table 3: Co-solvent effect on the AAC reaction of aldehydes 64a,b 
 
O
O
OP
Me
Me Ph
PhH
O
Me
OP TMS-quinine (10 mol %),
 LiI, iPr2NEt, -78 °C
propionyl chloride,
10:1/CH2Cl2:X
69a,b
syn, anti, anti
64a,b
 
entry
a
b
c
d.r.Conversion
64ab
~86%
90%
83%
5:1
9:1
>50:1
Aldehyde
64aa
64ab
X
d 64bb 75% 15:1
e 64bb 76% >50:1
THF
Et2O
Et2O
DMF
DMF
 
a Based on crude 1H NMR.  b Conversions and d.r. measured using HPLC analysis (see Experimental for condition 
details).  Major diastereomer is the depicted cis β-lactone product 
 
Since the diastereoselectivities achieved by model aldehydes 64a,b in the AAC reaction were 
equivalent up to this point, it was decided to use only one of the substrates for further studies.  
Due to the extra stability possessed by a TES protecting group compared to a TMS protecting 
group, as well as to demonstrate that aldehydes with bulkier silyl groups in the β-position can be 
used in the AAC reaction, anti-aldehyde 64b was chosen for further studies.  Since β-lactone 
69b was already being produced as a single diastereomer, the only aspect of the reaction left to 
optimize was to increase the conversion of aldehyde 64b into the β-lactone product.  It was felt 
that the best way to accomplish this would be to increase the temperature at which the reaction 
was run.  With that in mind, a temperature study for the AAC reaction of aldehyde 64b was 
conducted (Table 4).  Gratifyingly, it was found that by performing the reaction at −50 ºC 
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provided almost complete consumption of aldehyde 64b while still upholding the production of 
β-lactone 69b as a single diastereomer. 
 
Table 4: Temperature effect on the AAC reaction of aldehyde 64b       
 
O
O
OTES
Me
Me Ph
PhH
O
Me
OTES TMS-quinine (10 mol %),
 LiI, iPr2NEt,
propionyl chloride,
10:1/CH2Cl2:DMF
69b
syn, anti, anti
64b
 
entry
a
b
c
d.r.Conversion
−50 °C
76%
92%
97%
single diastereomer
single diastereomer
single diastereomer
Temperature
−78 °C
−60 °C
d −25 °C 86% single diastereomer
 
Conversions and diastereomeric ratios measured by HPLC analysis (see Experimental for condition details). 
 
The overall optimized reaction for aldehyde 64b in the presence of a catalytic amount of TMS-
QN produced the desired β-lactone 69b in 81% yield as a single diastereomer (Scheme 22).  In 
order to unambiguously prove the stereochemistry of the β-lactone product, highly crystalline β-
lactone 70 was synthesized.  Starting with β-lactone 69a, removal of the silyl protecting group 
with HF/pyridine provided alcohol 71 in 70% yield.  Subsequent formation of the ester with 3,5-
dinitrobenzoyl chloride in the presence of DMAP yielded β-lactone 70 in 87% yield.  After 
recrystallization via slow vapor diffusion, the X-ray data obtained unambiguously proved that 
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the matched AAC reaction for aldehydes 64a,b yielded β-lactone products that possessed the 
expected syn, anti, anti stereoarray (Appendix A).   
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As with the model syn-aldehyde, when the anti-aldehyde was subjected to the AAC reaction in 
the presence of the pseudoenantiomeric TMS-QD a similar type of matched /mismatched 
phenomenon was observed, however to a more severe extent.  While subjection of aldehyde 64b 
to the AAC reaction with TMS-QN yielded expected β-lactone product 69b, subjection of the 
aldehyde to the AAC reaction with TMS-QD yielded only a minor amount (~20% conversion) of 
β-lactone product (Scheme 23).  Efforts to improve this transformation, which included 
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screening various Lewis acids, proved fruitless as the reactivity of aldehyde 64b in the TMS-QD-
catalyzed AAC reaction remained poor.   
 
Scheme 23         
PhH
O
Me
OTES    TMS-quinidine (10 mol%),
 LiI, iPr2NEt, Poor conversion (~20%)
and poor d.r. (~1.5:1)propionyl chloride
Ineffective LA: Mg(ClO4), MgCl2, La(OTf)3, ZnCl2, AlCl3
64b
 
   
In general, the reactivity of syn-aldehyde 57 seems to be greater than that of anti-aldehyde 64b in 
the AAC reaction.  To explain this, as well as speculate on the greater disparity observed in the 
matched/mismatched phenomenon with the anti-aldehyde versus the syn-aldehyde, the reactive 
conformers of the aldehydes needed to be determined.  In order to do so, the Reetz-Evans model 
for the preferred reactive conformers of substituted aldehydes will be invoked.50  It is crucial 
though to keep in mind that since (Z)-enolates are exclusively being formed that an anti-Felkin 
trajectory of the enolate to the aldehyde is preferred.  Therefore, in the case of syn-aldehyde 57 it 
can be seen that in both transition states F and G the syn-aldehyde is able to attain a reactive 
conformer where both the α- and β-stereocenters are in a desired arrangement (Figure 17).  This 
conformer should be the lowest energy conformer that the aldehyde can attain, thereby 
facilitating the reaction.    
 
                                                 
50 (a) Reetz, M. T.; Kesseler, K. Jung, A. Tetrahedron 1984, 40, 4327-4336. (b) Reetz, M. T.; Kesseler, K. J. Chem. 
Soc., Chem. Commun. 1984, 1079-1080. (c) Evans, D. A.; Dart, M. J.; Duffy, J. L.; Yang, M. G. J. Am. Chem. Soc. 
1996, 118, 4322-4343. 
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Figure 17: Reetz-Evans model of aldehyde 57 
 
Applying the Reetz-Evans model to anti-aldehyde 64b shows that unlike syn-aldehyde 57, in 
transition states H and I the reactive conformer of the anti-aldehyde can only have the α-
stereocenter in a preferred arrangement (Figure 18).  Due to the relative stereochemistry in the 
starting aldehyde, as well as the strong preference for an anti-Felkin approach, the β-stereocenter 
on the aldehyde is unable to attain the lowest energy conformation.  It is speculated that the 
higher reactivity of the syn-aldehyde in the AAC reaction is due to the difference in energies 
between the possible reactive conformers of the syn- and anti-aldehydes.  Additionally, it is 
speculated that in the mismatched AAC reaction with anti-aldehyde 64b (transition state I) the 
reaction is more disfavored and sluggish due to the higher energy of the operative transition state 
of this cyclocondensation (reactive conformer’s energy plus the boat transition state).   
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Figure 18: Reetz-Evans model of aldehyde 64b 
 
2.2.3 Synthesis and reactivity of aldehyde ent-64b 
To determine the relationship between the enantiomer of the starting aldehyde and the Cinchona 
alkaloid employed, the enantiomer of model anti-aldehyde 64b was synthesized and tested in the 
AAC reaction.  The synthetic sequence commenced by α-methylating known β-lactone ent-65 
(94% ee) with NaHMDS and MeI to produce trans-β-lactone ent-66 in 50% yield (Scheme 24).48  
Subsequent ring-opening of β-lactone ent-66 to β-hydroxy Weinreb amide ent-67 with 
(MeO)NHMe·HCl and Me2AlCl proceeded in 91% yield.  Silylation of the β-hydroxy group of 
amide ent-67 using TESCl in the presence of imidazole afforded a 94% yield of silyl ether ent-
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68b.  Reduction of the Weinreb amide moiety on silyl ether ent-68b with iBu2AlH afforded the 
desired model aldehyde, ent-64b, in 93% yield.   
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As presumed, when aldehyde ent-64b was subjected to the AAC reaction conditions optimized 
for aldehyde 64b the matched reaction was now with the pseudoenantiomeric TMS-QD (Scheme 
25).  The β-lactone product from that reaction was the expected syn, anti, anti masked 
polypropionate unit ent-69b which was synthesized in 84% yield and as a single diastereomer.  
Similar to aldehyde 64b, when aldehyde ent-64b was subjected to the AAC reaction under the 
catalytic influence of the other cinchona alkaloid, TMS-QN, poor conversion to the β-lactone 
product was observed.       
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2.2.4 Synthesis and reactivity of aldehyde 72 
Another type of aldehyde that was synthesized and tested in the Cinchona alkaloid-catalyzed 
AAC reaction was a monosubstituted substrate that possessed a β-silyloxy group and no α-
substituent.  The product from this AAC reaction would be a “skipped” polypropionate unit.  
Aldehyde 72 was chosen as the model substrate and the synthesis of 72 began by opening known 
β-lactone 65 (94% ee) to β-hydroxy Weinreb amide 73 with (MeO)NHMe·HCl and Me2AlCl in 
96% yield (Scheme 26).  Silylation of the β-hydroxy group of amide 73 using TESCl and 
imidazole afforded a 99% yield of silyl ether 74.  Reduction of the Weinreb amide moiety on 
silyl ether 74 with iBu2AlH afforded the desired model aldehyde 72 in 81% yield.   
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Since aldehyde 72 possessed no α-substituent, the observed reactivity was greater than other 
aldehydes previously tested in the AAC reaction.  Therefore, some minor optimization of 
reaction conditions needed to be carried out.  It was found that when β-triethylsilyloxy aldehyde 
72 was subjected to the AAC reaction in the presence of a catalytic amount of TMS-QD, 
expected β-lactone product 75 was formed as a single diastereomer (Scheme 27).  Due to an 
inability to isolate the desired product in pure form, crude β-lactone 75 was opened to the 
corresponding bis-hydroxy Weinreb amide using (MeO)NHMe·HCl and Me2AlCl to produce 
amide 76 in 71% yield over the two steps.  Alternatively,  it was found that the optimal 
conditions for the AAC reaction of aldehyde 72 catalyzed by TMS-QN was in a 2:1/CH2Cl2:Et2O 
solvent system where β-lactone 77 was formed in 79% yield as a 10:1 inseparable mixture of 
diastereomers, with the cis-diastereomer predominating.   
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2.2.5 Iterative polypropionate unit formation  
To test the further potential of this transformation, tetrasubstituted aldehyde 78 was synthesized 
to demonstrate the capability of the Cinchona alkaloid-catalyzed AAC reaction to form iterative 
polypropionate units.  If successful, the β-lactone product from the AAC reaction would be a 
masked polypropionate unit with six contiguous stereocenters.  The synthesis of tetrasubstituted 
aldehyde 78 commenced with opening of β-lactone 61 using (MeO)NHMe·HCl and Me2AlCl, 
with concomitant cleavage of the TMS ether, to produce bis-hydroxy amide 79 (Scheme 28).  
Protection of both hydroxy groups with TMSCl, followed by treatment of the crude residue with 
iBu2AlH afforded tetrasubstituted aldehyde 78 in 84% overall yield.  Gratifyingly, aldehyde 78 
was a competent substrate in the AAC reaction, producing the desired syn, anti, syn, anti, syn 
masked polypropionate unit 80 as a single diastereomer in 76% yield. 
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The Nelson group was successful in developing an efficient alternative method for the 
production of polypropionate units utilizing a modified version of the asymmetric Cinchona 
alkaloid-catalyzed AAC reaction.  A variety of aldehydes proved amenable to this transformation 
as flexibility in reaction conditions allowed for optimization of the AAC reaction for a specific 
aldehyde.51  In most cases, the transformation was clean and the β-lactone products were easily 
isolated or could be used crude in subsequent elaborations.  The potential of this 
cyclocondensation for the synthesis of iterative polypropionate units was further demonstrated 
by synthesizing a masked polypropionate unit possessing six contiguous stereocenters in 
diastereomerically pure form. 
                                                 
51 Additional aldehydes not presented here were synthesized and tested by Ms. Junping Zhao.  
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2.3 EXPERIMENTAL 
General Information: 1H NMR spectra were recorded on Bruker DPX 301 and DPX 302 (300 
MHz) spectrometers.  The chemical shifts are reported in ppm from tetramethylsilane with either 
the solvent resonance as the internal standard (CHCl3: δ 7.27 ppm) or tetramethylsilane as an 
external standard (TMS: δ ppm).  Data is reported as follows: chemical shift (ppm), multiplicity 
(s = singlet, d = doublet, t = triplet, q = quartet, p = pentet, app = apparent, br = broad, m = 
multiplet), coupling constants (Hz), integration.  13C NMR spectra were recorded on Bruker DPX 
301 and DPX 302 spectrometers (75 MHz) with complete proton decoupling.  The chemical 
shifts are reported in ppm from tetramethylsilane with either the solvent resonance as the internal 
standard (CDCl3: δ 77.0 ppm) or tetramethylsilane as an external standard (TMS: δ ppm).  
Optical rotations were measured on a Perkin-Elmer 241 digital polarimeter with a sodium lamp 
at ambient temperature and are reported as follows: [α]D (c g/100 mL) with units of degree•g•cm-
3.  Infrared spectra were taken on a Nicolet Avatar 360 FT-IR spectrometer.  Mass spectra were 
obtained on a VG-7070 or Fisons Autospec high resolution magnetic sector mass spectrometer.  
Analytical thin layer chromatography was performed on EM Reagent 0.25 mm silica gel 
60-F plates.  Flash chromatography was performed as previously described on EM silica gel 60 
(230-240 mesh).37 Automated flash chromatography was performed using an ISCO CombiFlash® 
Companion™ using disposable RediSep™ columns. Analytical gas liquid chromatography (GLC) 
was performed on a Varian 3900 gas chromatograph with a flame ionization detector and split 
mode capillary injection system using a VarianCP Wax 52CB column (30 m x 0.25 mm).  
Hydrogen was used as the carrier gas at the indicated pressures.  Analytical high performance 
liquid chromatography (HPLC) was performed on a Hewlett Packard 1100 liquid chromatograph 
equipped with a variable wavelength UV detector (deuterium lamp, 190-600 nm), using a Daicel 
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Chiralcel™ OD-H column (250 x 4.6 mm) (Daicel Inc.).  HPLC grade isopropanol and hexanes 
were used as the eluting solvents.  Melting points were measured using a Mel-Temp apparatus 
and are uncorrected. 
Unless otherwise stated, all experiments were carried out under a nitrogen atmosphere in 
oven or flame-dried glassware using standard inert atmosphere techniques for introducing 
reagents and solvents.  Anhydrous solvents were obtained by passage through successive 
alumina- and Q5 reactant-packed columns on a solvent purification system.  Amines were 
purified via distillation from CaH2.  Propionyl chloride was purified by distillation prior to use. 
Unless otherwise stated, commercially available reagents were used as received without any 
further purification.  All water used in reactions and in aqueous solutions was deionized.   
 
(3S,4R)-4-((2R,3S)-3-Trimethylsilyloxy-5-phenylpentan-2-yl)-3-
methyloxetan-2-one (61):52  A flame-dried 25 mL round bottom flask 
was charged with TMS-quinidine (45 mg, 1.14 x 10-4 mol) and LiI 
(0.456 g, 3.41 mmol).  To the mixture was added sequentially CH2Cl2 (3.3 mL), DMF (0.3 mL) 
and iPr2NEt (0.50 mL, 2.84 mmol).  The resulting mixture was stirred at ambient temperature for 
5 min then cooled to −50 °C.  To the reaction mixture was added aldehyde 57 (0.300 g, 1.14 
mmol) followed by dropwise addition of a solution of propionyl chloride (0.20 mL, 2.27 mmol) 
in CH2Cl2 (0.76 mL) over 2 h.  The resulting heterogeneous reaction mixture was stirred 
vigorously overnight at −50 °C, after which the reaction mixture was partitioned between ether 
(15 mL) and H2O (15 mL).  The layers were separated and the aqueous layer extracted with ether 
(2x).  The combined organic extracts were then washed with water (2x) and then brine (1x).  The 
O
O
OTMS
Me
Me Ph
                                                 
52 Reaction with DMF that the author of this document performed. 
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combined organic extracts were dried over Na2SO4, filtered and concentrated in vacuo.  The 
crude residue was purified via column chromatography (24:1/hexanes:ethyl acetate) to yield 
0.300 g (83%) of β-lactone 61:  Diastereomeric ratio determined by crude 1H NMR (300 MHz; δ 
4.40 ppm) showed the title compound was produced as a single diastereomer; [α]D = +23.4 (c 
2.2, CHCl3); IR (thin film) 2952, 1827, 1250, 1148, 1118, 1044, 1001 cm-1; 1H NMR (300 MHz, 
CDCl3): δ 7.33-7.18 (m, 5H), 4.40 (dd, J = 11.0, 6.3 Hz, 1H), 4.01 (td, J = 6.6, 0.9 Hz, 1H), 3.77 
(app p, J = 7.6 Hz, 1H), 2.67 (ddd, J = 13.5, 10.8, 6.0 Hz, 1H), 2.54 (ddd, J = 13.5, 10.7, 6.0 Hz, 
1H), 1.91-1.70 (m, 3H), 1.33 (d, J = 7.7 Hz, 3H), 0.85 (d, J = 6.6 Hz, 3H), 0.14 (s, 9H); 13C 
NMR (75 MHz, CDCl3): δ 172.4, 141.7, 128.3 (2C), 128.1 (2C), 125.7, 75.9, 70.1, 46.3, 37.2, 
37.0, 32.5, 8.3, 7.4, 0.3 (3C); EI-MS m/z 320 (M)+, 305, 249, 230, 207; HRMS calcd for 
C18H28O3Si: 320.1808, found 320.1804. 
 
(2S,3S)-3-Hydroxy-N-methoxy-N,2-dimethyl-5-phenylpentanami-
de (67):  To a 0 °C mixture of N,O-dimethylhydroxylamine 
hydrochloride (6.44 g, 66.0 mmol) in CH2Cl2 (122 mL) was added dimethylaluminum chloride 
(66.0 mL, 66.0 mmol, 1.0 M in hexanes) in a slow, dropwise fashion.  The resulting solution was 
allowed to warm to ambient temperature and stirred for 2 h.  Subsequently, the homogenous 
solution was cooled to 0 °C and diluted with CH2Cl2 (72 ml).  To the resulting solution was 
added a solution of β-lactone 66 (6.26 g, 33.0 mmol) in CH2Cl2 (50 mL).  The reaction mixture 
was then warmed to ambient temperature and allowed to stir for 3 h.  Cooled the reaction 
mixture to 0 °C and quenched slowly with aqueous phosphate buffer (100 mL, pH = 7).  The 
resulting biphasic mixture was warmed to ambient temperature and stirred vigorously for 1h.  
The layers of the mixture were then separated and the aqueous extracted with CH2Cl2 (3x).  The 
PhN
MeO
Me
O
Me
OH
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combined organic extracts were dried over Na2SO4, filtered and concentrated in vacuo.  The 
crude oil was purified by silica gel chromatography (3:1/hexanes:ethyl acetate) to provide 7.59 g 
(92%) of amide 67: [α]D = +13.4 (c 2.5, CHCl3);  IR (thin film) 3434, 2937, 1636, 1495, 1454, 
1388 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.31-7.16 (m, 5H), 3.71 (s, 3H), 3.71-3.61 (m, 1H), 
3.51 (d, J = 8.0 Hz, 1H), 3.20 (s, 3H), 2.97-2.87 (m, 2H), 2.70 (dt, J = 13.8, 8.3 Hz, 1H), 1.81-
1.74 (m, 2H), 1.25 (d, J = 7.1 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 176.7, 141.8, 128.0 (2C), 
127.8 (2C), 125.2, 72.5, 61.0, 39.8, 36.7, 31.7, 31.3, 14.4; EI-MS m/z 251 (M+) 191, 173, 145; 
HRMS calcd for C14H21NO3: 251.1521, found 251.1519. 
 
(2S,3S)-3-Trimethylsilyloxy-N-methoxy-N,2-dimethyl-5-phenylpe-
ntanamide (68a):  To a solution of β-hydroxyl amide 67 (2.60 g, 10.4 
mmol) in CH2Cl2 (116 mL) at ambient temperature was added 2,6-lutidine (1.81 mL, 15.5 
mmol).  The resulting solution was cooled to −78 °C and TMSOTf (2.25 mL, 12.4 mmol) was 
added, after which the reaction mixture was stirred at −78 °C for 0.5 h and then warmed to 
ambient temperature and stirred for an additional 2 h.  The reaction mixture was quenched by 
addition of saturated aqueous NaHCO3 (40 mL).  The layers were separated and the aqueous 
layer was extracted with CH2Cl2 (2x).  The combined organic extracts were washed with 1.0 M 
NaHSO4 (1x) and brine (1x), dried over Na2SO4, filtered and concentrated in vacuo.  The crude 
oil was purified by silica gel chromatography (9:1/hexanes:ethyl acetate) to provide 3.4 g (100%) 
of amide 68a: [α]D = +33.0 (c 1.0, CHCl3);  IR (thin film) 2954, 1660, 1454, 1249, 1097, 1071, 
1053 cm-1; 1H NMR (300MHz, CDCl3): δ 7.32-7.17 (m, 5H), 4.03 (ddd, J = 9.7, 8.2, 3.0 Hz, 
1H), 3.72 (s, 3H), 3.20 (s, 3H), 3.20-3.13 (m, 1H), 2.76 (td, J = 13.3, 5.4 Hz, 1H), 2.62 (td, J = 
13.4, 5.3 Hz, 1H), 1.91-1.69 (m, 2H), 1.06 (d, J = 6.9 Hz, 3H), 0.12 (s, 9H); 13C NMR (75MHz, 
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CDCl3): δ 176.0, 142.3, 128.2 (4C), 125.6, 73.7, 61.2, 41.2, 35.8, 31.7, 31.1, 13.4, 0.3 (3C); ESI-
MS m/z 346.3 (M + Na)+, 234.2; HRMS calcd for C17H29NNaO3Si (M + Na)+: 346.1814 , found 
346.1803. 
 
(2S,3S)-3-Trimethylsilyloxy-2-methyl-5-phenylpentanal (64a):  To a     
−78 °C solution of amide 68a (1.59 g, 4.90 mmol) in THF (46 mL) was 
added iBu2AlH (6.90 mL, 6.90 mmol, 1.0 M in hexanes) in a slow, dropwise fashion.  The 
resulting solution was maintained at −78 °C for 3 h after which saturated aqueous Rochelle’s 
salts was added (25 mL).  The biphasic mixture was allowed to warm to ambient temperature 
and was stirred vigorously for 1 h.  The layers were separated and the aqueous layer was 
extracted with ether (3x).  The combined organic extracts were washed with brine (1x), dried 
over Na2SO4, filtered and concentrated in vacuo.  The crude oil was purified by silica gel 
chromatography (30:1/hexanes:ethyl acetate) to provide 1.00 g (80%) of aldehyde 64a: [α]D = 
+26.6 (c 2.7, CHCl3);  IR (thin film) 2954, 1726, 1454, 1251, 1069 cm-1; 1H NMR (300 MHz, 
CDCl3): δ 9.76 (d, J = 2.3 Hz, 1H), 7.33-7.18 (m, 5H), 4.00 (dt, J = 6.4, 5.2 Hz, 1 H), 2.78-2.63 
(m, 2H), 2.56 (qdd, J = 7.1, 5.7, 2.4 Hz, 1H), 1.94-1.75 (m, 2H), 1.11 (d, J = 7.0 Hz, 3H), 0.16 
(s, 9H); 13C NMR (75 MHz, CDCl3): δ 203.9, 141.5, 128.1 (2C), 128.0 (2C), 125.6, 72.7, 51.1, 
36.4, 31.2, 10.0, 0.1 (3C); EI-MS m/z 265 (M)+, 249, 207, 190, 174; HRMS calcd for 
C15H24O2Si: 264.1546, found 264.1554. 
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(3R,4S)-4-((2S,3S)-3-Trimethylsilyloxy-5-phenylpentan-2-yl)-3-me-
thyloxetan-2-one (69a):  A flame-dried 25 mL round bottom flask was 
charged with TMS-quinine (30 mg, 7.56 x 10-5 mol) and LiI (0.304 g, 
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2.27 mmol).  To the mixture of solids was added CH2Cl2 (2.1 mL), THF (0.20 mL) and iPr2NEt 
(0.330 mL, 1.90 mmol).  The resulting mixture was stirred at ambient temperature for 5 minutes 
then cooled to −78 °C.  To the reaction mixture was added aldehyde 64a (0.200 g, 0.760 mmol) 
followed by dropwise addition of a solution of propionyl chloride (0.130 mL, 1.51 mmol) in CH-
2Cl2 (0.5 mL) over 4 h.  The heterogeneous reaction mixture was stirred vigorously overnight at 
−78 °C.  The reaction mixture was quenched with ether (4 mL) and the white precipitate was 
filtered off over a plug of silica which was eluted with ether (80 mL).  The filtrate was then 
concentrated in vacuo and the resulting residue purified via column chromatography 
(24:1/hexanes:ethyl acetate) to yield 0.190 g (78%) of β-lactone 69a:  Diastereomeric ratio 
determined by crude 1H NMR (300 MHz): 82% (δ 4.36 ppm) : 18 % (δ 4.19  ppm) / cis β-
lactone 69a (title compound) : trans β-lactone (not isolated); m.p. = 76-77 °C;  [α]D = −49.1 (c 
1.3, CHCl3); IR (CH2Cl2) 2954, 1826, 1250, 1118, 1087, 1066 cm-1; 1H NMR (300 MHz, 
CDCl3): δ 7.32-7.17 (m, 5H), 4.36 (dd, J = 11.3, 6.3 Hz, 1H), 3.97-3.92 (m, 1H), 3.78 (app p, J = 
7.7 Hz, 1H), 2.80 (ddd, J = 13.6, 10.0, 6.6 Hz, 1H), 2.52 (ddd, J = 13.5, 9.6, 7.0 Hz, 1H), 2.10 
(dqd, J = 10.3, 6.8, 3.3 Hz, 1H), 1.80-1.70 (m, 2H), 1.35 (d, J = 7.7 Hz, 3H), 0.89 (d, J = 6.8 Hz, 
3H), 0.16 (s, 9H); 13C NMR (75 MHz, CDCl3): δ 171.7, 141.9, 128.0 (4C), 125.4, 75.8, 72.0, 
47.1, 38.5, 33.5, 32.6, 9.5, 8.2, 0.1 (3C) ; EI-MS m/z 320 (M)+, 261, 249, 230, 207, 174; HRMS 
calcd for C18H28O3Si: 320.1808, found 320.1825. 
 
(2S,3S)-3-Triethylsilyloxy-N-methoxy-N,2-dimethyl-5-phenylpent-
anamide (68b):  To a solution of β-hydroxyl amide 67 (1.00 g, 4.00 
mmol) in CH2Cl2 (44 mL) was added imidazole (0.463 g, 6.80 mmol).  The homogenous 
solution was cooled to 0 °C and TESCl (1.00 mL, 6.00 mmol) was added in a dropwise fashion.  
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After complete addition, the resulting heterogeneous mixture was warmed to ambient 
temperature and stirred overnight.  The reaction mixture was then quenched by addition of 
saturated aqueous NaHCO3 (20 mL), the layers separated and the organic layer washed with  
1.0 M aqueous NaHSO4 (1x).  The organic layer was dried over Na2SO4, filtered and 
concentrated in vacuo.  The crude oil was purified by silica gel chromatography 
(9:1/hexanes:ethyl acetate) to provide 1.29 g (88%) of amide 68b: [α]D = +32.6 (c 2.3, CHCl3);  
IR (thin film) 2953, 2911, 2876, 1663, 1456, 1416, 1093, 1002 cm-1; 1H NMR (300 MHz, 
CDCl3): δ 7.32-7.16 (m, 5H), 4.09 (dt, J = 8.6, 4.5 Hz, 1H), 3.73 (s, 3H), 3.20 (s, 3H), 3.20-3.15 
(m, 1H), 2.71 (dd, J = 10.0, 6.7 Hz, 2H), 1.87-1.80 (m, 2H), 1.07 (d, J = 7.0 Hz, 3H), 0.98 (t, J = 
7.9 Hz, 9H), 0.63 (q, J = 7.8 Hz, 6H) ; 13C NMR (75 MHz, CDCl3): δ 175.5, 142.1, 127.9 (4C), 
125.3, 72.6, 60.8, 40.1, 35.3, 31.4, 29.8, 12.8, 6.5, 4.6; EI-MS m/z 365 (M)+, 336, 305, 249, 145; 
HRMS calcd for C20H35NO3Si: 365.2386, found 365.2394. 
 
(2S,3S)-3-Triethylsilyloxy-2-methyl-5-phenylpentanal (64b):  To a  
−78 °C solution of amide 68b (2.91 g, 8.00 mmol) in THF (75 mL) was 
added iBu2AlH (11.2 mL, 11.2 mmol, 1.0 M in hexanes) in a slow, dropwise fashion.  The 
resulting solution was maintained at −78 °C for 3 h after which saturated aqueous Rochelle’s 
salts was added (50 mL).  The biphasic mixture was allowed to warm to ambient temperature 
and was stirred vigorously for 1 h.  The layers were separated and the aqueous layer was 
extracted with ether (3x).  The combined organics were washed with brine (1x), dried over 
Na2SO4, filtered and concentrated in vacuo.  The crude oil was purified by silica gel 
chromatography (30:1/hexanes:ethyl acetate) to provide 2.31 g (95%) of aldehyde 64a: [α]D = 
+29.6 (c 2.8, CHCl3);  IR (thin film) 2954, 2876, 1725, 1455, 1093, 1007 cm-1; 1H NMR (300 
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MHz, CDCl3): δ 9.77 (d, J = 2.2 Hz, 1H), 7.32-7.17 (m, 5H), 4.04 (app q, J = 5.3 Hz, 1H), 2.69 
(app t, J = 8.4 Hz, 2H), 2.59 (qdd, J = 7.2, 5.3, 2.2 Hz, 1H), 1.95-1.74 (m, 2H), 1.12 (d, J = 7.0 
Hz, 3H), 0.98 (t, J = 7.9 Hz, 9H), 0.63 (q, J = 7.7 Hz, 6H) ; 13C NMR (75 MHz, CDCl3): δ 204.2, 
141.7, 128.3 (2C), 128.1 (2C), 125.7, 72.8, 51.2, 36.6, 31.1, 10.0, 6.7 (3C), 5.0 (3C) ; EI-MS m/z 
277 (M−Et)+, 249, 173, 143; HRMS calcd for C16H25O2Si (M−Et)+: 277.1624, found 277.1632. 
 
(3R,4S)-4-((2S,3S)-3-Triethylsilyloxy-5-phenylpentan-2-yl)-3-meth-
yloxetan-2-one (69b):  A flame-dried 25 mL round bottom flask was 
charged with TMS-quinine (52 mg, 0.13 mmol) and LiI (0.522 g, 3.90 
mmol).  To the mixture of solids was sequentially added CH2Cl2 (3.6 mL), DMF (0.35 mL) and 
iPr2NEt (0.570 mL, 3.25 mmol).  The resulting mixture was stirred at ambient temperature for 5 
minutes then cooled to −50 °C.  To the reaction mixture was added aldehyde 64b (0.400 g, 1.30 
mmol) followed by dropwise addition of a solution of propionyl chloride (0.230 mL, 2.60 mmol) 
in CH2Cl2 (0.86 mL) over 4 h.  The heterogeneous reaction mixture was stirred vigorously 
overnight at −50 °C.  The resulting mixture was partitioned between ether (15 mL) and H2O (15 
mL).  The layers were separated and the aqueous layer extracted with ether (2x).  The combined 
organic extracts were then washed with water (2x) followed by brine (1x).  The combined 
organic extracts were then dried over Na2SO4, filtered and concentrated in vacuo.  The crude 
residue was purified via column chromatography (24:1/hexanes:ethyl acetate) to yield 0.381 g 
(81%) of β-lactone 69b:  Diastereomeric ratio determined by crude 1H NMR (300 MHz; δ 4.35 
ppm) and HPLC analysis (column OD-H, eluent 1.5:98.5/iPrOH:hexanes, flow rate 1mL/min; Tr 
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7.014 min) showed that the title compound was produced as a single diastereomer;53 [α]D = 
−44.1 (c 1.6, CHCl3);  IR (thin film) 3435, 2953, 2876, 1826, 1455, 1117, 1087 cm-1; 1H NMR 
(300 MHz, CDCl3): δ 7.35-7.17 (m, 5H), 4.35 (dd, J = 11.3, 6.3 Hz, 1H), 3.98 (dt, J = 8.3, 3.6 
Hz, 1H), 3.78 (qd, J = 7.7, 6.4 Hz, 1H), 2.83 (ddd, J = 13.4, 10.4, 6.3 Hz 1H), 2.54 (ddd, J = 
13.3, 10.5, 6.2 Hz, 1H), 2.13 (dqd, J = 10.2, 6.8, 3.3 Hz, 1H), 1.78-1.68 (m, 2H), 1.35 (d, J = 7.7 
Hz, 3H), 1.0 (t, J = 7.7 Hz, 9H), 0.90 (d, J = 6.9 Hz, 3H), 0.65 (q, J = 7.5 Hz, 6H); 13C NMR 
(75MHz, CDCl3): δ 172.1, 142.3, 128.2 (4C), 125.7, 76.1, 71.9, 47.4, 38.9, 33.8, 32.9, 9.5, 8.4, 
6.8 (3C), 5.0 (3C); EI-MS m/z 363 (M)+, 333, 289, 277, 249, 173; HRMS calcd for 
C21H34NaO3Si (M+Na)+: 385.2175, found ESI-MS 385.2194.   
 
                                                
(3R,4S)-4-((2S,3S)-3-Hydroxy-5-phenylpentan-2-yl)-3-methyloxeta-
n-2-one (71):   To a 0 °C solution of silyl ether 69a (0.340 g, 1.06 
mmol) in THF (4.6 mL) was added HF/pyridine (0.23 mL).  The 
resulting solution was maintained at 0 °C for 5 min then warmed to ambient temperature and 
allowed to stir for 2 h.  The reaction mixture was cooled to 0 °C and quenched by slow addition 
of saturated aqueous NaHCO3 (5 mL).  The layers were partitioned with CH2Cl2 (5 mL), 
separated and the aqueous layer extracted with CH2Cl2 (3x).  The combined organic extracts 
were dried over Na2SO4, filtered and concentrated in vacuo.  The crude oil was purified by silica 
gel chromatography (9:1/hexanes:ethyl acetate ? 2:1/hexanes:ethyl acetate) to provide 0.236 g 
(70%) of β-lactone 71: m.p. = 62-63 °C; [α]D = −31.1 (c 1.7, CHCl3);  IR (CH2Cl2) 3448 (br), 
2973, 2942, 1813, 1454, 1152 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.33-7.18 (m, 5H), 4.42 (dd, 
J = 11.1, 6.4 Hz, 1H), 3.89-3.77 (m, 2H), 2.88 (ddd, J = 14.1, 9.4, 5.9 Hz, 1H), 2.70 (ddd, J = 
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53 In trials where one of the trans β-lactone diastereomers could be seen, the distinctive 1H NMR shift and HPLC 
retention time of that trans-diastereomer is δ 4.22 ppm and Tr = 8.955 min, respectively.  
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13.7, 9.1, 7.0 Hz, 1H), 2.09 (dqd, J = 12.1, 6.8, 5.2 Hz, 1H), 1.91-1.73 (m, 3H), 1.37 (d, J = 7.8 
Hz, 3H), 0.88 (d, J = 6.8 Hz, 3H) ; 13C NMR (75 MHz, CDCl3): δ 172.1, 141.7, 128.0 (2C), 
127.9 (2C), 125.4, 76.7, 72.0, 47.4, 38.3, 34.2, 32.0, 10.6, 8.0 ; EI-MS m/z 248 (M)+, 230, 157, 
134, 117 ; HRMS calcd for C15H18O2 (M−H2O)+: 230.1307, found 230.1309. 
 
(3S,4S)-4-((2S,3R)-3-Methyl-4-oxooxetan-2-yl)-1-phenylpentan-3-
yl 3,5-dinitrobenzoate (70):  To a solution of alcohol 71 (41 mg, 
0.17 mmol) in CH2Cl2 (1.0 mL) was added 3,5-dinitrobenzoyl 
chloride (50 mg, 0.22 mmol).  To the reaction mixture was then added 
DMAP (1.0 mg, 8.3 x 10-6 mol) followed by triethylamine (35 μL, 0.25 mmol).  The resulting 
solution was stirred at ambient temperature for 8 h, after which the reaction mixture was 
quenched with saturated aqueous NaHCO3 (3 mL).  The layers were separated and the aqueous 
layer was extracted with CH2Cl2 (3x).  The combined organic extracts were washed with brine 
(1x), dried over Na2SO4, filtered and concentrated in vacuo.  The crude oil was purified by silica 
gel chromatography (2:1/hexanes:ethyl acetate) to provide 64 mg (87%) of β-lactone 70.  The 
afforded solid was recrystallized via vapor diffusion recrystallization (CH2Cl2/hexanes): m.p. = 
167-168 °C; [α]D = −35.6 (c 1.0, CHCl3);  IR (CH2Cl2) 3054, 2986, 1827, 1731, 1548, 1345, 
1265 cm-1; 1H NMR (300 MHz, CDCl3): δ 9.21 (app t, J = 1.9 Hz, 1H); 9.00 (d, J = 1.9 Hz, 2H), 
7.22-7.02 (m, 5H), 5.47 (ddd, J = 8.9, 5.2, 3.0 Hz, 1H), 4.45 (dd, J = 11.0, 6.2 Hz, 1H), 3.84 (qd, 
J = 7.4, 6.7 Hz, 1H), 2.74 (m, 2H), 2.49-2.37 (m, 1H), 2.30-2.06 (m, 2H), 1.37 (d, J = 7.8 Hz, 
3H), 1.00 (d, J = 6.8 Hz, 3H) ; 13C NMR (75 MHz, CDCl3): δ 171.2, 162.1, 148.5 (2C), 140.7, 
133.8, 129.3 (2C), 128.5 (2C), 128.2 (2C), 126.0, 122.3, 78.0, 75.9, 48.2, 36.8, 32.3, 31.7, 11.4, 
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8.5 ; ESI-MS m/z 465.22 (M + Na)+, 357, 229; HRMS calcd for C22H22N2NaO8 (M + Na)+: 
465.1274, found 465.1274. 
 
(3R,4R)-3-methyl-4-phenethyloxetan-2-one (ent-66):  To a −100 °C 
solution of β-lactone ent-65 (2.50 g, 14.2 mmol) in THF (710 mL) was 
added MeI (4.42 mL, 71.0 mmol).  Subsequently, NaHMDS (14.2 mL, 14.2 mmol, 1.0 M in 
THF) was added to the reaction mixture in a dropwise fashion over 2 h.  After complete addition, 
the resulting solution was maintained for an additional hour at −100 °C.  The reaction mixture 
was quenched by addition of saturated aqueous NH4Cl (50 mL) and allowed to warm to ambient 
temperature.  The layers were separated and the aqueous layer extracted with ethyl acetate (2x).  
The combined organic extracts were washed with brine (1x), dried over Na2SO4, filtered and 
concentrated in vacuo.  The crude oil was purified using an ISCO CombiFlash® Companion™ 
(hexanes? 5% ethyl acetate, 330 g column) to yield 1.35 g (50%) of disubstituted β-lactone ent-
66: [α]D =  +72.7 (c 1.9, CHCl3); 1H NMR (300 MHz, CDCl3): δ 7.34-7.18 (m, 5H), 4.17 (ddd, J 
= 7.4, 5.9, 4.0 Hz, 1H), 3.20 (qd, J = 7.5, 3.9 Hz, 1H), 2.83 (ddd, J = 14.0, 8.7, 5.8 Hz, 1H), 2.76-
2.66 (m, 1H), 2.26-2.02 (m, 2H), 1.32 (d, J = 7.5 Hz, 3H). 
O
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(2R,3R)-3-Hydroxy-N-methoxy-N,2-dimethyl-5-phenylpentanam-
ide (ent-67): To a 0 °C mixture of N,O-dimethylhydroxylamine 
hydrochloride (1.38 g, 14.2 mmol) in CH2Cl2 (25 mL) was added dimethylaluminum chloride 
(14.2 mL, 14.2 mmol, 1.0 M in hexanes) in a slow, dropwise fashion.  The resulting solution was 
allowed to warm to ambient temperature and stirred for 2 h.  Subsequently, cooled the 
homogenous solution to 0 °C and added a solution of β-lactone ent-66 (1.35 g, 7.08 mmol) in 
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CH2Cl2 (25 mL) via syringe.  The reaction mixture was then warmed to ambient temperature and 
allowed to stir for 3 h.  Cooled the reaction mixture to 0 °C and quenched slowly with aqueous 
phosphate buffer (25 mL, pH = 7).  The resulting biphasic mixture was warmed to ambient 
temperature and stirred vigorously for 1 h.  The layers of the mixture were separated and the 
aqueous extracted with CH2Cl2 (3x).  The combined organic extracts were dried over Na2SO4, 
filtered and concentrated in vacuo.  The crude oil was purified by silica gel chromatography 
(3:1/hexanes:ethyl acetate) to provide 1.62 g (91%) of amide ent-67: [α]D = −14.2 (c 1.6, 
CHCl3); 1H NMR (300 MHz, CDCl3): δ 7.32-7.17 (m, 5H), 3.71 (s, 3H), 3.71-3.61 (m, 1H), 3.21 
(s, 3H), 2.97-2.87 (m, 2H), 2.71 (dt, J = 13.8, 8.3 Hz, 1H), 1.82-1.75 (m, 2H), 1.25 (d, J = 7.1 
Hz, 3H). 
 
(2R,3R)-3-Triethylsilyloxy-N-methoxy-N,2-dimethyl-5-phenylpen-
tanamide (ent-68b):  To a  solution of β-hydroxyl amide ent-67  PhN
MeO
Me
O
Me
OTES
(1.78 g, 7.08 mmol) in CH2Cl2 (78 mL) was added imidazole (0.819 g, 12.0 mmol).  The 
homogenous solution was cooled to 0 °C and TESCl (1.78 mL, 10.6 mmol) was added in a 
dropwise fashion.  After complete addition, the resulting heterogeneous mixture was warmed to 
ambient temperature and stirred overnight.  The reaction mixture was then quenched by addition 
of saturated aqueous NaHCO3 (35 mL), the layers separated and the organics washed with 1.0 M 
aqueous NaHSO4 (1x).  The combined organic extracts were dried over Na2SO4, filtered and 
concentrated in vacuo.  The crude oil was purified by silica gel chromatography 
(9:1/hexanes:ethyl acetate) to provide 2.44 g (94%) of amide ent-68b: [α]D = −32.5 (c 2.0, 
CHCl3); 1H NMR (300MHz, CDCl3): δ 7.31-7.16 (m, 5H), 4.08 (dt, J = 8.6, 4.5 Hz, 1H), 3.72 (s, 
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3H), 3.19 (s, 3H), 3.19-3.15 (m, 1H), 2.71 (dd, J = 9.9, 6.8 Hz, 2H), 1.87-1.79 (m, 2H), 1.06 (d, J 
= 7.0 Hz, 3H), 0.97 (t, J = 8.0 Hz, 9H), 0.62 (q, J = 7.9 Hz, 6H). 
 
 
(3S,4R
(2R,3R)-3-Triethylsilyloxy-2-methyl-5-phenylpentanal (ent-64b):  To a 
−78 °C solution of amide ent-68b (2.44 g, 6.68 mmol) in THF (63 mL) was 
added iBu2AlH (9.40 mL, 9.35 mmol, 1.0 M in hexanes) in a slow, dropwise fashion.  The 
resulting solution was maintained at −78 °C for 3 h after which saturated aqueous Rochelle’s 
salts was added (30 mL).  The biphasic mixture was allowed to warm to ambient temperature 
and was stirred vigorously for 1 h.  The layers were separated and the aqueous layer extracted 
with ether (3x).  The combined organic extracts were washed with brine (1x), dried over Na2SO4, 
filtered and concentrated in vacuo.  The crude oil was purified by silica gel chromatography 
(30:1/hexanes:ethyl acetate) to provide 1.90 g (93%) of aldehyde ent-64b: [α]D = −32.1 (c 2.2, 
CHCl3); 1H NMR (300 MHz, CDCl3): 9.76 (d, J = 2.2 Hz, 1H), 7.32-7.16 (m, 5H), 4.04 (app q, J 
= 5.4 Hz, 1H), 2.68 (app t, J = 8.4 Hz, 2H), 2.58 (qdd, J = 7.1, 5.3, 2.2 Hz, 1H), 1.93-1.73 (m, 
2H), 1.11 (d, J = 7.0 Hz, 3H), 0.97 (t, J = 8.0 Hz, 9H), 0.63 (q, J = 7.7 Hz, 6H). 
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)-4-((2R,3R)-3-Triethylsilyloxy-5-phenylpentan-2-yl)-3-meth-
yloxetan-2-one (ent-69b):  A flame-dried 25 mL round bottom flask 
was charged with TMS-quinidine (30 mg, 7.56 x 10-5 mol) and LiI 
(0.303 g, 2.27 mmol).  To the mixture was sequentially added CH2Cl2 (2.1 mL), DMF (0.20 mL) 
and iPr2NEt (0.330 mL, 1.89 mmol).  The resulting mixture was stirred at ambient temperature 
for 5 min then cooled to −50 °C.  To the reaction mixture was added aldehyde ent-64b (0.232 g, 
0.760 mmol) followed by dropwise addition of a solution of propionyl chloride (0.131 mL, 1.51 
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mmol) in CH2Cl2 (0.50 mL) over 4 h after which the heterogeneous reaction mixture was stirred 
vigorously overnight at −50 °C.  The reaction mixture was partitioned between ether (15 mL) 
and H2O (15 mL), the layers separated and the aqueous layer extracted with ether (2x).  The 
combined organic extracts were washed with water (2x) followed by brine (1x) and then were 
dried over Na2SO4, filtered and concentrated in vacuo.  The crude residue was purified via 
column chromatography (24:1/hexanes:ethyl acetate) to yield 0.234 g (84%) of β-lactone ent-
69b:  Diastereomeric ratio determined by crude 1H NMR (300 MHz; δ 4.35 ppm) showed the 
title compound was produced as a single diastereomer; [α]D = +40.0 (c 1.3, CHCl3); 1H NMR 
(300 MHz, CDCl3): δ 7.32-7.16 (m, 5H), 4.35 (dd, J = 11.3, 6.3 Hz, 1H), 3.98 (dt, J = 8.3, 3.5 
Hz, 1H), 3.78 (qd, J = 7.7, 6.2, 1H), 2.83 (ddd, J = 13.4, 10.5, 6.2 Hz, 1H), 2.54 (ddd, J = 13.5, 
10.6, 6.2 Hz, 1H), 2.14 (dqd, J = 10.2, 6.8, 3.4 Hz, 1H), 1.80-1.68 (m, 2H), 1.35 (d, J = 7.7 Hz, 
3H), 1.0 (t, J = 7.7 Hz, 9H), 0.90 (d, J = 6.8 Hz, 3H), 0.65 (q, J = 7.5 Hz, 6H). 
 
(S)-3-Hydroxy-N-methoxy-N-methyl-5-phenylpentanamide (73): 
To a 0 °C mixture of N,O-dimethylhydroxylamine hydrochloride 
(1.66 g, 17.0 mmol) in CH2Cl2 (30 mL) was added dimethylaluminum chloride (17.0 mL, 17.0 
mmol, 1.0 M in hexanes) in a slow, dropwise fashion.  The resulting solution was allowed to 
warm to ambient temperature and stirred for 2 h.  Subsequently, cooled the homogenous solution 
to 0 °C and added a solution of β-lactone 65 (1.50 g, 8.51 mmol) in CH2Cl2 (30 mL) via syringe.  
The reaction mixture was then warmed to ambient temperature and allowed to stir for 3 h.  
Cooled the reaction mixture once again to 0 °C and quenched slowly with aqueous phosphate 
buffer (50 mL, pH = 7).  The resulting biphasic mixture was warmed to ambient temperature and 
stirred vigorously for 1 h.  The layers of the mixture were separated and the aqueous layer 
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extracted with CH2Cl2 (3x).  The combined organic extracts were dried over Na2SO4, filtered and 
concentrated in vacuo.  The crude oil was purified by silica gel chromatography 
(3:1/hexanes:ethyl acetate) to provide 1.93 g (96%) of amide 73: [α]D =  +29.0 (c 1.8, CHCl3); IR 
(thin film) 3435, 2937, 1639, 1454, 1389 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.31-7.16 (m, 
5H), 4.09-4.00 (m, 1H), 3.89 (d, J = 2.8 Hz, 1H), 3.67 (s, 3H), 3.19 (s, 3H), 2.86 (ddd, J = 14.0, 
9.7, 5.5 Hz, 1H), 2.77-2.64 (m, 2H), 2.48 (dd, J = 16.8, 9.4 Hz, 1H), 1.89 (dtd, J = 13.9, 9.0, 5.5 
Hz, 1H), 1.74 (m, 1H); 13C NMR (75 MHz, CDCl3): δ 172.4, 141.3, 127.6 (2C), 127.4 (2C), 
124.8, 66.2, 60.2, 37.8, 37.7, 31.0, 30.8; EI-MS m/z 237 (M)+, 159, 135, 117; HRMS calcd for 
C13H19NO3: 237.1365, found 237.1361. 
 
(S)-3-Triethylsilyloxy-N-methoxy-N-methyl-5-phenylpentanamide 
(74):  To a  solution of β-hydroxyl amide 73 (1.93 g, 8.13 mmol) in 
CH2Cl2 (90 mL) was added imidazole (0.941 g, 13.8 mmol).  The homogenous solution was 
cooled to 0 °C and TESCl (2.05 mL, 12.2 mmol) added in a dropwise fashion.  After complete 
addition, the resulting heterogeneous mixture was warmed to ambient temperature and stirred 
overnight.  The reaction mixture was then quenched by addition of saturated aqueous NaHCO3 
(40 mL), the layers separated and the organics washed with 1.0 M aqueous NaHSO4 (1x).  The 
combined organic extracts were dried over Na2SO4, filtered and concentrated in vacuo.  Purified 
the crude oil by silica gel chromatography (9:1/hexanes:ethyl acetate) to provide 2.83 g (99%) of 
amide 74: [α]D = +17.9 (c 1.4, CHCl3);  IR (thin film) 2953, 2912, 2875, 1663, 1455, 1415, 1385, 
1091 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.31-7.16 (m, 5H), 4.34 (app p, J = 6.1 Hz, 1H), 3.69 
(s, 3H), 3.19 (s, 3H), 2.81-2.60 (m, 3H), 2.52 (dd, J = 15.0, 5.8 Hz, 1H), 1.94-1.74 (m, 2H), 0.97 
(t, J = 7.7 Hz, 9H), 0.63 (q, J = 8.0 Hz, 6H); 13C NMR (75MHz, CDCl3): δ 171.8, 141.9, 127.9 
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(4C), 125.3, 68.6, 60.8, 39.4, 31.5, 31.2, 6.5 (3C), 4.7 (3C); EI-MS m/z 351 (M)+, 321, 291, 248, 
218; HRMS calcd for C19H33NO3Si: 351.2230, found 351.2219. 
 
(S)-3-Triethylsilyloxy-5-phenylpentanal (72): To a −78 °C solution of 
amide 74 (2.53 g, 7.19 mmol) in THF (67 mL) was added iBu2AlH (10.1 
mL, 10.1 mmol, 1.0 M in hexanes) in a slow, dropwise fashion.  The resulting solution was 
maintained at −78 °C for 3 h after which saturated aqueous Rochelle’s salts was added (40 mL).  
The biphasic mixture was allowed to warm to ambient temperature and stirred vigorously for 1 h.  
The layers were separated and the aqueous layer extracted with ether (3x).  The combined 
organic extracts were washed with brine (1x), dried over Na2SO4, filtered and concentrated in 
vacuo.  The crude oil was purified by silica gel chromatography (30:1/hexanes:ethyl acetate) to 
provide 1.71 g (81%) of aldehyde 72: [α]D = +9.1 (c 1.5, CHCl3) ;  IR (thin film) 2954, 2912, 
2876, 1726, 1455, 1239, 1110 cm-1; 1H NMR (300 MHz, CDCl3): δ 9.83 (app t, J = 2.2 Hz, 1H), 
7.32-7.15 (m, 5H), 4.28 (app p, J = 5.8 Hz, 1H); 2.68 (td, J = 7.6, 3.5 Hz, 2H); 2.60 (dt, J = 5.9, 
2.7 Hz, 2H), 1.91-1.84 (m, 2H), 0.97 (t, J = 7.9 Hz, 9H), 0.63 (q, J = 7.7 Hz, 6H); 13C NMR (75 
MHz, CDCl3): δ 200.6, 141.3, 128.0 (2C), 127.9 (2C), 125.5, 67.2, 50.4, 39.3, 31.1, 6.5 (3C), 4.6 
(3C); EI-MS m/z 263 (M−Et)+, 159, 143, 129; HRMS calcd for C15H23O2Si (M−Et)+: 263.1467, 
found 263.1470.        
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(2S,3R,5S)-3,5-Dihydroxy-N-methoxy-N,2-dimethyl-7-pheny-
lheptanamide (76):  A flame-dried 25 mL round bottom flask 
was charged with TMS-quinidine (15 mg, 3.75 x 10-5 mol) and LiClO4 (0.120 g, 1.13 mmol).  To 
the mixture of solids was sequentially added CH2Cl2 (1.1 mL), DMF (0.1 mL) and iPr2NEt (0.16 
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mL, 0.94 mmol).  The resulting mixture was stirred at ambient temperature for 5 min then cooled 
to −50 °C.  To the reaction mixture was added aldehyde 72 (0.110 g, 0.380 mmol) followed by 
dropwise addition of a solution of propionyl chloride (65 μL, 0.75 mmol) in CH2Cl2 (0.25 mL) 
over 2 h.  The heterogeneous reaction mixture was stirred vigorously overnight at −50 °C.  The 
resulting mixture was partitioned between ether (10 mL) and H2O (10 mL), the layers separated 
and the aqueous layer extracted with ether (2x).  The combined organic extracts were then 
washed with water (2x) followed by brine (1x).  The organic layer was dried over Na2SO4, 
filtered and concentrated in vacuo.  The crude residue was purified via column chromatography 
(24:1/hexanes:ethyl acetate) to yield 0.118 g (90%) of β-lactone 75  which contained a slight 
amount of an inseparable silyl impurity:  Diastereomeric ratio determined by crude 1H NMR 
(300 MHz; δ 4.79 ppm) showed that β-lactone 75 was produced as a single diastereomer. 
 To a 0 °C mixture of N,O-dimethylhydroxylamine hydrochloride (66 mg, 0.68 mmol) in 
CH2Cl2 (1.3 mL) was added dimethylaluminum chloride (0.68 mL, 0.68 mmol, 1.0 M in 
hexanes) in a slow, dropwise fashion.  The resulting solution was allowed to warm to ambient 
temperature and stirred for 2 h.  Subsequently, cooled the homogenous solution to 0 °C and 
added a solution of impure β-lactone 75 (0.118 g, 0.340 mmol) in CH2Cl2 (3 mL) via syringe.  
The reaction mixture was then warmed to ambient temperature and allowed to stir for 18 h.  
Cooled the reaction mixture once again to 0 °C and quenched slowly with aqueous phosphate 
buffer (25 mL, pH = 7).  The resulting biphasic mixture was filtered over a plug of celite which 
was washed with CH2Cl2 (35 mL).  The layers of the filtrate were then separated and the aqueous 
layer extracted with CH2Cl2 (3x).  The combined organic extracts were washed with brine (1x), 
dried over Na2SO4, filtered and concentrated in vacuo.  The crude oil was purified by silica gel 
chromatography (1:1/hexanes:ethyl acetate) to provide 79 mg (79%) of amide 76 (71 % yield 
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over 2 steps): [α]D = +2.3 (c 1.0, CHCl3);  IR (thin film) 3415 (br), 2937, 1635, 1455, 1388 cm-1; 
1H NMR (300 MHz, CDCl3): δ 7.32-7.16 (m, 5H), 4.24 (dt, J = 10.2, 2.7 Hz, 1H), 4.00-3.93 (m, 
2H), 3.69 (s, 3H), 3.20 (s, 3H), 2.89-2.80 (m, 2H), 2.69 (ddd, J = 13.7, 9.6, 6.7 Hz, 1H), 2.45 (br 
s, 1H), 1.95-1.74 (m, 3H), 1.42 (ddd, J = 14.1, 7.9, 2.7 Hz, 1H), 1.21 (d, J = 7.1 Hz, 3H); 13C 
NMR (75 MHz, CDCl3): δ 177.8, 142.1, 128.3 (2C), 128.2 (2C), 125.6, 68.7, 68.5, 61.4, 40.3, 
39.5, 39.1, 32.2, 31.9, 10.9; ESI-MS m/z 318 (M+Na)+; HRMS calcd for C16H25NNaO4 
(M+Na)+: 318.1681, found 318.1679.      
 
(3R,4S)-4-((S)-2-Triethylsilyloxy-4-phenylbutyl)-3-methyloxetan-2-
one (77):  A flame-dried 25 mL round bottom flask was charged with 
TMS-quinine (14 mg, 3.42 x 10-5 mol) and LiClO4 (0.109 g, 1.03 mmol).  To the mixture of 
solids was sequentially added CH2Cl2 (0.68 mL), Et2O (0.34 mL) and iPr2NEt (0.15 mL, 0.86 
mmol).  The resulting mixture was stirred at ambient temperature for 5 min then cooled to −78 
°C.  To the reaction mixture was added aldehyde 72 (0.100 g, 0.34 mmol) followed by dropwise 
addition of a solution of propionyl chloride (60 μL, 0.68 mmol) in CH2Cl2 (0.24 mL) over 2 h.  
The heterogeneous reaction mixture was stirred vigorously overnight at −78 °C.  The resulting 
mixture was partitioned between ether (10 mL) and H2O (10 mL).  The layers were separated 
and the aqueous layer extracted with ether (2x).  The combined organic extracts were then 
washed with water (1x) followed by brine (1x).  Dried the organic layer over Na2SO4, filtered 
and concentrated in vacuo.  The crude residue was purified via column chromatography 
(24:1/hexanes:ethyl acetate) to yield 0.094 g (79%) of an inseparable mixture of β-lactone 
diastereomers. Diastereomeric ratio determined by crude 1H NMR (300 MHz): 91.5% (δ 4.82 
ppm) : 8.5 % (δ 4.41 ppm) / cis β-lactone 77 (title compound) : trans β-lactone.  Characterization 
O
O
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Me Ph
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data for cis β-lactone 77 (title compound): IR (thin film) 2954, 2912, 2876, 1826, 1111, 1068 
cm-1; 1H NMR (300 MHz, CDCl3): δ 7.32-7.18 (m, 5H), 4.82 (ddd, J = 10.3, 6.5, 4.1 Hz, 1H), 
3.94 (app p, J = 5.9 Hz, 1H), 3.79 (qd, J = 7.7, 14.4 Hz, 1H), 2.76-2.60 (m, 2H), 2.01 (ddd, J = 
14.4, 9.0, 4.8 Hz, 1H), 1.93-1.77 (m, 3H), 1.28 (d, J = 7.7 Hz, 3H), 0.98 (t, J = 8.0 Hz, 9H), 0.62 
(q, J = 8.0 Hz, 6H); 13C NMR (75 MHz, CDCl3): δ 172.4, 141.8, 128.3 (2C), 128.2 (2C), 125.8, 
72.1, 68.6, 47.5, 38.4, 36.9, 31.6, 8.4, 6.8 (3C), 4.9 (3C); EI-MS m/z 319 (M−Et)+, 275, 263, 249, 
185, 159; HRMS calcd for C18H27O3Si (M−Et)+: 319.1729, found 319.1734.      
 
(2S, 3R, 4R, 5S)-3,5-Bistrimethylsilyloxy-2,4-dimethyl-7-phenylhe-
ptanal (78):  To a 0 °C mixture of N,O-dimethylhydroxylamine 
hydrochloride (0.770 g, 7.90 mmol) in CH2Cl2 (9.7 mL) was added dimethylaluminum chloride 
(7.90 mL, 7.90 mmol, 1.0 M in hexanes) in a slow, dropwise fashion.  The resulting solution was 
allowed to warm to ambient temperature and stirred for 2 h.  Subsequently, cooled the 
homogenous solution to 0 °C and added a solution of β-lactone 61 (0.842 g, 2.63 mmol) in  
Ph
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CH2Cl2 (9.7 mL) via syringe.  The reaction mixture was then warmed to ambient temperature and 
allowed to stir overnight.  Cooled the reaction mixture once again to 0 °C and quenched slowly 
with aqueous phosphate buffer (25 mL, pH = 7).  The layers of the biphasic mixture were 
separated and the aqueous layer extracted with CH2Cl2 (3x).  The combined organic extracts 
were dried over Na2SO4, filtered and concentrated in vacuo.   
To a solution of the crude residue in CH2Cl2 (26 mL) at ambient temperature was added 
imidazole (0.590 g, 8.68 mmol).  The resulting solution was cooled to −78 °C and TMSCl (1.00 
mL, 7.90 mmol) was added.  Subsequently warmed the reaction mixture to ambient temperature 
and stirred overnight.  Quenched the reaction mixture by addition of saturated aqueous NaHCO3 
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(20 mL).  The layers were separated and the aqueous layer was extracted with CH2Cl2 (3x).  The 
combined organic extracts were dried over Na2SO4, filtered and concentrated in vacuo. 
 To a −78 °C solution of the crude residue in THF (26 mL) was added iBu2AlH (3.70 mL, 
3.70 mmol, 1.0 M in hexanes) in a slow, dropwise fashion.  The resulting solution was 
maintained at −78 °C for 3 h after which saturated aqueous Rochelle’s salts was added (30 mL).  
The biphasic mixture was allowed to warm to ambient temperature and was stirred vigorously 
for 1 h.  The layers were separated and the aqueous layer extracted with ether (3x).  The 
combined organic extracts were dried over Na2SO4, filtered and concentrated in vacuo.  The 
crude oil was purified by silica gel chromatography (24:1/hexanes:ethyl acetate) to provide 0.870 
g (84% over 3 steps) of aldehyde 78: [α]D = +43.2 (c 1.06, CHCl3) ;  IR (thin film) 2954, 1728, 
1251, 1108, 1080, 1032 cm-1; 1H NMR (300 MHz, CDCl3): δ 9.72 (s, 1H), 7.32-7.18 (m, 5H), 
4.26 (dd, J = 8.0, 2.4 Hz, 1H), 3.96 (td, J = 6.8, 2.6 Hz, 1H), 2.61-2.47 (m, 3H), 1.91-1.82 (m, 
2H), 1.75-1.69 (m, 1H), 1.11 (d, J = 7.0 Hz, 3H), 0.85 (d, J = 7.0 Hz, 3H), 0.14 (s, 9H), 0.08 (s, 
9H); 13C NMR (75 MHz, CDCl3): δ 204.3, 141.6, 128.2 (2C), 128.0 (2C), 125.6, 72.2, 71.9, 
49.7, 41.0, 37.2, 32.1, 9.75, 6.69, 1.07 (3C), 0.55 (3C); ESI-MS m/z 417 (M+Na)+; HRMS calcd 
for C21H38NaO3Si2 (M+Na)+: 417.2257, found 417.2273.      
 
(3R, 4S)-4-((2S, 3R, 4R, 5S)-3,5-Bistrimethylsilyloxy-4-methyl-
7-phenylheptan-2-yl)-3-methyloxetan-2-one (80):  A flame-
dried 25 mL round bottom flask was charged with TMS-quinine 
(29 mg, 72.0 μmol) and LiI (0.289 g, 2.16 mmol).  To the mixture of solids was sequentially 
added CH2Cl2 (2.1 mL), Et2O (0.20 mL) and iPr2NEt (0.310 mL, 1.80 mmol).  The resulting 
mixture was stirred at ambient temperature for 5 min then cooled to −50 °C.  To the reaction 
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mixture was added aldehyde 78 (0.284 g, 0.720 mmol) followed by dropwise addition of a 
solution of propionyl chloride (0.130 mL, 1.44 mmol) in CH2Cl2 (0.48 mL) over 2h.  The 
heterogeneous reaction mixture was stirred vigorously overnight at −50 °C.  The resulting 
mixture was diluted with ether and filtered over a plug of silica gel, eluting with ether.  The 
filtrate was concentrated in vacuo and the crude residue purified via column chromatography 
(24:1/hexanes:ethyl acetate) to yield 0.248 g (76%) of β-lactone 80: Diastereomeric ratio 
determined by crude 1H NMR (300 MHz; δ 4.37 ppm) showed the title compound was produced 
as a single diastereomer; [α]D = −4.0 (c 1.0, CHCl3) ;  IR (thin film) 2954, 1828, 1250, 1148, 
1117, 1080, 1050, 1002 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.32-7.18 (m, 5H), 4.37 (dd, J = 
11.1, 6.3 Hz, 1H), 3.95-3.91 (m, 2H), 3.77 (dq, J = 14.1, 7.7 Hz, 1H), 2.59 (dd, J = 10.1, 6.4 Hz, 
2H), 2.00-1.82 (m, 3H), 1.74-1.65 (m, 1H), 1.34 (d, J = 7.8 Hz, 3H), 0.83 (d, J = 7.0 Hz, 3H), 
0.82 (d, J = 6.6 Hz, 3H), 0.14 (s, 18H); 13C NMR (75 MHz, CDCl3): δ 172.1, 141.8, 128.2 (2C), 
128.0 (2C), 125.6, 75.9, 72.3, 71.7, 46.3, 41.2, 37.3, 35.2, 32.0, 9.6, 8.2, 7.9, 1.2 (3C), 0.6 (3C); 
ESI-MS m/z 473 (M+Na)+; HRMS calcd for C24H42NaO4Si2 (M+Na)+: 473.2519, found 
473.2532.      
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3.0  EFFORTS TOWARDS A CATALYTIC, ASYMMETRIC SYNTHESIS OF AN 
ANALOGUE OF (+)-DISCODERMOLIDE  
3.1 ISOLATION AND BIOACTIVITY  
(+)-Discodermolide (81) is a naturally occurring marine polyketide metabolite that was isolated 
from the rare deep sea sponge Discodermia dissoluta by Gunasekara and coworkers in 1990 at 
the Harbor Branch Oceanographic Institution (Figure 19).54  (+)-Discodermolide’s structure, as 
determined by spectroscopic studies and single crystal X-ray crystallography, contains 13 
stereocenters (six of which are hydroxyl-bearing), a tetrasubstituted δ-lactone, one disubstituted 
and one trisubstituted (Z)-olefin, a carbamate moiety and a terminal (Z)-diene.55  In order to 
minimize 1,3-allylic strain and the syn-pentane interactions along the skeleton, discodermolide 
adopts a U-shaped conformation with the bend occurring at the central stereotriad (C10-C12).   
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Figure 19: (+)-Discodermolide (81) 
                                                 
54 Paterson, I.; Florence, G. J. Eur. J. Org. Chem. 2003, 2193-2208. 
55 Arefolov, A.; Panek, J. S. J. Am. Chem. Soc. 2005, 127, 5596-5603. 
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Discodermolide possesses a very impressive pharmacological profile as an immunosuppressive 
agent with some additional anti-fungal properties.  Recent studies have revealed that 
discodermolide is a potent antimitotic agent and is recognized as a member of a specialized 
group of natural products, which includes cytotoxins such as Taxol® and laulimalide, that act as 
microtubule-stabilizing agents and mitotic spindle poisons.  Biological testing has unveiled that 
discodermolide possesses impressive cytotoxicity in a variety of human cell lines (IC50 3-80 nM) 
causing cell death by apoptosis.56  Comparative studies have shown that discodermolide was 
1000-fold more active than Taxol® in promoting the same microtubule polymerization and 
bundling.57  In addition to discodermolide’s inherent cytotoxic capabilities, it has also shown 
amplified synergistic cytotoxicity when combined with other antimitotic agents.58  
3.2 PAST SYNTHESES AND RETROSYNTHETIC ANALYSIS 
Due to the strong cytotoxic profile possessed by discodermolide, as well as our ability to harvest 
it from nature in only scarce amounts (isolation yield is 0.002% w/w from frozen sponge; 7 mg 
of natural product from 434 g of sponge), discodermolide has drawn the attention of many 
research groups.59  The problem of limited supply can only be solved by total synthesis of the 
natural product as no semi-synthetic pathways or fermentation processes currently exist for its 
production.  Consequently, there exists several total syntheses and numerous partial syntheses of 
                                                 
56 (a) ter Haar, E.; Kowalski, R. J.; Hamel, E.; Lin, C. M.; Longley, R. E.; Gunasekera, S. P.; Rosenkranz, H. S.; 
Day, B. W. Biochemistry 1996, 35, 243-250. (b) Kowalski, R. J.; Giannakakou, P.; Gunasekera, S. P.; Longley, R. 
E.; Day, B. W.; Hamel, E.  Mol. Parmacol. 1997, 52, 613-622. (c) Balachandran, R.; ter Haar, E.; Welsh, M. J.; 
Grant, S. C.; Day, B. W. Anti-Cancr Drugs 1998, 9, 67-76. 
57 Paterson, I.; Lyothier, I. J. Org. Chem. 2005, 70, 5494-5507. 
58 Harried, S. S.; Lee, C. P; Yang, G.; Lee, T. I. H.; Myles, D. C. J. Org. Chem. 2003, 68, 6646-6660. 
59 Smith III, A. B.; Kaufman, M. D.; Beauchamp, T. J.; LaMarche, M. J.; Arimoto, H. Org. Lett. 1999, 1, 1823-
1826. 
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discodermolide.  Included within the total syntheses to date is an industrial synthesis completed 
by Novartis Pharmaceutical Corporation who brought discodermolide into clinical trials.57       
It is not surprising that all the total syntheses of discodermolide disconnect the 
polypropionate backbone into three fragments of similar size and stereochemical complexity 
(Figure 20).  Most of the syntheses disassembly the skeleton at or in close proximity of the two 
(Z)-alkenes, highlighting the larger number of present methodologies to form these types of 
bonds.  The polypropionate backbone of discodermolide has been made utilizing an assortment 
of asymmetric technologies including auxiliary/non-auxiliary controlled aldol reactions and 
crotylsilane and allenylstannane additions to aldehydes.            
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Figure 20: Retrosyntheses of (+)-discodermolide 
 
Interest in discodermolide as a synthetic target was piqued because of the heavily 
polypropionate-containing skeleton that it possesses.  It was felt that discodermolide would 
provide an ideal platform to demonstrate the utility of the recently developed Cinchona alkaloid-
catalyzed AAC reaction for polypropionate unit formation in complex natural product synthesis.  
With that goal in mind, and taking into consideration the existence of numerous completed total 
syntheses of discodermolide, a derivative of the natural product, polysilylated analogue 82, 
became the main synthetic target (Figure 21).   
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Figure 21: Polysilylated analogue 82 
 
Since the main concern was formation of the polypropionate unit skeleton using AAC 
technology, the proposed retrosynthetic strategy for analogue 82 is similar to those already 
proposed for discodermolide.  It was decided to disassemble the molecule into three fragments, 
all of somewhat equal size and complexity, near the two (Z)-alkenes (Figure 22).  The initial 
disconnection is the same used by Marshall and coworkers in their synthesis of discodermolide 
where the C7-C8 bond is cleaved.  It is felt that this bond can be made, with concomitant setting 
of the C7-stereocenter, by addition of an alkyne into aldehyde 83, the left fragment.  The second 
disconnection is at the trisubstituted olefin and is similar to the Novartis synthesis of 
discodermolide where the C14-C15 bond is made via a Suzuki cross-coupling reaction.  This 
disconnection generates the other two fragments, center fragment 84 and right fragment 85. 
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Figure 22: Retrosynthetic analysis of analogue 82 
 
Further disassembly of aldehyde 83 shows that the δ-lactone can be synthesized from masked 
polypropionate unit 86, which is a product from the Cinchona alkaloid-catalyzed AAC reaction 
(Figure 23).  Polypropionate unit 86 is derived from disubstituted trans-β-lactone 87 which, 
using chemistry developed in the Nelson group, can be made from commercially available 3-
benzyloxy-1-propanol. 
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Figure 23: Retrosynthetic analysis of left fragment 83 
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As other research groups have also realized, the center and right fragments possess the same 
stereotriad and therefore can be derived from the same common intermediate.  Alkyne 84 and 
iodide 85 can both be formed from a common intermediate, elaborate Weinreb amide 88 (Figure 
24).  Amide 88 can be made from β-lactone 89, which is a product derived using AAC 
technology.  Masked polypropionate unit 89 can be synthesized from the commercially available 
(S)-Roche ester in four steps.  
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Figure 24: Retrosynthetic analysis of fragments 84 and 85 
3.3 RESULTS AND DISCUSSION 
3.3.1 Synthesis of aldehyde 83  
Synthetic efforts towards the catalytic, asymmetric synthesis of analogue 82 began with 
formation of the initial desired left fragment, aldehyde 83.  The sequence began with known β-
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lactone 90 (91% ee) which is made from commercially available 3-benzyloxy-1-propanol in two 
steps (Scheme 29).  Alkylation of β-lactone 90 with NaHMDS and MeI at −100 ºC afforded α-
methylated β-lactone 87 in 62% yield.  Opening of β-lactone 87 with (MeO)NHMe·HCl and 
Me2AlCl produced β-hydroxy Weinreb amide 91 in 83% yield.  Silylation of amide 91 with 
TMSCl afforded a 97% yield of silyl ether 92, which was subsequently treated with iBu2AlH to 
produce aldehyde 93 in 86% yield.  Subjection of aldehyde 93 to the AAC reaction catalyzed by 
TMS-QN yielded masked polypropionate 86 in 75% yield as a single diastereomer.  It is worth 
noting that for this AAC reaction a 6 hour addition time for the solution of propionyl chloride in 
CH2Cl2 was found to be optimal.   
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Hydrolysis of β-lactone 86 with a biphasic mixture of aqueous KOH and THF, followed by 
acidification of the reaction mixture to a pH ~ 2 with concentrated HCl, afforded δ-lactone 94 in 
90% yield (Scheme 30).  Protection of the β-hydroxy group on δ-lactone 94 as a TBS-ether 
proved difficult, as a mixture of desired silyl ether 95 (55% yield) and undesired enoate 96 (22% 
yield) was obtained.  It is speculated that this undesired elimination reaction was the effect of the 
very Lewis acidic TBSOTf in the presence of base, as well as trans-annular strain caused by the 
bulky β-silyloxy group in the δ-lactone.  The latter hypothesis was validated by acylating the β-
hydroxy group in δ-lactone 94 as a 3,5-dinitrobenzoyl group (81% yield) and obtaining a X-ray 
crystal structure of tetrasubstituted δ-lactone 97 (Appendix A).  From the crystal structure it can 
be seen that the protected β-hydroxy group on the lactone is in the axial position, thereby 
facilitating the undesired elimination reaction.   
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Even though silylation of the hydroxy group was problematic, the synthesis of aldehyde 83 was 
continued in order to test the aldehyde-alkyne coupling.  Removal of the benzyl ether on 95 via 
hydrogenolysis yielded primary alcohol 98 in 90% yield (Scheme 31).  The left fragment was 
completed by oxidation of primary alcohol 98 to aldehyde 83 using DMP.  The aldehyde proved 
to be somewhat unstable and could not be purified, so the crude product was used in the 
attempted coupling reaction.  The initial hope was to perform an asymmetric addition of the 
center fragment into the left fragment, therefore a very simplistic test reaction using Carreira’s 
N-methylephedrine modified zinc-acetylide addition reaction was performed.60  However, 
immediately upon subjection of aldehyde 83 to the reaction conditions, the starting material 
decomposed to yield a mixture of different α, β-unsaturated carbonyl products.  As previously 
hypothesized, it was felt that the trans-annular strain across the δ-lactone was the cause of the 
problem.  At this point it was realized that aldehyde 83 would not be a viable fragment and 
decided to revise our target substrate.    
 
 
 
 
 
                                                 
60 Boyall, D.; Frantz, D. E.; Carreira, E. M. Org. Lett. 2002, 4, 2605-2606. 
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Scheme 31 
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3.3.2 Synthesis of aldehyde 99 
The initial failure at forming the C7-C8 bond was felt to be a direct cause of the instability of the 
target fragment chosen rather than the method of formation of the bond, so the target was revised 
to a more stable and easily handled alternative.  Since inherent strain in the δ-lactone was 
believed to be the source of the problem, a logical choice for an alternative fragment would be an 
acyclic variant that could be transformed into the δ-lactone if desired.  Additionally, the new 
target had to be a potentially viable substrate for the aldehyde-alkyne coupling reaction and not 
introduce any chemoselectivity issues.  With this in mind, it was felt that aldehyde 99 was a 
suitable choice for the revised left fragment (Figure 25).             
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Figure 25: Revised retrosynthetic analysis  
 
As depicted in Figure 25, the revised left fragment 99 can be derived from known β-lactone 86 
and therefore the already developed forward sequence.  Opening of β-lactone 86 with 
(MeO)NHMe·HCl in the presence of Me2AlCl, with concomitant cleavage of the silyl ether, 
produced an intermediate bis-hydroxy Weinreb amide that was treated with TBSOTf to afford 
elaborate Weinreb amide 101 in 88% yield over two steps (Scheme 32).  Deprotection of the 
benzyl ether via hydrogenolysis, followed by oxidation of the crude primary alcohol with DMP 
completed the revised left fragment, aldehyde 99, in 88% yield over two steps.        
 
 
 
 
 
 108 
Scheme 32 
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3.3.3 Synthesis of iodide 85  
With the synthesis of the left fragment completed, the synthesis of the right fragment, iodide 85, 
commenced.  The synthesis of iodide 85 began with aldehyde 102 which can be made from the 
commercially available (S)-Roche ester in 3 steps (Scheme 33).  Subjection of aldehyde 102 to 
the Cinchona alkaloid-catalyzed AAC reaction in the presence of a catalytic amount of TMS-QN 
produced β-lactone 89 in 77% yield as a single diastereomer.  Treatment of β-lactone 89 with 
(MeO)NHMe·HCl and Me2AlCl at −30 ºC afforded a 91% yield of β-hydroxy Weinreb amide 
103.  Silylation of amide 103 with TBSOTf produced the common synthetic intermediate for the 
center and right fragment, amide 88, in 98% yield. 
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The synthesis of the completed right fragment was accomplished in 5 steps from common 
intermediate 88 (Scheme 34).  Reduction of the Weinreb amide moiety in common intermediate 
88 with iBu2AlH afforded a quantitative yield of aldehyde 104.  As mention previously, the 
desired syn, syn, syn polypropionate unit is unable to be produced using the AAC technology.  
Since a more elaborate variant of this subunit is needed for the right fragment of discodermolide, 
alternative methods were employed to obtain the desired stereoarray.  Utilizing auxiliary-
controlled aldol chemistry developed by Crimmins and coworkers, the desired syn, syn, syn, anti 
polypropionate unit 105 was synthesized from aldehyde 104 in 91% yield as a single 
diastereomer.61  Protection of the hydroxy group in 105 with TBSOTf yielded oxazolidithione 
106 in 95% yield.  Subsequent removal of the chiral oxazolidithione auxiliary on 106 with LiBH4 
                                                 
61 Crimmins, M. T.; King, B. W.; Tabet, E. A.; Chaudhary, K. J. Org. Chem. 2001, 66, 894-902. 
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in MeOH afforded primary alcohol 107 in 83% yield.  The synthesis of the right fragment was 
completed by subjecting alcohol 107 to PPh3, iodine and imidazole to produce primary iodide 85 
in 71% yield.    
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3.3.4 Synthesis of the model alkyne 108  
Before efforts towards the synthesis of the actual center fragment commenced, model center 
fragment 108 was synthesized in order to test the coupling of the center and left fragments.  The 
synthesis of the model alkyne began by treating known β-lactone 109 with (MeO)NHMe·HCl 
and Me2AlCl to produce an 84% yield of β-hydroxy amide 110 (Scheme 35).  Protection of the 
 111 
free alcohol on amide 110 as a MOM ether, followed by twofold reduction of the amide moiety 
with iBu2AlH afforded primary alcohol 111 in 66% overall yield.  Formation of a benzyl ether 
using BnBr and NaH in the presence of TBAI, followed by subsequent deprotection of the 
TBDPS ether with TBAF produced an 82% yield of benzyl ether 112 over the two steps.  
Oxidation of the primary alcohol on 112 with DMP, followed by subjection of the intermediate 
aldehyde to TMSCHN2 and freshly generated LDA completed the synthesis of the model center 
fragment, alkyne 108, in 75% yield over the final two steps.    
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With the synthesis of the model alkyne completed, it was time to test the aldehyde-alkyne 
coupling.  As discussed before, the initial hope was to perform an asymmetric addition of the 
center fragment into the left fragment in order to reinforce setting the C7-stereocenter with the 
proper stereochemistry.  To do so, two of the more common asymmetric addition reactions, 
 112 
conditions developed by Pu and coworkers [Ti(OiPr)4-ZnEt2-BINOL] and conditions developed 
by Chan and coworkers [Ti(OiPr)4-ZnMe2-BINOL], were attempted (Table 5).62  Additionally, 
the more recent InBr3-BINOL reaction conditions developed by Shibasaki and coworkers were 
attempted.63  Disappointingly, while these reaction conditions work well for simple aldehydes 
and alkynes, they failed to produce any desired product when the complex aldehyde and alkyne 
fragments were used.       
 
Table 5: Addition of model alkyne 108 into aldehyde 99 
OBn
Me
OMOM
Me
99
P = TBS
N
MeO
Me
O
Me
OP
Me
OP O
H
N
MeO
Me
O
Me
OP
Me
OP OH
OMOM
MeMe
OBn
113
P = TBS
+
108
entry
a
b
c
Resultsa
InBr3, (S)_BINOL, Cy2NMe
no desired product
no desired product
no desired product
Conditions
ZnMe2, Ti(OiPr)4, (R)_BINOL
ZnEt2, Ti(OiPr)4, (R)_BINOL
d 2.5:1/desired:undesired (~8% enal)
e nBuLi, LiBr, THF, −78 °C 4.4:1/desired:undesired (~8% enal)
f nBuLi, MgBr2·OEt2, THF, −78 °C 6.0:1/desired:undesired (~8% enal)
nBuLi, LiBr, toluene, −78 °C
 
a Determined using crude 1H NMR and HPLC analysis.  The desired diastereomer is amide 113 which is depicted.  
Isolated yields not obtained 
                                                 
62 (a) Gao, G.; Moore, D.; Xie, R.-G.; Pu, L. Org. Lett. 2002, 4143-4146. (b) Pu, L. Tetrahedron 2003, 59, 9873-
9886. (c) Li, X.-S.; Lu, G.; Kwok, W. H.; Chan, A. S. C. J. Am. Chem. Soc. 2002, 124, 12636-12637. 
63 Takita, R.; Yakura, K.; Ohshima, T.; Shibasaki, M. J. Am. Chem. Soc. 2005, 127, 13760-13761. 
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After the failure of the asymmetric alkyne addition reactions to produce any desired product, 
unmodified anionic acetylide addition reactions into aldehyde 99 were attempted.  Based on the 
electrostatic minimization model proposed by Reetz and Evans, aldehyde 99 should adopt a 
reactive conformer that inherently favors production of the desired 1,3-anti diastereomer, alcohol 
113, as the major product.50  Preliminary studies with this type of addition were performed using 
the lithium acetylide of alkyne 108 generated from deprotonation with nBuLi.  Addition of the 
lithium acetylide into aldehyde 99 in toluene at −78 ºC did yield the aldehyde addition products 
and a minor amount of enal (~8% yield).64  As hypothesized, the desired alcohol 113 was the 
major product, being produced in a diastereomeric ratio of 2.5:1 with the undesired diastereomer.  
A quick survey of conditions showed that changing the solvent to THF had a beneficial effect as 
the diastereomeric ratio increased to 4.4:1/desired:undesired.  The best diastereomeric ratio 
(6.0:1/desired:undesired) was obtained in THF when the lithium acetylide was transmetallated 
into a magnesium bromide acetylide prior to addition to the aldehyde. 
3.3.5 First attempt at the synthesis of alkyne 84  
With the testing of the aldehyde-alkyne coupling reaction complete, the synthesis of the actual 
center fragment was undertaken.65  Besides formation of the polypropionate unit backbone, the 
center fragment also possessed the challenge of making a trisubstituted (Z)-olefin with one of the 
substituents being an iodide.  In the preliminary studies for the synthesis of alkyne 84, Panek’s 
method of using hydrozirconation to form the trisubstituted olefin was employed.55  In this 
sequence, a vinyl TMS group acts as a masked vinyl iodide. 
                                                 
64 Alcohol 113 was not purified or fully characterized, only crude 1H NMR was used. 
65 When this route was attempted, amide 103 was the common intermediate.  Upon failure of this route, the common 
intermediate became amide 88.  
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The synthetic sequence begins with protection of the β-hydroxy group on Weinreb amide 
103 as a MOM-ether using MOMCl and TBAI to produce amide 114 (Scheme 36).  Reduction of 
the Weinreb amide moiety on amide 114 with iBu2AlH, followed by transformation of aldehyde 
115 into an alkyne with TMSCHN2 and freshly prepared LDA afforded alkyne 116 in 71% 
overall yield.  Deprotonation of the terminal alkyne 116 using nBuLi with subsequent reaction of 
the generated lithium acetylide with TMSCl produced an 80% yield of silyl ether 117. 
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With alkyne 117 synthesized, attempts at forming the requisite trisubstituted olefin utilizing 
Panek’s methodology were made.  Unfortunately, despite multiple attempts the desired olefin 
was unable to be obtained (Scheme 37).  The hydrozirconation/iodination reaction proved to be 
irreproducible as the amount of starting material that was converted to desired product 118 
varied greatly.  Additionally, desired iodide 118 was contaminated with a minor amount of an 
 115 
undesired alkene byproduct (~3-5% yield) that was unable to be removed.  Based on crude 1H 
NMR data, this undesired olefin byproduct is speculated to be alkene 119.   
 
Scheme 37 
Me
OMOM
Me
OTBS
TMS 1) Cp2Zr(H)Cl (2.5eqs.),
55 °C
2) I2
Me
OMOM
Me
OTBS
I
TMS
Me
OMOM
Me
OTBS
I
119
~3-5% yield
117
118
 
 
To complicate the reaction sequence further, the subsequent Negishi cross-coupling reaction to 
install the methyl group was very problematic as well.  While the desired trisubstituted (Z)-olefin 
120 was obtained from the cross-coupling reaction, there was a persistent failure to achieve full 
consumption of the starting material despite the use of an excess amount of MeZnCl (Scheme 
38).  Also, as with the hydrozirconation/iodination reaction, this reaction formed an undesired 
olefin containing byproduct (~3-10%) that was inseparable from the desired product.  Due to the 
problems associated with these two synthetic steps, this route to alkyne 84 was abandoned.                  
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3.3.6 Revised synthesis of alkyne 84 
After the failure of Panek’s methodology to form the requisite trisubstituted olefin from alkyne 
117, an alternative sequence to the olefin using the Zhao-Wittig olefination was attempted.66  
The synthetic sequence to the precursor for the Zhao-Wittig olefination can be made from 
common intermediate 88 in 6 steps.  Treatment of amide 88 with HCl and MeOH cleaved the 
primary silyl ether and catalyzed lactonization to produce an 84% yield of δ-lactone 121 
(Scheme 39).  Opening of δ-lactone 121 to a Weinreb amide with ensuing Parikh-Doering 
oxidation of primary alcohol 122 afforded a 79% yield of aldehyde 123 over the two steps.    
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Transformation of the aldehyde functionality in 123 to a terminal alkyne required the use of mild 
reaction conditions as the aldehyde proved to be somewhat sensitive.  Employing Ohira’s reagent 
                                                 
66 Chen, J.; Zhao, K. Tetrahedron Lett. 1994, 35, 2827-2828. 
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with Cs2CO3 in iPrOH, alkyne 124 was produced in 97% yield from aldehyde 123.67  Reduction 
of amide 124 with iBu2AlH yielded the precursor for the Zhao-Wittig olefination, aldehyde 125, 
in 79% yield.  While the Zhao-Wittig olefination is not an extremely efficient reaction (normally 
20-40% yield, 6-19:1/Z:E), this transformation installs the necessary functionalities to complete 
the target center fragment in one step.  Subjection of aldehyde 125 to a solution of freshly 
prepared phosphonium salt 126 in the presence of NaHMDS afforded the completed center 
fragment 84 in 21% yield as a 10:1/Z:E inseparable mixture of olefin isomers. 
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Currently, the Nelson group possesses a working synthetic sequence to all the target fragments of 
analogue 100.  Most of the polypropionate units along the backbone of analogue 100 were 
successfully set using AAC chemistry, with the center and right fragments both being formed 
from an elaborate common intermediate.  Subsequent studies on the coupling of these three 
                                                 
67 Ghosh, A.; Bischoff, A.; Cappiello, J. Eur. J. Org. Chem. 2003, 821-832. 
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fragments into analogue 100, as well as derivatization of the analogue into other congeners of 
(+)-discodermolide, will be conducted in the future. 
3.4 EXPERIMENTAL 
General Information: 1H NMR spectra were recorded on Bruker DPX 301 and DPX 302 (300 
MHz) spectrometers.  Chemical shifts are reported in ppm from tetramethylsilane with either the 
solvent resonance as the internal standard (CHCl3: δ 7.27 ppm) or tetramethylsilane as an 
external standard (TMS: δ ppm).  Data is reported as follows: chemical shift (ppm), multiplicity 
(s = singlet, d = doublet, t = triplet, q = quartet, p = pentet, sept = septet, app = apparent, br = 
broad, m = multiplet), coupling constants (Hz), integration.  13C NMR spectra were recorded on 
Bruker DPX 301 and DPX 302 spectrometers (75 MHz) with complete proton decoupling.  
Chemical shifts are reported in ppm from tetramethylsilane with either the solvent resonance as 
the internal standard (CDCl3: δ 77.0 ppm) or tetramethylsilane as an external standard (TMS: δ 
ppm).  Optical rotations were measured on a Perkin-Elmer 241 digital polarimeter with a sodium 
lamp at ambient temperature and are reported as follows: [α]D (c g/100 mL) with units of 
degree•g•cm-3.  Infrared spectra were recorded on a Nicolet Avatar 360 FT-IR spectrometer.  
Mass spectra were obtained on a VG-7070 or Fisons Autospec high resolution magnetic sector 
mass spectrometer.  
Analytical thin layer chromatography was performed on EM Reagent 0.25 mm silica gel 
60-F plates.  Flash chromatography was performed as previously described on EM silica gel 60 
(230-240 mesh).37 Automated flash chromatography was performed using an ISCO CombiFlash® 
Companion™ using disposable RediSep™ columns. Analytical gas liquid chromatography (GLC) 
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was performed on a Varian 3900 gas chromatograph with a flame ionization detector and split 
mode capillary injection system using a VarianCP Wax 52CB column (30 m x 0.25 mm).  
Hydrogen was used as the carrier gas at the indicated pressures.  Analytical high performance 
liquid chromatography (HPLC) was performed on a Hewlett Packard 1100 liquid chromatograph 
equipped with a variable wavelength UV detector (deuterium lamp, 190-600 nm), using a Daicel 
Chiralcel™ OD-H column (250 x 4.6 mm) (Daicel Inc.).  HPLC grade isopropanol and hexanes 
were used as the eluting solvents.  Melting points were measured using a Mel-Temp apparatus 
and are uncorrected. 
Unless otherwise stated, all experiments were carried out under a nitrogen atmosphere in 
oven or flame-dried glassware using standard inert atmosphere techniques for introducing 
reagents and solvents.  Anhydrous solvents were obtained by passage through successive 
alumina- and Q5 reactant-packed columns on a solvent purification system.  Amines were 
purified via distillation from CaH2.  Propionyl chloride, TBSOTf and MOMCl were purified by 
distillation prior to use.   Unless otherwise stated, commercially available reagents were used as 
received without any further purification.  All water used in reactions and in aqueous solutions 
was deionized.   
 
(3S,4S)-4-(2-(Benzyloxy)ethyl)-3-methyloxetan-2-one (87):  To a solution 
of β-lactone 90 (2.88 g, 14.0 mmol) in THF (700 mL) at ambient temperature 
was added MeI (4.35 mL, 69.9 mmol).  The  reaction mixture was then cooled to −100 °C and 
NaHMDS (14.0 mL, 14.0 mmol, 1.0 M in THF) was added in a dropwise fashion over 2 h.  After 
complete addition the resulting solution was maintain for an additional hour at −100 °C.  The 
reaction mixture was quenched by addition of saturated aqueous NH4Cl (50 mL) and allowed to 
O
O
OBn
Me
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warm to ambient temperature.  The layers were separated and the aqueous layer extracted with 
ethyl acetate (3x).  The combined organic extracts were washed with brine (1x), dried over 
Na2SO4, filtered and concentrated in vacuo.  The crude residue was purified by silica gel 
chromatography (19:1/hexanes:ethyl acetate) to provide 1.91 g (62%) of disubstituted β-lactone 
87:  [α]D = −39.6 (c 1.4, CHCl3);  IR (thin film) 2935, 2872, 1824, 1454, 1385, 1363, 1124 cm-1; 
1H NMR (300 MHz, CDCl3): δ 7.40-7.31 (m, 5H), 4.52 (br s, 2H), 4.38 (td, J = 6.6, 4.0 Hz, 1H), 
3.67-3.56 (m, 2H), 3.36 (qd, J = 7.6, 4.0 Hz, 1H), 2.16-2.08 (m, 2H), 1.37 (d, J = 7.5 Hz, 3H); 
13C NMR (75 MHz, CDCl3): δ 171.4, 137.6, 127.8 (2C), 127.1, 127.0 (2C), 76.7, 72.4, 65.3, 
50.4, 33.5, 11.6; EI-MS m/z 205 (M−Me)+ 192, 174, 146; HRMS calcd for C12H16O2 (M−CO)+: 
192.1150, found 192.1148. 
 
(2S,3S)-5-(Benzyloxy)-3-hydroxy-N-methoxy-N,2-dimethylpent-
anamide (91):  To a 0 °C mixture of N,O-dimethylhydroxylamine 
hydrochloride (6.77 g, 69.4 mmol) in CH2Cl2 (125 mL) was added dimethylaluminum chloride 
(69.0 mL, 69.4 mmol, 1.0 M in hexanes) in a slow, dropwise fashion.  The resulting solution was 
allowed to warm to ambient temperature and stirred for 2 h.  Subsequently, the homogenous 
solution was cooled to 0 °C and diluted with CH2Cl2 (75 ml).  To the resulting solution was 
added a solution of β-lactone 87 (7.64 g, 34.7 mmol) in CH2Cl2 (50 mL) via syringe.  The 
reaction mixture was then warmed to ambient temperature and allowed to stir for 2 h.  Cooled 
the reaction mixture once again to 0 °C and quenched slowly with aqueous phosphate buffer 
(100 mL, pH = 7).  The resulting biphasic mixture was warmed to ambient temperature and 
stirred vigorously for 1 h.  The layers of the mixture were then separated and the aqueous layer 
extracted with CH2Cl2 (3x).  The combined organic extracts were dried over Na2SO4, filtered and 
MeO
N OBn
Me
O
Me
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concentrated in vacuo.  The crude oil was purified by silica gel chromatography 
(2:1/hexanes:ethyl acetate) to provide 8.10 g (83%) of amide 91: [α]D = +13.6 (c 1.0, CHCl3);  IR 
(thin film) 3443 (br), 2938, 2866, 1636, 1454, 1420, 1100 cm-1; 1H NMR (300 MHz, CDCl3): δ 
7.35-7.27 (m, 5H), 4.53 (br s, 2H), 3.89 (dtd, J = 9.4, 6.2, 3.1 Hz, 1H), 3.77-3.62 (m, 3H), 3.69 
(s, 3H), 3.20 (s, 3H), 2.99-2.96 (m, 1H), 1.91-1.70 (m, 2H), 1.22 (d, J = 7.1 Hz, 3H); 13C NMR 
(75 MHz, CDCl3): δ 176.6, 138.0, 128.0 (2C), 127.3 (2C), 127.2, 72.8, 71.7, 67.8, 61.1,  40.0, 
34.6, 31.4, 14.3; EI-MS m/z 221 (M−(MeO)NMe)+ 221, 157, 151, 146; HRMS calcd for 
C13H17O3 (M−(MeO)NMe)+: 221.1178, found 221.1177. 
 
(2S,3S)-5-(Benzyloxy)-3-trimethylsilyloxy-N-methoxy-N,2-dime-
thylpentanamide (92):  To a solution of β-hydroxyl amide 91 (2.24 
g, 7.97 mmol) in CH2Cl2 (100 mL) at 0 °C was added 2,6-lutidine (2.32 mL, 19.9 mmol).  
Subsequently, freshly distilled TMSCl (2.22 mL, 17.5 mmol) was added to the reaction mixture.  
The resulting solution was warmed to ambient temperature and stirred 1 h, after which the 
reaction mixture was quenched by addition of saturated aqueous NaHCO3 (40 mL).  The layers 
were separated and the organic layer washed with 1.0 M aqueous NaHSO4 (1x).  The combined 
aqueous layers were then extracted with CH2Cl2 (3x) and the combined organic extracts dried 
over Na2SO4, filtered and concentrated in vacuo.  The crude oil was purified by silica gel 
chromatography (6:1/hexanes:ethyl acetate) to provide 2.74 g (97%) of silyl ether 92:  [α]D = 
+18.1 (c 1.2, CHCl3);  IR (thin film) 2957, 2898, 1660, 1454, 1248, 1112 cm-1; 1H NMR (300 
MHz, CDCl3): δ 7.36-7.28 (m, 5H), 4.51 (d, J = 3.7 Hz, 2H), 4.11 (td, J = 8.4, 2.9 Hz, 1H), 3.69 
(s, 3H), 3.63-3.57 (m, 2H), 3.19 (s, 3H), 3.15-3.02 (m, 1H), 1.93 (dtd, J = 14.1, 7.4, 3.0 Hz, 1H), 
1.69 (ddt, J = 14.2, 8.2, 6.1 Hz, 1H), 1.06 (d, J = 6.9 Hz, 3H), 0.08 (s, 9H); 13C NMR (75 MHz, 
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CDCl3): δ 175.2, 138.0, 127.6 (2C), 126.9 (2C), 126.8, 72.2, 70.7, 65.9, 60.5, 41.3, 33.2, 31.1, 
12.7, −0.3 (3C); EI-MS m/z 338 (M−Me)+ 293, 157; HRMS calcd for C18H31NO4Si: 353.2022, 
found 353.2023. 
 
 
(2S,3S)-5-(Benzyloxy)-3-trimethylsilyloxy-2-methylpentanal (93):  To 
a −78 °C solution of amide 92 (2.74 g, 7.75 mmol) in THF (75 mL) was 
added iBu2AlH (11.0 mL, 10.9 mmol, 1.0 M in hexanes) in a slow, dropwise fashion.  The 
resulting solution was maintained at −78 °C for 2 h after which saturated aqueous Rochelle’s 
salts (30 mL) was added.  The biphasic mixture was allowed to warm to ambient temperature 
and stirred vigorously for 1 h.  The layers were separated and the aqueous layer extracted with 
ether (3x).  The combined organic extracts were washed with brine (1x), dried over Na2SO4, 
filtered and concentrated in vacuo.  The crude oil was purified by silica gel chromatography 
(30:1/hexanes:ethyl acetate) to provide 1.97 g (86%) of aldehyde 93:  [α]D = +12.9 (c 1.2, 
CHCl3);  IR (thin film) 2956, 2860, 1725, 1251, 1110 cm-1; 1H NMR (300 MHz, CDCl3): δ 9.73 
(d, J = 2.3 Hz, 1H), 7.36-7.30 (m, 5H), 4.50 (d, J = 3.5 Hz, 2H), 4.15 (dt, J = 6.6, 5.3 Hz, 1H), 
3.60-3.54 (m, 2H), 2.50 (qdd, J = 7.1, 5.1, 2.3 Hz, 1H), 1.86-1.79 (m, 2H), 1.11 (d, J = 7.0 Hz, 
3H), 0.12 (s, 9H); 13C NMR (75 MHz, CDCl3): δ 203.3, 138.0, 127.9 (2C), 127.0 (2C), 126.9, 
72.3, 70.1, 66.0, 51.3, 34.4, 9.8, −0.2 (3C); EI-MS m/z 237 (M−C3H5O)+ 187, 176, 159; HRMS 
calcd for C16H26O3Si: 294.1651, found 294.1641. 
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(3R,4S)-4-((2S,3S)-5-(Benzyloxy)-3-trimethylsilyloxypentan-2-yl)-
3-methyloxetan-2-one (86):  A flame-dried round bottom flask was 
charged with TMS-quinine (0.350 g, 0.883 mmol) and LiI (3.55 g, 
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26.5 mmol).  To the mixture of solids was sequentially added CH2Cl2 (26 mL), DMF (2.6 mL) 
and iPr2NEt (3.85 mL, 22.1 mmol).  The resulting mixture was stirred at ambient temperature for 
5 min then cooled to −40 °C.  To the reaction mixture was added aldehyde 93 (2.60 g, 8.83 
mmol) followed by dropwise addition of a solution of propionyl chloride (1.54 ml, 17.7 mmol) in 
CH2Cl2 (7.3 mL) over 6 h.  The heterogeneous reaction mixture was stirred vigorously overnight 
at −40 °C.  The reaction mixture was quenched with ether and the white precipitate filtered off 
over a plug of silica which was eluted with ether.  The filtrate was then concentrated in vacuo 
and the resulting residue purified via silica gel chromatography (9:1/hexanes:ethyl acetate) to 
yield 2.32 g (75%) of β-lactone 86:  Diastereomeric ratio determined by crude 1H NMR (300 
MHz, δ 4.34 ppm) determined the title compound was produced as a single diastereomer; [α]D = 
−23.3 (c 1.0, CHCl3); IR (thin film) 2956, 1826, 1454, 1251, 1153, 1099 cm-1; 1H NMR (300 
MHz, CDCl3): δ 7.33-7.24 (m, 5H), 4.47 (d, J = 4.2 Hz, 2H), 4.34 (dd, J = 11.2, 6.3 Hz, 1H), 
4.04 (dt, J = 7.4, 3.3 Hz, 1H), 3.74 (app p, J = 7.7 Hz, 1H), 3.57-3.46 (m, 2H), 2.02 (app pd, J = 
6.9, 3.1 Hz, 1H), 1.82-1.65 (m, 2H), 1.30 (d, J = 7.7 Hz, 3H), 0.86 (d, J = 6.8 Hz, 3H), 0.09 (s, 
9H); 13C NMR (75 MHz, CDCl3): δ 171.9, 138.2, 128.1 (2C), 127.4 (2C), 127.2, 75.8, 72.6, 
69.4, 67.1, 47.2, 38.5, 32.0, 10.0, 8.3, 0.1 (3C) ; EI-MS m/z 350 (M)+, 305, 277, 237, 179; 
HRMS calcd for C13H21O2Si (M−C6H9O2)+: 237.1311, found 237.1320. 
 
(3R,4S,5R,6S)-6-(2-(Benzyloxy)ethyl)-tetrahydro-4-hydroxy-3,5-
dimethylpyran-2-one (94): To a solution of β-lactone 86 (0.348 g, 
1.00 mmol) in THF (2 mL) at ambient temperature was added KOH 
(2.0 mL, 1.0 M in H2O).  The biphasic reaction mixture was stirred vigorously at ambient 
temperature for 8 hours.  Subsequently, the reaction mixture was cooled to 0 °C and acidified to 
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a pH = 2 by slow addition of conc. HCl.  The resulting reaction mixture was then warmed to 
ambient temperature and stirred vigorously for 1 hour.  The reaction mixture was diluted with 
EtOAc (5 mL) and the layers separated.  The organic layer was washed with sat. aq. NaHCO3 
(1x) followed by H2O (1x).  Subsequently, the combined aqueous layers were extracted with 
EtOAc (3x).  The combined organic extracts were then dried over Na2SO4, filtered and 
concentrated in vacuo.  The crude oil was purified by silica gel chromatography 
(2:1/hexanes:ethyl acetate) to provide 0.248 g (90%) of alcohol 94:  [α]D = −50.7 (c 1.1, CHCl3);  
IR (thin film) 3434 (br), 2972, 2936, 2881, 1727, 1455, 1236, 1096 cm-1; 1H NMR (300 MHz, 
CDCl3): δ 7.36-7.26 (m, 5H), 4.57-4.47 (m, 3H), 3.75-3.68 (m, 3H), 2.67 (qd, J = 7.4, 4.3 Hz, 
1H), 2.11-1.92 (m, 3H), 1.82 (ddt, J = 14.5, 10.2, 5.3 Hz, 1H), 1.31 (d, J = 7.3 Hz, 3H), 1.07 (d, J 
= 6.9 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 174.7, 137.9, 128.1 (2C), 127.4 (2C), 127.3, 77.7, 
72.9, 72.3, 65.8, 43.0, 34.8, 33.1, 15.4, 12.4; EI-MS m/z 278 (M)+ 173, 164, 146; HRMS calcd 
for C16H22O4: 278.1518, found 278.1510. 
 
(3R,4S,5R,6S)-6-(2-(Benzyloxy)ethyl)-tetrahydro-4-tert-butyldim-
ethylsilyloxy-3,5-dimethylpyran-2-one (95):  To a solution of 
alcohol 94 (1.20 g, 4.33 mmol) in CH2Cl2 (7.3 mL) at ambient 
temperature was added 2,6-lutidine (0.76 mL, 6.50 mmol).  The resulting reaction mixture was 
cooled to −78 °C and then TBSOTf (1.30 mL, 5.63 mmol) was added in a slow, dropwise 
fashion.  The reaction mixture was stirred at −78 °C for 2 hours.  Subsequently, the reaction 
mixture was quenched by addition of H2O (5 mL) and warmed to ambient temperature.  The 
layers were separated and the aqueous layer was extracted with ether (3x).  The combined 
organic extracts were then dried over Na2SO4, filtered and concentrated in vacuo.  The crude oil 
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was purified by silica gel chromatography (5:1/hexanes:ethyl acetate) to provide 1.38 g (55%) of 
silyl ether 95 and 0.248 g (22%) of enoate 96.  Characterization data for silyl ether 95: [α]D = 
−23.8 (c 1.3, CHCl3);  IR (thin film) 2955, 2930, 2883, 2857, 1735, 1462, 1253, 1095, 1067 cm-
1; 1H NMR (300 MHz, CDCl3): δ 7.34-7.28 (m, 5H), 4.55-4.48 (m, 3H), 3.73-3.65 (m, 3H), 2.64 
(qd, J = 7.6, 3.1 Hz, 1H), 2.10-1.75 (m, 3H), 1.25 (d, J = 7.6 Hz, 3H), 1.01 (d, J = 6.7 Hz, 3H), 
0.89 (s, 9H), 0.08 (s, 3H), 0.07 (s, 3H); 13C NMR (75 MHz, CDCl3): δ 173.3, 137.9, 127.8 (2C), 
127.0 (3C), 77.8, 73.8, 72.6, 65.6, 43.4, 33.4, 33.1, 25.3 (3C), 17.5, 15.7, 13.4, −5.03, −5.26; EI-
MS m/z 335 (M−tBu)+ 305, 279, 173; HRMS calcd for C22H36O4Si: 392.2383, found 392.2379.  
Characterization data for enoate 96: [α]D = −35.4 (c 1.0, CHCl3);  IR (thin film) 2926, 1717, 
1453, 1363, 1217, 1101 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.35-7.30 (m, 5H), 6.35 (dd, J = 
2.3, 1.4 Hz, 1H), 4.52 (d, J = 2.7 Hz, 2H), 4.22 (td, J = 9.6, 2.9 Hz, 1H), 3.76-3.65 (m, 2H), 2.50 
(qdd, J = 7.1, 4.7, 2.3 Hz, 1H), 2.12-2.00 (m, 2H), 1.98-1.85 (m, 3H), 1.11 (d, J = 7.2 Hz, 3H); 
13C NMR (75 MHz, CDCl3): δ 165.4, 145.6, 138.0, 128.1 (2C), 127.4 (3C), 126.7, 80.4, 72.8, 
65.5, 33.4, 32.8, 16.6, 16.3; EI-MS m/z 260 (M)+ 173, 154, 147, 125; HRMS calcd for C16H20O3: 
260.1412, found 260.1402. 
 
(2S,3S,4S,5R)-2-(2-(Benzyloxy)ethyl)-tetrahydro-3,5-di 
methyl-6-oxo-2H-pyran-4-yl 3,5-dinitrobenzoate (97):  To 
a solution of alcohol 94 (0.109 g, 0.390 mmol) in CH2Cl2 
(2.5 mL) at ambient temperature was added DMAP (3.0 mg) 
followed by 3,5-dinitrobenzoyl chloride (0.117 g, 0.510 
mmol).  The reaction mixture was then treated with triethylamine (82 μL, 0.590 mmol) and was 
subsequently stirred at ambient temperature overnight.  Quenched the reaction by addition of sat. 
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aq. NaHCO3, separated the layers and washed the organic layer with 1.0 M aqueous NaHSO4 
(1x).  The aqueous layer was extracted with CH2Cl2 (3x) and the combined organic extracts were 
dried over Na2SO4, filtered and concentrated in vacuo.  The crude residue was purified by silica 
gel chromatography (4:1/hexanes:ethyl acetate) to provide 0.150 g (81%) of δ-lactone 97:  [α]D = 
−26.1 (c 0.9, CHCl3);  IR (thin film) 3100, 2936, 1735, 1628, 1545, 1459, 1345, 1275 cm-1; 1H 
NMR (300 MHz, CDCl3): δ 9.28-9.27 (m, 1H), 9.12-9.11 (m, 2H), 7.37-7.20 (m, 5H), 5.29 (app 
t, J = 4.3 Hz, 1H), 4.65 (td, J = 9.3, 2.9 Hz, 1H), 4.60 (d, J = 11.9 Hz, 1H), 4.52 (d, J = 11.8 Hz, 
1H), 3.81-3.71 (m, 2H), 2.97 (qd, J = 7.2, 4.6 Hz, 1H), 2.37 (dqd, J =  10.4, 6.9, 4.5 Hz, 1H), 
2.21-2.10 (m, 1H), 1.92 (ddt, J = 13.9, 9.3, 4.9 Hz, 1H), 1.42 (d, J = 7.4 Hz, 3H), 1.10 (d, J = 6.9 
Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 171.7, 161.9, 148.6 (2C), 138.0, 132.9, 129.2 (2C), 
128.3 (2C), 127.5 (3C), 122.7, 77.9, 77.7, 73.2, 65.3, 39.9, 33.7, 33.4, 15.6, 12.6; EI-MS m/z 472 
(M)+ 455, 422, 293, 260, 212; HRMS calcd for C23H24N2O9: 472.1482, found 472.1469.  An x-
ray crystal structure of the title compound was obtained from crystals grown via slow vapor 
diffusion using hexanes and ethyl acetate as the recrystallization solvents. 
 
(3R,4S,5R,6S)-6-(2-(Hydroxy)ethyl)-tetrahydro-4-tert-butyldimet-
hylsilyloxy-3,5-dimethylpyran-2-one (98):  To a solution of benzyl 
ether 95 (1.35 g, 3.44 mmol) in ethyl acetate (7.4 mL) at ambient 
temperature was added Pd/C (10% activated, 0.370 g).  The atmosphere was evacuated and 
refilled with H2(g) (3x) and then vigorously stirred at ambient temperature overnight.  The 
heterogeneous reaction mixture was filtered over a plug of celite and the filtrate concentrated in 
vacuo.  The crude residue was purified by silica gel chromatography (2:1/hexanes:ethyl acetate) 
to provide 0.936 g (90%) of alcohol 98:  [α]D = −18.6 (c 1.0, CHCl3);  IR (thin film) 3442 (br), 
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2955, 2884, 2857, 1731, 1462, 1252, 1098, 1055 cm-1; 1H NMR (300 MHz, CDCl3): δ 4.52 (td, J 
= 9.8, 2.6 Hz, 1H), 3.90-3.87 (m, 2H), 3.68 (app t, J = 2.6 Hz, 1H), 2.67 (qd, J = 7.6, 3.0 Hz, 
1H), 2.06-1.92 (m, 3H), 1.86-1.73 (m, 1H), 1.28 (d, J = 7.6 Hz, 3H), 1.01 (d, J = 6.8 Hz, 3H), 
0.90 (s, 9H), 0.09 (s, 3H), 0.08 (s, 3H); 13C NMR (75 MHz, CDCl3): δ 174.0, 79.0, 74.1, 58.7, 
43.7, 35.9, 34.0, 25.6 (3C), 17.8, 16.1, 13.8, −4.7, −4.9; EI-MS m/z 303 (M)+ 287, 257, 245, 215, 
189; HRMS calcd for C11H21O4Si (M−tBu)+: 245.1209, found 245.1202.    
 
(2R,3S,4S,5S)-7-(Benzyloxy)-3,5-bis-(tert-butyldimethylsil-
yloxy)-N-methoxy-N,2,4-trimethylheptanamide (101):  To a 
0 °C mixture of N,O-dimethylhydroxylamine hydrochloride 
(0.254 g, 2.60 mmol) in CH2Cl2 (3.3 mL) was added dimethylaluminum chloride (2.60 mL, 2.60 
mmol, 1.0 M in hexanes) in a slow, dropwise fashion.  The resulting solution was allowed to 
warm to ambient temperature and was stirred for 2 h.  Subsequently, the homogenous solution 
was cooled to 0 °C and diluted with CH2Cl2 (1.0 ml).  To the resulting solution was added a 
solution of β-lactone 86 (0.304 g, 0.870 mmol) in CH2Cl2 (2.3 mL) via syringe.  The reaction 
mixture was then warmed to ambient temperature and allowed to stir for 2 h.  Cooled the 
reaction mixture once again to 0 °C and quenched slowly with aqueous phosphate buffer (pH = 
7).  The resulting biphasic mixture was warmed to ambient temperature and stirred vigorously 
for 1 h.  The layers of the mixture were then separated and the aqueous extracted with EtOAc 
(3x).  The combined organic extracts were washed with brine (1x), dried over Na2SO4, filtered 
and concentrated in vacuo. 
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To a solution of the crude residue in CH2Cl2 (2.0 mL) at ambient temperature was added 
2,6-lutidine (0.30 mL, 2.60 mmol).  Subsequently, the reaction mixture was cooled to −78 °C 
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and TBSOTf (0.50 mL, 2.17 mmol) was added in a dropwise fashion.  The resulting solution was 
warmed to 0 °C and stirred for 2 h.  The reaction mixture was quenched by addition of saturated 
aqueous NaHCO3, the layers separated and the organic layer washed with 1.0 M aqueous 
NaHSO4 (1x).  The combined aqueous layers were then extracted with EtOAc (3x) and the 
combined organic extracts dried over Na2SO4, filtered and concentrated in vacuo.  The crude oil 
was purified by silica gel chromatography (6:1/hexanes:ethyl acetate) to provide 0.431 g (88% 
over 2 steps) of silyl ether 101: [α]D = −22.8 (c 1.0, CHCl3); IR (thin film) 2955, 2929, 2885, 
2856, 1667, 1471, 1254, 1092 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.34-7.28 (m, 5H), 4.48 (s, 2 
H), 4.03 (ddd, J = 10.0, 4.0, 2.4 Hz, 1H), 3.98 (dd, J = 6.9, 4.5 Hz, 1H), 3.59 (s, 3H), 3.61-3.49 
(m, 2H), 3.15 (s, 3H), 2.98-2.91 (m, 1H), 1.92-1.80 (m, 2H), 1.74-1.62 (m, 1H), 1.11 (d, J = 6.9 
Hz, 3H), 0.93-0.89 (m, 12H), 0.87 (s, 9H), 0.04 (s, 3H), 0.03 (s, 3H), 0.01 (s, 6H); 13C NMR (75 
MHz, CDCl3): δ 175.8, 138.4, 128.1 (2C), 127.6 (2C), 127.3, 74.3, 72.9, 68.7, 67.8, 60.5, 43.4, 
39.2, 32.0, 31.6, 26.1 (3C), 25.8 (3C), 18.2, 17.9, 11.6, 10.4, −3.6, −4.1, −4.5, −5.0; ESI-MS 
HRMS calcd for C30H57NNaO5Si2 (M+Na)+: 590.3673, found 590.3616. 
 
(2R,3S,4S,5S)-6-Formyl-3,5-bis-(tert-butyldimethylsilyloxy)-
N-methoxy-N,2,4-trimethylhexanamide (99):  To a solution of 
benzyl ether 101 (0.353 g, 0.620 mmol) in ethyl acetate (2.2 mL) at ambient temperature was 
added Pd/C (10 % activated, 0.084 g).  The atmosphere was evacuated and refilled with H2(g) 
(3x) and then vigorously stirred at ambient temperature for 2h.  The heterogeneous reaction 
mixture was filtered over a plug of celite and the filtrate concentrated in vacuo.   
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To a solution of the crude residue in CH2Cl2 (6.2 mL) was added NaHCO3 (0.157 g, 1.87 
mmol).  Subsequently, cooled the reaction mixture to 0 °C and added DMP (0.304 g, 0.716 
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mmol).  The resulting mixture was warmed to ambient temperature and stirred for 2h.  The 
reaction was quenched by addition of hexanes (6 mL) and filtered over a plug of florisil which 
was washed with a solution of 4:1/hexanes:EtOAc.  Concentrated the filtrate in vacuo and 
purified the crude residue by silica gel chromatography (4:1/hexanes:ethyl acetate) to provide 
0.260 g (88% over 2 steps) of aldehyde 99:  [α]D = −22.3 (c 1.1, CHCl3); IR (thin film) 2955, 
2930, 2886, 2857, 1728, 1667, 1471, 1463, 1254, 1087, 1055, 1022, 1004 cm-1; 1H NMR (300 
MHz, CDCl3): δ 9.80 (app t, J = 2.3 Hz, 1H), 4.54 (dt, J = 8.1, 3.8 Hz, 1 H), 3.93 (app t, J = 5.8 
Hz, 1H), 3.72 (s, 3H), 3.18 (s, 3H), 3.00 (app p, J = 6.7 Hz, 1H), 2.61-2.46 (m, 2H), 1.95 (dp, J = 
11.4, 6.9 Hz, 1H), 1.14 (d, J = 7.0 Hz, 3H), 0.94-0.92 (m, 12H), 0.85 (s, 9H), 0.06 (s, 6H), 0.04 
(s, 3H), 0.03 (s, 3H); 13C NMR (75 MHz, CDCl3): δ 202.4, 175.6, 74.8, 67.3, 60.8, 46.5, 43.2, 
39.3, 31.9, 26.1 (3C), 25.5 (3C), 18.2, 17.7, 12.9, 10.6, −3.4, −4.1, −4.5, −5.1; EI-MS m/z 460 
(M−Me)+, 418, 300, 286, 260, 197; HRMS calcd for C23H49NO5Si2 (M−Me)+: 460.2915, found 
460.2906. 
 
(3R,4S)-4-((S)-1-(tert-Butyldimethylsilyloxy)propan-2-yl)-3-methyloxet-
an-2-one (89):  A flame-dried round bottom flask was charged with TMS-
quinine (63 mg, 0.160 mmol) and LiI (0.428 g, 3.20 mmol).  To the mixture 
of solids was sequentially added CH2Cl2 (4.0 mL), Et2O (0.4 mL) and iPr2NEt (0.70 mL, 4.00 
mmol).  The resulting mixture was stirred at ambient temperature for 5 min then cooled to −78 
°C.  To the reaction mixture was added aldehyde 102 (0.323 g, 1.60 mmol) followed by 
dropwise addition of a solution of propionyl chloride (0.28 mL, 3.20 mmol) in CH2Cl2 (0.8 mL) 
over 1.5 h.  The heterogeneous reaction mixture was stirred vigorously overnight at −78 °C.  The 
reaction mixture was quenched with ether and the white precipitate was filtered off over a plug 
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of silica which was eluted with ether.  The filtrate was then concentrated in vacuo and the 
resulting residue purified via silica gel chromatography (19:1/hexanes:ethyl acetate) to yield 
0.318 g (77%) of β-lactone 89:  Diastereomeric ratio determined by crude 1H NMR (300 MHz, δ 
4.42 ppm) determined the title compound was produced as a single diastereomer; [α]D = −25.1 (c 
1.0, CHCl3); IR (thin film) 2955, 2930, 2889, 2857, 1828, 1471, 1255, 1117 cm-1; 1H NMR (300 
MHz, CDCl3): δ 4.42 (dd, J = 11.0, 6.3 Hz, 1H), 3.77 (qd, J = 7.7, 6.6 Hz, 1H), 3.73-3.65 (m, 
2H), 1.97 (qdd, J = 6.7, 4.4, 3.4 Hz, 1H), 1.35 (d, J = 7.7 Hz, 3H), 0.97 (d, J = 6.7 Hz, 3H), 0.90 
(s, 9H), 0.06 (s, 6H); 13C NMR (75 MHz, CDCl3): δ 172.4, 75.8, 63.5, 46.6, 35.7, 25.7(3C), 18.1, 
12.2, 8.4, −5.6, −5.7; EI-MS e/v 243 (M−Me)+, 201, 187, 171, 157, 145; HRMS calcd for 
C12H23O3Si (M−Me)+: 243.1416, found 243.1433. 
 
(2R,3S,4S)-5-(tert-Butyldimethylsilyloxy)-3-hydroxy-N-methoxy-
N,2,4-trimethylpentanamide (103):  To a 0 °C mixture of N,O-
dimethylhydroxylamine hydrochloride (2.76 g, 28.3 mmol) in CH2Cl2 (50 mL) was added 
dimethylaluminum chloride (28.2 mL, 28.2 mmol, 1.0 M in hexanes) in a slow, dropwise 
fashion.  The resulting solution was allowed to warm to ambient temperature and stirred for 2 h.  
Subsequently, the homogenous solution was cooled to −30 °C and diluted with CH2Cl2 (30 ml).  
To the resulting solution was added a solution of β-lactone 89 (3.65 g, 14.1 mmol) in CH2Cl2 (20 
mL) via syringe.  The reaction mixture was then allowed to stir at −30 °C until complete 
consumption of the starting material (monitored by TLC).  Cooled the reaction mixture once 
again to 0 °C and quenched slowly with aqueous phosphate buffer (pH = 7).  The resulting 
biphasic mixture was warmed to ambient temperature and stirred vigorously for 1 h.  The layers 
of the mixture were then separated and the aqueous extracted with EtOAc (3x).  The combined 
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organic extracts were washed with brine (1x), dried over Na2SO4, filtered and concentrated in 
vacuo.  The crude oil was purified by silica gel chromatography (3:1/hexanes:ethyl acetate) to 
provide 4.09 g (91%) of amide 103:  [α]D = −8.1 (c 1.1, CHCl3); IR (thin film) 3468, 2957, 2857, 
1639, 1462, 1254, 1089 cm-1; 1H NMR (300 MHz, CDCl3): δ 4.00 (d, J = 3.1 Hz, 1H), 3.80-3.67 
(m, 3H), 3.72 (s, 3H), 3.20 (s, 3H), 3.08-3.04 (m, 1H), 1.78-1.67 (m, 1H), 1.20 (d, J = 7.0 Hz, 
3H), 0.96 (d, J = 6.9 Hz, 3H), 0.90 (s, 9H), 0.07 (s, 6H); 13C NMR (75 MHz, CDCl3): δ 177.3, 
73.2, 64.9, 60.8, 37.0, 36.2, 31.4, 25.4 (3C), 17.6, 13.3, 10.2, −6.0 (2C); EI-MS m/z 304 
(M−Me)+, 285, 262, 232, 201, 145; HRMS calcd for C14H30NO4Si (M−Me)+: 304.1944, found 
304.1946. 
 
(2R,3S,4S)-3,5-Bis(tert-butyldimethylsilyloxy)-N-methoxy-N,2, 
4-trimethylpentanamide (88):  To a solution of alcohol 103 (1.60 
g, 5.01 mmol) in CH2Cl2 (11.6 mL) at ambient temperature was added 2,6-lutidine (0.94 mL, 
8.01 mmol).  Subsequently, the reaction mixture was cooled to −78 °C and TBSOTf (1.50 mL, 
6.51 mmol) was added in a dropwise fashion.  The resulting solution was warmed to 0 °C and 
stirred for 2 h.  The reaction mixture was then quenched by addition of saturated aqueous 
NaHCO3.  The layers were separated and the organic layer washed with 1.0 M aqueous NaHSO4 
(1x).  The combined aqueous layers were then extracted with CH2Cl2 (3x) and the combined 
organic extracts dried over Na2SO4, filtered and concentrated in vacuo.  The crude oil was 
purified by silica gel chromatography (7:1/hexanes:ethyl acetate) to provide 2.12 g (98%) of silyl 
ether 88: [α]D = −11.0 (c 1.5, CHCl3); IR (thin film) 2956, 2929, 2885, 2857, 1668, 1471, 1255, 
1086 cm-1; 1H NMR (300 MHz, CDCl3): δ 3.95 (dd, J = 7.0, 4.0 Hz, 1H), 3.72 (dd, J = 9.9, 4.5 
Hz, 1H), 3.70 (s, 3H), 3.32 (dd, J = 9.8, 8.5 Hz, 1H), 3.17 (s, 3H), 3.17-3.07 (m, 1H), 1.76 (tqd, J 
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= 8.3, 6.9, 4.3 Hz, 1H), 1.12 (d, J = 6.9 Hz, 3H), 0.98 (d, J = 6.9 Hz, 3H), 0.91 (s, 9H), 0.89 (s, 
9H), 0.08 (s, 3H), 0.05 (s, 3H), 0.03 (s, 6H); 13C NMR (75 MHz, CDCl3): δ 176.0, 74.3, 64.4, 
60.5, 41.3, 38.3, 31.7, 25.7 (3C), 25.5 (3C), 17.8, 17.7, 13.8, 13.2, −4.4, −4.6, −5.8 (2C); EI-MS 
m/z 418 (M−Me)+, 376, 260, 204, 185; HRMS calcd for C20H44NO4Si2 (M−Me)+: 418.2809, 
found 418.2801. 
 
(2R,3S,4S)-3,5-Bis(tert-butyldimethylsilyloxy)-2,4-dimethylpentanal 
(104):  To a −78 °C solution of amide 88 (2.12 g, 4.89 mmol) in THF 
(47 mL) was added iBu2AlH (9.80 mL, 9.78 mmol, 1.0 M in hexanes) in a slow, dropwise 
fashion.  The resulting solution was maintained at −78 °C for 2 h after which saturated aqueous 
Rochelle’s salts (30 mL) was added.  The biphasic mixture was allowed to warm to ambient 
temperature and stirred vigorously for 1 h.  The layers were separated and the aqueous layer 
extracted with ether (3x).  The combined organic extracts were washed with brine (1x), dried 
over Na2SO4, filtered and concentrated in vacuo.  The crude oil was purified by silica gel 
chromatography (24:1/hexanes:ethyl acetate) to provide 1.83 g (quantitative) of aldehyde 104: 
[α]D = −36.5 (c 1.26, CHCl3); IR (thin film) 2956, 2929, 2884, 2857, 1729, 1472, 1254, 1091 
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cm-1; 1H NMR (300 MHz, CDCl3): δ 9.72 (s, 1H), 4.24 (dd, J = 6.6, 3.1 Hz, 1H), 3.61 (dd, J = 
10.0, 5.6 Hz, 1H), 3.52 (dd, J = 10.0, 5.9 Hz, 1H), 2.50 (qd, J = 6.9, 3.1 Hz, 1H), 1.87 (app. sept., 
J = 6.7 Hz, 1H), 1.11 (d, J = 6.9 Hz, 3H), 0.93-0.91 (m, 12H), 0.87 (s, 9H), 0.08 (s, 3H), 0.05 (s, 
6H), 0.00 (s, 3H); 13C NMR (75 MHz, CDCl3): δ 203.9, 71.4, 64.4, 49.5, 40.3, 25.7 (3C), 25.6 
(3C), 18.0 (2C), 13.4, 7.6, −4.4, −4.5, −5.5, −5.7; EI-MS m/z 317 (M−tBu)+, 259, 201, 185; 
HRMS calcd for C15H33O3Si2 (M−tBu)+:317.1968, found 317.1981. 
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1-((R)-4-Benzyl-2-thioxooxazolidin-3-yl)propan-1-one:  1H NMR (300 MHz, 
CDCl3): δ 7.37-7.20 (m, 5H), 4.95 (ddt, J = 10.2, 6.7, 3.2 Hz, 1H), 4.40-4.26 (m, 
2H), 3.43 (dq, J = 18.0, 7.3 Hz, 1H), 3.35-3.20 (m, 2H), 2.78 (dd, J = 13.2, 10.1 
Hz, 1H), 1.24 (app t, J = 7.2 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 184.9, 174.2, 134.9, 129.0 
(2C), 128.5 (2C), 126.9, 70.0, 59.4, 37.1, 31.0, 8.1. 
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(2R,3S,4S,5S,6S)-1-((R)-4-Benzyl-2-thioxooxazolidin-3-yl)-
5,7-bis(tert-butyldimethylsilyloxy)-3-hydroxy-2,4,6-trimet-
hylheptan-1-one (105): To a solution of oxazolidinethione 
(0.082 g, 0.330 mmol) in CH2Cl2 (1.5 mL) at 0 °C was added TiCl4 (0.330 mL, 0.330 mmol, 1.0 
M in CH2Cl2) and the resulting yellow, homogenous solution was allowed to stir at 0 °C for 5 
minutes.  Subsequently, to the reaction mixture was added (−)-sparteine (0.190 mL, 0.825 mmol) 
in a dropwise fashion and the resulting mixture was stirred at 0 °C for an additional 20 minutes.  
To the deep-red reaction mixture was added a solution of aldehyde 104 (0.110 g, 0.300 mmol) in 
CH2Cl2 (1.0 mL) and the resulting reaction mixture allowed to stir at 0 °C for 1h.  The reaction 
was quenched by addition of half-saturated aqueous NH4Cl, the layers separated and the aqueous 
layer extracted with CH2Cl2 (3x).  The combined organic extracts were dried over Na2SO4, 
filtered and concentrated in vacuo.  The crude oil was purified by silica gel chromatography 
(10:1/hexanes:ethyl acetate) to provide 0.171 g (91%) of alcohol 105: Diastereomeric ratio 
determined by crude 1H NMR (300 MHz) determined the title compound was produced as a 
single diastereomer; [α]D = −39.2 (c 1.1, CHCl3); IR (thin film) 3534, 2955, 2929, 2884, 2856, 
1678, 1497, 1368, 1318, 1087 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.38-7.21 (m, 5H), 4.96 (ddt, 
J = 10.2, 6.0, 3.2 Hz, 1H), 4.79 (qd, J = 6.9, 4.9 Hz, 1H), 4.36-4.23 (m, 2H), 3.98 (ddd, J = 6.2, 
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4.8, 2.7 Hz, 1H), 3.76 (dd, J = 6.2, 2.8 Hz, 1H), 3.66 (dd, J = 9.9, 5.8 Hz, 1H), 3.49 (dd, J = 10.0, 
6.3 Hz, 1H), 3.24 (dd, J = 13.2, 3.5 Hz, 1H), 3.24 (d, J = 2.7 Hz, 1H), 2.76 (dd, J = 13.3, 10.1 
Hz, 1H), 1.91 (app sept., J = 6.5 Hz, 1H), 1.77 (pd, J = 6.7, 3.0 Hz, 1H), 1.35 (d, J = 6.9 Hz, 3H), 
0.99 (d, J = 6.8 Hz, 3H), 0.93-0.90 (m, 21H), 0.08 (s, 3H), 0.07 (s, 6H), 0.01 (s, 3H); 13C NMR 
(75 MHz, CDCl3): δ 184.1, 178.0, 135.0, 129.0 (2C), 128.6 (2C), 127.0, 73.9, 73.0, 69.8, 64.8, 
59.4, 40.1, 39.8, 37.7, 37.1, 25.7 (3C), 25.6 (3C), 18.0, 17.9, 13.7, 11.9, 9.1, −4.2, −4.3, −5.6, 
−5.7; ESI-MS HRMS calcd for C32H57NNaO5SSi2 (M+Na)+: 646.3394, found 646.3387. 
 
(2R,3S,4R,5S,6S)-1-((R)-4-Benzyl-2-thioxooxazolidin-3-yl)-
3,5,7-tris(tert-butyldimethylsilyloxy)-2,4,6-trimethylheptan 
-1-one (106):  To a solution of alcohol 105 (2.05 g, 3.29 mmol) 
in CH2Cl2 (12.2 mL) at ambient temperature was added 2,6-lutidine (0.61 mL, 5.26 mmol).  
Subsequently, the reaction mixture was cooled to −78 °C and TBSOTf (1.00 mL, 4.28 mmol) 
was added in a dropwise fashion.  The resulting solution was warmed to 0 °C and stirred for 2 h.  
The reaction mixture was quenched by addition of saturated aqueous NaHCO3, the layers 
separated and the organic layer washed with 1.0 M aqueous NaHSO4 (1x).  The combined 
aqueous layers were then extracted with CH2Cl2 (3x) and the combined organic extracts dried 
over Na2SO4, filtered and concentrated in vacuo.  The crude oil was purified by silica gel 
chromatography (15:1/hexanes:ethyl acetate) to provide 2.30 g (95%) of silyl ether 106: [α]D = 
−58.3 (c 0.5, CHCl3); IR (thin film) 2927, 2856, 1693, 1471, 1361, 1252, 1186, 1027 cm-1; 1H 
NMR (300 MHz, CDCl3): δ 7.34-7.23 (m, 5H), 4.95-4.85 (m, 2H), 4.34-4.24 (m, 2H), 4.14 (dd, J 
= 6.9, 3.0 Hz, 1H), 3.74 (dd, J = 9.7, 4.0 Hz, 1H), 3.57 (dd, J = 7.9, 2.4 Hz, 1H), 3.40 (app t, J = 
9.5 Hz, 1H), 3.23 (dd, J = 13.2, 3.2 Hz, 1H), 2.73 (dd, J = 13.1, 10.3 Hz, 1H), 2.06-1.93 (m, 1H), 
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1.70-1.60 (m, 1H), 1.30 (d, J = 6.9 Hz, 3H), 1.03 (d, J = 6.9 Hz, 3H), 0.95 (s, 9H), 0.92-0.90 (m, 
21H), 0.13 (s, 6H), 0.07 (s, 9H), 0.02 (s, 3H); 13C NMR (75 MHz, CDCl3): δ 184.4, 176.6, 135.0, 
129.2 (2C), 128.8 (2C), 127.2, 75.9, 73.6, 69.7, 63.8, 59.9, 42.3, 41.6, 38.8, 37.4, 26.2 (6C), 25.9 
(3C), 18.5, 18.4, 18.2, 15.9, 14.7, 11.5, −3.2, −3.3, −3.5, −3.6, −5.3 (2C); ESI-MS HRMS calcd 
for C38H71NNaO5SSi3 (M+Na)+: 760.4258, found 760.4280. 
 
(2S,3R,4S,5S,6S)-3,5,7-Tris(tert-butyldimethylsilyloxy)-2,4,6-trim-
ethylheptan-1-ol (107):  To a solution of oxazolidinethione 106 
(0.190 g, 0.260 mmol) in THF (1.4 mL) at 0 °C was added MeOH (21 μL, 0.52 mmol).  
Subsequently, LiBH4 (0.26 mL, 0.52 mmol, 2.0 M in THF) was added to the reaction mixture in 
a dropwise fashion.  The resulting solution was stirred at 0 °C for 0.5 h, after which it was 
warmed to ambient temperature and stirred an additional 2h.  The reaction was quenched by the 
addition of saturated aqueous Rochelle’s salts and stirred vigorously at ambient temperature for 
1h.  The layers were then separated and the aqueous layer extracted with ether (3x).  The 
combined organic extracts were dried over Na2SO4, filtered and concentrated in vacuo.  The 
crude oil was purified by silica gel chromatography (20:1/hexanes:ethyl acetate) to provide 0.119 
g (83%) of alcohol 107: [α]D = −2.0 (c 0.5, CHCl3); IR (thin film) 3456 (br s), 2956, 2885, 2857, 
1472, 1463, 1255, 1092, 1028 cm-1; 1H NMR (300 MHz, CDCl3): δ 3.73-3.57 (m, 4H), 3.49 (dt, 
J = 10.8, 5.4 Hz, 1H), 3.40 (dd, J = 9.7, 6.8 Hz, 1H), 2.00-1.78 (m, 3H), 1.65 (app t, J = 4.2 Hz, 
1H), 0.97 (d, J = 5.9 Hz, 3H), 0.92 (s, 18H), 0.90 (s, 9H), 0.08-0.04 (m, 18H); 13C NMR (75 
MHz, CDCl3): δ 74.1, 73.7, 66.0, 65.1, 41.0, 39.5, 38.3, 26.2 (3C), 26.1 (3C), 25.9 (3C), 18.4 
(2C), 18.2, 14.7, 12.1, 10.7, −3.3, −3.5, −3.8, −3.9, −5.3, −5.4; EI-MS m/z 491 (M−tBu)+, 401, 
359, 317, 243; HRMS calcd for C24H55O4Si3 (M−tBu)+: 491.3408, found 491.3416. 
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 1-(((2S,3S,4R,5S,6R)-3,5-Bis(tert-butyldimethylsilyloxy)-7-iodo-2, 
4,6-trimethylheptyloxy)methyl)benzene (85):  To a solution of PPh3 
(0.054g, 0.206 mmol) in CH2Cl2 (0.7 mL) at 0 °C was added I2 (0.052 g, 0.206 mmol).  The 
heterogeneous solution was allowed to stir at 0 °C for 10 minutes.  Subsequently, a solution of 
alcohol 107 (0.075g, 0.137 mmol) and imidazole (0.027 g, 0.400 mmol) in CH2Cl2 (1.0 mL) was 
cannulated into the reaction mixture and the resulting mixture was warmed to ambient 
temperature and stirred for 6 hours.  The reaction was quenched by the addition of saturated 
aqueous NaHCO3, the layers separated and the aqueous extracted with CH2Cl2 (3x).  The 
combined organic extracts were dried over Na2SO4, filtered and concentrated in vacuo.  The 
crude oil was purified by silica gel chromatography (50:1/hexanes:ethyl acetate) to provide 0.064 
g (71%) of iodide 85: [α]D = +4.3 (c 1.6, CHCl3); IR (thin film) 2956, 2929, 2885, 2857, 1471, 
1256, 1089, 1028 cm-1; 1H NMR (300 MHz, CDCl3): δ 3.65-3.62 (m, 2H), 3.59 (dd, J = 10.0, 
6.3, Hz 1H), 3.41 (dd, J = 10.0, 6.5 Hz, 1H), 3.23 (dd, J = 9.5, 6.3 Hz, 1H), 3.10 (dd, J = 9.4, 7.8 
Hz, 1H), 2.15-2.00 (m, 1H), 1.87-1.76 (m, 2H), 0.98 (d, J = 6.7 Hz, 3H), 0.95-0.88 (m, 33H), 
0.11 (s, 3H), 0.09 (s, 9H), 0.05 (s, 3H), 0.04 (s, 3H); 13C NMR (75 MHz, CDCl3): δ 76.0, 73.6, 
65.1, 41.6, 40.8, 39.0, 26.3 (3C), 26.2 (3C), 26.0 (3C), 18.6, 18.5, 18.3, 14.2, 14.1, 14.0, 12.4,  
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−3.2, −3.3, −3.4, −3.8, −5.2, −5.3; EI-MS m/z 643 (M−Me)+, 601, 511, 469, 429, 395, 358, 341; 
HRMS calcd for C24H54IO3Si3 (M−tBu)+: 601.2425, found 601.2443. 
 
(2R,3S,4S)-5-(tert-Butyldiphenylsilyloxy)-3-hydroxy-N-methoxy-
N,2,4-trimethylpentanamide (110):  To a 0 °C mixture of N,O-
dimethylhydroxylamine hydrochloride (3.74 g, 38.4 mmol) in CH2Cl2 (68 mL) was added 
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dimethylaluminum chloride (38.4 mL, 38.4 mmol, 1.0 M in hexanes) in a slow, dropwise 
fashion.  The resulting solution was allowed to warm to ambient temperature and stirred for 1.5 
h.  Subsequently, the homogenous solution was cooled to 0 °C and diluted with CH2Cl2 (38 ml).  
To the resulting solution was added a solution of β-lactone 109 (7.34 g, 19.2 mmol) in CH2Cl2 
(30 mL) via syringe.  The reaction mixture was then allowed to warm to ambient temperature 
and was stirred for 2 hours.  Cooled the reaction mixture once again to 0 °C and quenched slowly 
with aqueous phosphate buffer (pH = 7).  The resulting biphasic mixture was warmed to ambient 
temperature, the layers separated and the aqueous extracted with CH2Cl2 (3x).  The combined 
organic extracts were washed with brine (1x), dried over Na2SO4, filtered and concentrated in 
vacuo.  The crude oil was purified by silica gel chromatography (3:1/hexanes:ethyl acetate) to 
provide 7.16 g (84%) of amide 110:  [α]D = +2.3 (c 0.6, CHCl3); IR (thin film) 3462, 2961, 2932, 
1637, 1472, 1112, 1068 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.71-7.67 (m, 4H), 7.46-7.35 (m, 
6H), 4.01 (d, J = 2.8 Hz, 1H), 3.89 (dd, J = 9.8, 4.8 Hz, 1H), 3.83-3.80 (m, 1H), 3.77 (dd, J = 
9.8, 3.7 Hz, 1H), 3.67 (s, 3H), 3.19 (s, 3H), 3.12- 3.01 (m, 1H), 1.84-1.72 (m, 1H), 1.19 (d, J = 
7.0 Hz, 3H), 1.07 (s, 9H), 1.02 (d, J = 6.9 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 177.8, 135.4 
(4C), 133.3 (2C), 129.4 (2C), 127.4 (4C), 73.3, 65.9, 61.1, 37.4, 36.3, 31.8, 26.7 (3C), 19.1, 13.8, 
10.2; EI-MS m/z 444 (M)+, 386, 356, 308, 269, 239. 
 
(2S,3R,4S)-5-(tert-Butyldiphenylsilyloxy)-3-(methoxymethoxy)-2,4-
dimethylpentan-1-ol (111):  To a solution alcohol 110 (2.43 g, 5.49 
mmol) in iPr2NEt (22 mL) at ambient temperature was added TBAI (0.202 g, 0.549 mmol).  
Subsequently, added freshly distilled MOMCl (2.00 mL, 27.5 mmol) and allowed the reaction 
mixture to stir at ambient temperature for 3 hours.  After this time, another portion of MOMCl 
OTBDPS
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(2.00 mL, 27.5 mmol) was added and the resulting reaction mixture allowed to stir for an 
additional 4 hours.  Cooled the reaction mixture to 0 °C and quenched by slow addition of 1.0 M 
aqueous HCl.  Separated the layers and extracted the aqueous with CH2Cl2 (3x).  Washed the 
combined organic extracts with brine (1x), dried over Na2SO4, filtered and concentrated in 
vacuo.   
To a −78 °C solution of the crude oil in THF (72 mL) was added iBu2AlH (7.70 mL, 7.66 
mmol, 1.0 M in hexanes) in a slow, dropwise fashion.  The resulting solution was maintained at 
−78 °C for 2 h after which saturated aqueous Rochelle’s salts (30 mL) was added.  The biphasic 
mixture was allowed to warm to ambient temperature and was stirred vigorously for 1 h.  The 
layers were separated and the aqueous layer extracted with ether (3x).  The combined organic 
extracts were washed with brine (1x), dried over Na2SO4, filtered and concentrated in vacuo. 
To a −78 °C solution of the crude oil in THF (72 mL) was added iBu2AlH (7.70 mL, 7.66 
mmol, 1.0 M in hexanes) in a slow, dropwise fashion.  The resulting solution was maintained at 
−78 °C for 2 h after which saturated aqueous Rochelle’s salts (30 mL) was added.  The biphasic 
mixture was allowed to warm to ambient temperature and was stirred vigorously for 1 h.  The 
layers were separated and the aqueous layer extracted with EtOAc (3x).  The combined organic 
extracts were washed with brine (1x), dried over Na2SO4, filtered and concentrated in vacuo.  
The crude oil was purified by silica gel chromatography (5:1/hexanes:ethyl acetate) to provide 
1.55 g (66% over 3 steps) of alcohol 111:  [α]D = +53.4 (c 1.1, CHCl3); IR (thin film) 3440, 
3070, 2961, 2931, 2882, 2857, 1471, 1144, 1112, 1032 cm-1; 1H NMR (300 MHz, CDCl3): δ 
7.69-7.62 (m, 4H), 7.47- 7.35 (m, 6H), 4.69 (d, J = 6.5 Hz, 1 H), 4.44 (d, J = 6.5 Hz, 1H), 3.77-
3.63 (m, 3H), 3.50 (dd, J = 8.7, 6.9 Hz, 2H), 3.35 (s, 3H), 3.19 (dd, J = 7.6, 6.5 Hz, 1H), 1.99-
1.86 (m, 1H), 1.86-1.75 (m, 1H), 1.10 (s, 9H), 0.95 (d, J = 6.9 Hz, 3H), 0.75 (d, J = 6.9Hz, 3H); 
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13C NMR (75 MHz, CDCl3): δ 135.4 (2C), 135.3 (2C), 133.3, 133.2, 129.3 (2C), 127.3 (2C), 
127.2 (2C), 98.2, 79.7, 65.3, 64.4, 55.4, 38.1, 36.4, 26.7 (3C), 18.9, 14.0, 9.3; ESI-MS HRMS 
calcd for C25H38NaO4Si (M+Na)+: 453.2437, found 453.2395. 
 
(2S,3S,4S)-5-(Benzyloxy)-3-(methoxymethoxy)-2,4-dimethylpentan-1-ol  
(112):  To a suspension of NaH (0.170 g, 7.10 mmol, 60% dispersion) in THF 
(12 mL) was added TBAI (0.175 g, 0.473 mmol) followed by a solution of alcohol 111 (2.04 g, 
4.73 mmol) in THF (12 mL).  After stirring at ambient temperature for 0.5 h, BnBr (0.730 mL, 
6.15 mmol) was then added and the reaction mixture was allowed to stir at ambient temperature 
overnight.  The reaction was quenched by the addition of water, the layers were separated and 
the aqueous layer extracted with EtOAc (3x).  The combined organic extracts were washed with 
brine (1x), dried over Na2SO4, filtered and concentrated in vacuo.   
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To a solution of the crude residue in THF (25 mL) at 0 °C was added TBAF (14 mL, 14.2 
mmol, 1.0 M in THF).  The reaction mixture was warmed to ambient temperature and stirred for 
3 hours.  Subsequently, the reaction was quenched with saturated aqueous NaHCO3, the layers 
separated and the aqueous extracted with EtOAc (3x).  The combined organic extracts were 
washed with brine (1x), dried over Na2SO4, filtered and concentrated in vacuo.  The crude oil 
was purified by silica gel chromatography (3:1/hexanes:ethyl acetate?1:1/hexanes:ethyl acetate) 
to provide 1.01 g (82% over two steps) of alcohol 112:  [α]D = −33.5 (c 1.06, CHCl3); IR (thin 
film) 3456, 2965, 2933, 1454, 1209, 1140, 1093 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.62-7.28 
(m, 5H), 4.68 (d, J = 6.3 Hz, 1 H), 4.60 (d, J = 6.3 Hz, 1H), 4.50 (s, 2H), 3.84 (ddd, J = 11.4, 6.5, 
3.5 Hz, 1H), 3.69 (dd, J = 9.3, 2.3 Hz, 1H), 3.52 (ddd, J = 11.3, 7.2, 4.1 Hz, 1H), 3.41 (s, 3H), 
3.41-3.34 (m, 2H), 2.97 (app t, J = 6.6, 6.6 Hz, 1H), 2.06 (m, 1H), 1.85 (m, 1H), 0.95 (d, J = 7.0 
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Hz, 3H), 0.86 (d, J = 7.0 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 137.8, 127.8 (2C), 127.1 (2C), 
127.0, 98.0, 80.6, 72.3 (2C), 64.2, 55.3, 37.2, 34.5, 13.8, 9.7; ESI-MS HRMS calcd for 
C16H26NaO4 (M+Na)+: 305.1729, found 305.1701. 
 
1-(((2S,3S,4S)-3-(Methoxymethoxy)-2,4-dimethylhex-5-ynyloxy)methyl)-
benzene (108):  To a solution of alcohol 112 (0.167 g, 0.600 mmol) in CH2Cl2 
(4.0 mL) was added NMO (0.112 g, 0.950 mmol) followed by powdered 4 Å molecular sieves 
(0.297 g).  The mixture was allowed to stir at ambient temperature for 15 minutes, after which 
TPAP (0.011 g, 3.0 x 10-5 mol) was added in one portion.  The resulting reaction mixture was 
stirred for 2 h at ambient temperature and subsequently filtered through a plug of florisil which 
was washed with a solution of 4:1/hexanes:ethyl acetate.  The filtrate was concentrated in vacuo. 
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To a solution of diisopropylamine (0.110 mL, 0.780 mmol) in THF (2.0 mL) at 0 °C was 
added nBuLi (0.450 mL, 0.715 mmol, 1.6 M in hexanes) in a dropwise fashion.  The 
homogenous solution was allowed to stir at 0 °C for 10 minutes before it was cooled down to 
−78 °C.  To the reaction mixture was added TMSCHN2 (0.360 mL, 0.715 mmol, 2.0 M in Et2O) 
and the resulting solution was stirred at −78 °C for 0.5 h.  Subsequently, a solution of the crude 
residue in THF (3.2 mL) was then added and the resulting reaction mixture was allowed to warm 
to ambient temperature overnight.  The reaction was quenched with water, the layers separated 
and the aqueous extracted with Et2O (3x).  The combined organic extracts were washed with 
water (1x) and brine (1x), dried over Na2SO4, filtered and concentrated in vacuo.  The crude oil 
was purified by silica gel chromatography (24:1/hexanes:ethyl acetate) to provide 0.124 g (75% 
over two steps) of alkyne 108:  [α]D = +26.6 (c 1.1, CHCl3); IR (thin film) 3290, 2935, 1454, 
1364, 1150, 1091, 1034 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.36-7.27 (m, 5H), 4.88 (d, J = 6.8 
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Hz, 1 H), 4.81 (d, J = 6.8 Hz, 1H), 4.59 (d, J = 3.3 Hz, 2H), 3.66 (dd, J = 5.9, 4.3 Hz, 1H), 3.58 
(dd, J = 9.2, 6.7 Hz, 1H), 3.49 (dd, J = 9.1, 5.9 Hz, 1H), 3.48 (s, 3H), 2.83 (dqd, J = 9.5, 7.0, 2.5 
Hz, 1H), 2.18-2.08 (m, 2H), 1.23 (d, J = 7.1 Hz, 3H), 0.99 (d, J = 6.9 Hz, 3H); 13C NMR (75 
MHz, CDCl3): δ 138.3, 128.1 (2C), 127.4 (2C), 127.3, 98.0, 86.4, 81.8, 72.8, 72.7, 69.6, 55.8, 
35.9, 29.5, 17.7, 11.7; EI-MS m/z 231 (M−CH2OMe)+, 223, 193, 173, 161; HRMS calcd for 
C15H19O2 (M−CH2OMe)+: 231.1385, found 231.1390. 
 
General procedure for addition of alkyne 108 into aldehyde 99:  To a solution of alkyne 108 
(3.2 equivs.) in the designated solvent at −78 °C was added nBuLi (3.0 equivs.) and the resulting 
reaction mixture allowed to stir at −78 °C for 30 minutes.  The lithium alkynylide solution was 
then transferred via cannula into a −78 °C solution of either LiBr or MgBr2⋅OEt2 (3.2 equivs.) in 
the designated solvent and the resulting reaction mixture stirred at −78 °C for 1 hour.  
Subsequently, a precooled (−78 °C) solution of aldehyde 99 (1 equiv.) in the designated solvent 
was cannulated into the reaction mixture and the resulting reaction mixture allowed to stir an 
additional 0.5 h at −78 °C.  Quenched the reaction by addition of saturated aqueous NH4Cl and 
separated the layers.  Extracted the aqueous with EtOAc (3x) then dried the combined organic 
extracts over Na2SO4, filtered and concentrated in vacuo.  Excess alkyne 108 was recovered by 
silica gel chromatography (4:1/hexanes:ethyl acetate) and the two diastereomeric alkyne addition 
products were collected and combined.  The diastereomeric ratio was determined by HPLC 
analysis (column Zorbax, eluent 5.0:95.0/iPrOH:hexanes, flow rate 1mL/min; Tr: 7.010 min 
(113, desired), 11.622 min (undesired)). 
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((2S,3R,4S)-3-(Methoxymethoxy)-2,4-dimethylhex-5-ynyloxy)tert-
butyldimethylsilane (116):  To a 0 °C solution of alcohol 103 (3.78 g, 
11.8 mmol) in CH2Cl2 (95 mL) was added sequentially iPr2NEt (41.3 mL, 0.237 mol), TBAI 
(0.437 g, 1.18 mmol) and MOMCl (9.00 mL, 0.118 mol).  The reaction mixture was covered 
from light and stirred for 18 hours at ambient temperature.  Quenched the reaction mixture by 
addition of saturated aqueous NaHCO3, separated the layers and washed the organic layer with 
1.0 M aqueous NaHSO4.  The combined aqueous layers were extracted with ether (3x) and the 
combined organic extracts were washed with brine (1x), dried over Na2SO4, filtered and 
concentrated in vacuo.      
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To a −78 °C solution of the crude oil in THF (116 mL) was added iBu2AlH (17.8 mL, 17.8 
mmol, 1.0 M in hexanes) in a slow, dropwise fashion.  The resulting solution was maintained at 
−78 °C for 2 h after which saturated aqueous Rochelle’s salts (60 mL) was added.  The biphasic 
mixture was allowed to warm to ambient temperature and stirred vigorously for 1 h.  The layers 
were separated and the aqueous layer extracted with ether (3x).  The combined organic extracts 
were washed with brine (1x), dried over Na2SO4, filtered and concentrated in vacuo.  
 To a solution of diisopropylamine (2.20 mL, 15.4 mmol) in THF (39 mL) at 0 °C was 
added nBuLi (8.90 mL, 14.2 mmol, 1.6 M in hexanes) in a dropwise fashion.  The homogenous 
solution was allowed to stir at 0 °C for 10 mins. before it was cooled down to −78 °C.  To the 
reaction mixture was then added TMSCHN2 (7.10 mL, 14.2 mmol, 2.0 M in Et2O) and the 
resulting solution was stirred at −78 °C for 0.5h.  Subsequently, a solution of the crude residue in 
THF (64 mL) was then added and the resulting reaction mixture was allowed to warm to ambient 
temperature overnight.  The reaction was quenched with water, the layers were separated and the 
aqueous extracted with Et2O (3x).  The combined organic extracts were washed with water (1x) 
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and brine (1x), dried over Na2SO4, filtered and concentrated in vacuo.  The crude oil was 
purified by silica gel chromatography (30:1/hexanes:ethyl acetate) to provide 2.53 g (71% over 3 
steps) of alkyne 116:  [α]D = −32.0 (c 0.8, CHCl3); IR (thin film) 3312, 2955, 2929, 2884, 2857, 
1471, 1090, 1034 cm-1; 1H NMR (300 MHz, CDCl3): δ 4.79 (d, J = 6.5 Hz, 1 H), 4.73 (d, J = 6.5 
Hz, 1H), 3.79 (dd, J = 9.8, 4.5 Hz, 1H), 3.57 (dd, J = 9.8, 6.7 Hz, 1H), 3.48 (app t, J = 5.6 Hz, 
1H), 3.43 (s, 3H), 2.82-2.74 (m, 1H), 2.09 (d, J = 2.5 Hz, 1H), 2.01 (dp, J = 13.5, 6.8 Hz, 1H), 
1.22 (d, J = 7.0 Hz, 3H), 0.98 (d, J = 6.9 Hz, 3H), 0.91 (s, 9H), 0.05 (s, 6H); 13C NMR (75 MHz, 
CDCl3): δ 98.2, 87.4, 83.1, 70.0, 64.9, 56.3, 38.8, 29.0, 26.2 (3C), 18.5, 16.5, 14.7, 5.2 (2C); EI-
MS m/z 269 (M−OMe)+, 255, 247, 213, 201, 145; HRMS calcd for C15H29O2Si (M−OMe)+: 
269.1937, found 269.1954. 
 
((3S,4R,5S)-5-((tert-Butyldimethylsilyloxy)methyl)-4-(methoxy-
methoxy)-3-methylhex-1-ynyl)trimethylsilane (117):  To a 
solution of alkyne 116 (1.02 g, 3.39 mmol) in THF (5.1 mL) at −78 °C was added nBuLi (2.40 
mL, 3.73 mmol, 1.6 M in hexanes) in a dropwise fashion.  The reaction mixture was stirred at 
−78 °C for 1 h.  Freshly distilled TMSCl (0.52 mL, 4.07 mmol) was then added and the reaction 
mixture was warmed to ambient temperature and stirred for 2 hours.  The reaction was quenched 
by the addition of water, the layers were separated and the aqueous extracted with ether (3x).  
The combined organic extracts were washed with brine (1x), dried over Na2SO4, filtered and 
concentrated in vacuo.  The crude oil was purified by silica gel chromatography 
(30:1/hexanes:ethyl acetate) to provide 1.00 g (80%) of alkyne 117:  [α]D = −33.8 (c 0.7, CHCl3); 
IR (thin film) 2957, 2929, 2885, 2857, 2167, 1471, 1250, 1090, 1034 cm-1; 1H NMR (300 MHz, 
CDCl3): δ 4.80 (d, J = 6.5 Hz, 1 H), 4.71 (d, J = 6.5 Hz, 1H), 3.81 (dd, J = 9.8, 4.6 Hz, 1H), 3.54 
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(dd, J = 9.7, 7.0 Hz, 1H), 3.49-3.42 (m, 4H), 2.76 (dq, J = 13.7, 6.9 Hz, 1H), 2.05-1.92 (m, 1H), 
1.20 (d, J = 6.9 Hz, 3H), 0.96 (d, J = 6.9 Hz, 3H), 0.91 (s, 9H), 0.15 (s, 9H), 0.06 (s, 6H); 13C 
NMR (75 MHz, CDCl3): δ 110.1, 98.1, 85.6, 82.9, 64.8, 56.2, 38.7, 29.7, 25.9 (3C), 18.3, 16.2, 
14.3, 0.06 (3C), −5.4 (2C); EI-MS m/z 341 (M−OMe)+, 315, 295, 283, 247, 201; HRMS calcd 
for C15H31O3Si2 (M−tBu)+: 315.1812, found 315.1814. 
 
(3R,4S,5S)-Tetrahydro-4-tert-butyldimethylsilyloxy-3,5-dimethylpyran-2-
one (121):  To a −78 ºC solution of amide 88 (1.06 g, 2.44 mmol) in MeOH (25 
mL) was added conc. HCl (3.0 mL) in a dropwise fashion.  The reaction mixture 
was warmed to 0 ºC and stirred for 2 hours.  After that time, the reaction mixture was slowly 
quenched with saturated aqueous NaHCO3.  The layers were separated and the aqueous extracted 
with CH2Cl2 (3x).  The combined organic extracts were dried over Na2SO4, filtered and 
concentrated in vacuo.  The crude oil was purified by silica gel chromatography 
(9:1/hexanes:ethyl acetate) to provide 0.530 g (84%) of δ-lactone 121: 1H NMR (300 MHz, 
CDCl3): δ 4.26 (app t, J = 10.8 Hz, 1H), 4.13 (dd, J = 10.9, 4.9 Hz, 1H), 3.70 (app t, J = 3.0 Hz, 
1H), 2.63 (qd, J = 7.6, 3.8 Hz, 1H), 2.20 (dqdd, J = 9.4, 6.8, 4.8, 2.5 Hz, 1H), 1.31 (d, J = 7.6 Hz, 
3H), 0.98 (d, J = 6.8 Hz, 3H), 0.91 (s, 9H), 0.10 (s, 3H), 0.08 (s, 3H); 13C NMR (75 MHz, 
CDCl3): δ 172.4, 72.6, 69.2, 42.8, 29.5, 24.9 (3C), 17.1, 15.2, 11.1, −5.5, −5.6. 
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(2R,3S,4R)-4-Formyl-3-tert-butyldimethylsilyloxy-N-methoxy-N,2-
dimethylpentanamide (123):  To a solution of lactone 121 (0.100 g, 
0.390 mmol) in THF (1.3 mL) at ambient temperature was added (MeO)NHMe·HCl (0.059 g, 
0.600 mmol) in one portion.  Cooled the resulting heterogeneous mixture to −15 ºC and added a 
CHO
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solution of iPrMgCl (0.580 mL, 1.16 mmol, 2.0 M in THF) in a slow, dropwise fashion.  After 
complete addition, the reaction mixture was stirred an additional 1.5 h at −15 ºC before being 
diluted with ether and quenched with a solution of H2O (1 mL) and saturated aqueous NH4Cl (1 
mL).  Warmed the biphasic mixture to ambient temperature and stirred until all the salts 
dissolved.  The layers were then separated and the aqueous extracted with Et2O (3x).  The 
combined organic extracts were washed with brine (1x), dried over Na2SO4, filtered and 
concentrated in vacuo. 
 To a solution of crude residue in CH2Cl2 (0.4 mL) at 0 ºC was added TEA (0.22 mL) 
followed by DMSO (0.8 mL).  Subsequently added SO3·pyr (0.185 g, 1.16 mmol) in one portion 
and stirred at 0 ºC for 1.5 h.  Diluted the reaction mixture with ether and then quenched by 
dropwise addition of 1.0 M aqueous NaHSO4 (1.4 mL) and H2O (0.4 mL) afterwards stirring the 
resulting biphasic mixture at 0 ºC for 15 minutes.  The layers were separated and the aqueous 
layer extracted with ether (3x).  The combined organic extracts were washed with a solution of 
saturated aqueous NaHCO3 (2 mL) and H2O (2 mL), dried over Na2SO4, filtered and 
concentrated in vacuo.  The crude oil was purified by silica gel chromatography 
(6:1/hexanes:ethyl acetate) to provide 0.097 g (79% over 2 steps) of aldehyde 123:  m.p. 41-43 
ºC; [α]D = −64.2 (c 0.7, CHCl3); IR (thin film) 2936, 2885, 2857, 1723, 1655, 1462, 1256, 1101, 
1077, 1044 cm-1; 1H NMR (300 MHz, CDCl3): δ 9.72 (d, J = 1.6 Hz, 1H), 4.26 (dd, J = 9.0, 2.6 
Hz, 1H), 3.72 (s, 3H), 3.20-3.14 (m, 1H), 3.14 (s, 3H), 2.53-2.45 (m, 1H), 1.20 (d, J = 6.9 Hz, 
3H), 1.14 (d, J = 7.0 Hz, 3H), 0.91 (s, 9H), 0.13 (s, 3H), 0.12 (s, 3H); 13C NMR (75 MHz, 
CDCl3): δ 201.4, 174.6, 74.2, 60.7, 51.3, 38.6, 31.2, 25.2 (3C), 17.4, 14.4, 9.2, −4.9, −5.0; ESI-
MS HRMS calcd for C15H31NNaO4Si (M+Na)+: 340.1920, found 340.1933. 
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(2R,3S,4S)-3-tert-Butyldimethylsilyloxy-N-methoxy-N,2,4-trimethy-
lhex-5-ynamide (124):  To a solution of aldehyde 123 (1.50 g, 4.74 
mmol) and Ohira’s reagent (2.00 g, 10.4 mmol) in iPrOH (66 mL) at 0 ºC was added Cs2CO3 
(4.63 g, 14.2 mmol) in one portion.  The resulting mixture was stirred at 0 ºC for 1 hour then 
warmed to ambient temperature and stirred an additional 11 hours.  Subsequently cooled the 
reaction mixture to 0 ºC and quenched by addition of H2O.  The layers were separated and the 
aqueous layer extracted with EtOAc (3x).  The combined organic extracts were dried over 
Na2SO4, filtered and concentrated in vacuo.  The crude oil was purified by silica gel 
chromatography (8:1/hexanes:ethyl acetate) to provide 1.46 g (97%) of alkyne 124:  [α]D = −29.7 
(c 1.0, CHCl3); IR (thin film) 3310, 3250, 2936, 2894, 2856, 1655, 1461, 1254, 1074 cm-1; 1H 
NMR (300 MHz, CDCl3): δ 3.93 (dd, J = 8.8, 2.4 Hz, 1H), 3.77 (s, 3H), 3.30-3.20 (m, 1H), 3.18 
(s, 3H), 2.62 (qdd, J = 7.1, 6.5, 2.6 Hz, 1H), 2.04 (d, J = 2.5 Hz, 1H), 1.24 (d, J = 7.1 Hz, 3H), 
1.17 (d, J = 7.0 Hz, 3H), 0.95 (s, 9H), 0.11 (s, 6H); 13C NMR (75 MHz, CDCl3): δ 176.1, 85.3, 
74.9, 70.0, 61.0, 39.5, 31.7, 31.3, 25.6 (3C), 17.9, 17.4, 14.8, −3.9, −4.4; mass spectroscopy data 
pending. 
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(2R,3S,4S)-3-tert-Butyldimethylsilyloxy-2,4-dimethylhex-5-ynal (125): 
To a −78 °C solution of amide 124 (0.314 g, 1.00 mmol) in THF (7.4 mL) 
was added iBu2AlH (1.40 mL, 1.40 mmol, 1.0 M in hexanes) in a slow, dropwise fashion.  The 
resulting solution was maintained at −78 °C for 2 h after which saturated aqueous Rochelle’s 
salts was added.  The biphasic mixture was allowed to warm to ambient temperature and stirred 
vigorously for 1 h.  The layers were separated and the aqueous layer extracted with ether (3x).  
The combined organics were dried over Na2SO4, filtered and concentrated in vacuo.  The crude 
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oil was purified by silica gel chromatography (50:1/hexanes:ethyl acetate) to provide 0.201 g 
(79%) of aldehyde 125: [α]D = −48.8 (c 0.7, CHCl3); IR (thin film) 3311, 2955, 2931, 1724, 
1472, 1254, 1089, 1045 cm-1; 1H NMR (300 MHz, CDCl3): δ 9.90 (d, J = 1.0 Hz, 1H), 4.10 (app 
t, J = 4.6 Hz, 1H), 2.75-2.60 (m, 2H), 2.11 (d, J = 2.5 Hz, 1H), 1.23 (d, J = 7.1 Hz, 3H), 1.14 (d, 
J = 7.1 Hz, 3H), 0.91 (s, 9H), 0.12 (s, 3H), 0.07 (s, 3H); 13C NMR (75 MHz, CDCl3): δ 203.7, 
85.4, 73.6, 71.7, 50.4, 31.0, 25.7 (3C), 18.1, 16.9, 9.4, −4.4, −4.5; mass spectroscopy data 
pending. 
  
((Z,3S,4R,5S)-7-iodo-3,5-dimethyloct-6-en-1-yn-4-yloxy)tert-butyldi-
methylsilane (84):  A suspension of ethyltriphenylphosphonium iodide 
(0.594 g, 1.42 mmol) in THF (6.0 mL) at ambient temperature was treated dropwise with 
NaHMDS (1.50 mL, 1.50 mmol, 1.0 M in THF).  The reaction mixture immediately turned 
orange.  The resulting mixture was stirred at ambient temperature for 0.5 h before being added 
over a 1 h time period to a solution of iodine (0.360 g, 1.42 mmol) in THF (12 mL) at −78 °C.  
The resulting phosphonium salt 126 precipitated as a brown solid.  After stirring the suspension 
at −78 °C for 15 minutes, NaHMDS (1.40 mL, 1.42 mmol, 1.0 M in THF) was added in a 
dropwise fashion and the reaction mixture gradually cleared and became red.  The homogenous 
solution was stirred at −78 °C for 0.5 h after which a precooled (−78 °C ) solution of aldehyde 
125 (0.201 g, 0.790 mmol) in THF (2.0 mL) was added.  The resulting reaction mixture was 
stirred at −78 °C for 1.5 h before it was warmed to −20 °C and quenched with saturated aqueous 
NH4Cl (65 μL).  The beige suspension was partially concentrated to 18 mL of distillate then diluted 
with pentane (6 mL).  The mixture was partially concentrated again to 6 mL, then filtered and the 
filtercake washed with pentanes.  Concentrated the filtrate in vacuo and purified the residue via 
Me
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column chromatography (100:1/hexanes:ethyl acetate) to yield 65 mg (21%) of iodide 84 as an 
inseparable mixture of olefin isomers. Diastereomeric ratio determined by crude 1H NMR (300 
MHz): 90.9% (δ 3.62 ppm) : 9.1 % (δ 3.41 ppm) / (Z)-vinyl iodide 84 (title compound) : (E)-
vinyl iodide.  Characterization data for (Z)-vinyl iodide 84 (title compound): [α]D = +39.1 (c 1.0, 
CHCl3); IR (thin film) 3310, 2956, 2929, 2856, 1471, 1252, 1025 cm-1; 1H NMR (300 MHz, 
CDCl3): δ 5.42 (dd, J = 8.8, 1.4 Hz, 1H), 3.62 (app t, J = 5.6 Hz, 1H), 2.67-2.56 (m, 2H), 2.48 (d, 
J = 1.3 Hz, 3H), 2.08 (d, J = 2.6 Hz, 1H), 1.22 (d, J = 7.1 Hz, 3H), 0.99 (d, J = 6.7 Hz, 3H), 0.93 
(s, 9H), 0.10 (s, 3H), 0.06 (s, 3H); 13C NMR (75 MHz, CDCl3): δ 138.9, 99.4, 87.0, 70.3, 45.1, 
33.6, 31.7, 30.3, 26.0 (3C), 18.3, 17.0, 14.9, −3.9, −4.0; mass spectroscopy data pending. 
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